GSE58827: Dynamics of the Mouse Liver
Gene Symbol | Gene ID | Gene Info |
---|---|---|
Spi1
|
ENSMUSG00000002111.8 | spleen focus forming virus (SFFV) proviral integration oncogene |
Gene | Promoter | Pearson corr. coef. | P-value | Plot |
---|---|---|---|---|
Spi1 | mm10_v2_chr2_+_91082362_91082390 | 0.83 | 2.9e-10 | Click! |
Promoter | Log-likelihood | Transcript | Gene | Gene Info |
---|---|---|---|---|
chr11_+_87793722 | 26.67 |
ENSMUST00000143021.2
|
Mpo
|
myeloperoxidase |
chr3_+_103832562 | 22.10 |
ENSMUST00000062945.5
|
Bcl2l15
|
BCLl2-like 15 |
chr11_+_87793470 | 21.52 |
ENSMUST00000020779.4
|
Mpo
|
myeloperoxidase |
chr7_-_127137807 | 20.18 |
ENSMUST00000049931.5
|
Spn
|
sialophorin |
chrX_-_7964166 | 20.14 |
ENSMUST00000128449.1
|
Gata1
|
GATA binding protein 1 |
chr3_-_90695706 | 20.11 |
ENSMUST00000069960.5
ENSMUST00000117167.1 |
S100a9
|
S100 calcium binding protein A9 (calgranulin B) |
chr7_-_142661858 | 19.78 |
ENSMUST00000145896.2
|
Igf2
|
insulin-like growth factor 2 |
chr8_+_72761868 | 16.33 |
ENSMUST00000058099.8
|
F2rl3
|
coagulation factor II (thrombin) receptor-like 3 |
chr2_+_84980458 | 15.57 |
ENSMUST00000028467.5
|
Prg2
|
proteoglycan 2, bone marrow |
chr6_-_40585783 | 15.11 |
ENSMUST00000177178.1
ENSMUST00000129948.2 ENSMUST00000101491.4 |
Clec5a
|
C-type lectin domain family 5, member a |
chr13_-_37049203 | 14.85 |
ENSMUST00000037491.8
|
F13a1
|
coagulation factor XIII, A1 subunit |
chr5_+_90490714 | 14.84 |
ENSMUST00000042755.3
|
Afp
|
alpha fetoprotein |
chr8_-_85380964 | 14.81 |
ENSMUST00000122452.1
|
Mylk3
|
myosin light chain kinase 3 |
chr3_+_90669063 | 14.48 |
ENSMUST00000069927.8
|
S100a8
|
S100 calcium binding protein A8 (calgranulin A) |
chr15_+_78244781 | 14.33 |
ENSMUST00000096357.5
ENSMUST00000133618.1 |
Ncf4
|
neutrophil cytosolic factor 4 |
chr4_-_46404224 | 14.32 |
ENSMUST00000107764.2
|
Hemgn
|
hemogen |
chr14_-_56102458 | 14.09 |
ENSMUST00000015583.1
|
Ctsg
|
cathepsin G |
chr1_+_40515362 | 13.79 |
ENSMUST00000027237.5
|
Il18rap
|
interleukin 18 receptor accessory protein |
chr13_-_110357136 | 13.04 |
ENSMUST00000058806.5
|
Gapt
|
Grb2-binding adaptor, transmembrane |
chr10_+_127725392 | 12.82 |
ENSMUST00000026466.3
|
Tac2
|
tachykinin 2 |
chr19_-_11640828 | 12.75 |
ENSMUST00000112984.2
|
Ms4a3
|
membrane-spanning 4-domains, subfamily A, member 3 |
chr9_-_123968683 | 12.63 |
ENSMUST00000026911.4
|
Ccr1
|
chemokine (C-C motif) receptor 1 |
chr2_-_28084877 | 12.15 |
ENSMUST00000028179.8
ENSMUST00000117486.1 ENSMUST00000135472.1 |
Fcnb
|
ficolin B |
chr8_-_71723308 | 11.56 |
ENSMUST00000125092.1
|
Fcho1
|
FCH domain only 1 |
chr2_+_173022360 | 11.30 |
ENSMUST00000173997.1
|
Rbm38
|
RNA binding motif protein 38 |
chr16_+_32608973 | 10.91 |
ENSMUST00000120680.1
|
Tfrc
|
transferrin receptor |
chr4_-_118457450 | 10.85 |
ENSMUST00000106375.1
ENSMUST00000006556.3 ENSMUST00000168404.1 |
Mpl
|
myeloproliferative leukemia virus oncogene |
chr4_-_118457509 | 10.65 |
ENSMUST00000102671.3
|
Mpl
|
myeloproliferative leukemia virus oncogene |
chr14_+_80000292 | 10.60 |
ENSMUST00000088735.3
|
Olfm4
|
olfactomedin 4 |
chr7_-_17062384 | 10.08 |
ENSMUST00000153833.1
ENSMUST00000108492.2 |
Hif3a
|
hypoxia inducible factor 3, alpha subunit |
chr4_+_126556935 | 9.66 |
ENSMUST00000048391.8
|
Clspn
|
claspin |
chr10_+_79879614 | 9.56 |
ENSMUST00000006679.8
|
Prtn3
|
proteinase 3 |
chr2_+_173021902 | 9.50 |
ENSMUST00000029014.9
|
Rbm38
|
RNA binding motif protein 38 |
chr7_+_24370255 | 9.44 |
ENSMUST00000171904.1
|
Kcnn4
|
potassium intermediate/small conductance calcium-activated channel, subfamily N, member 4 |
chr5_-_107726017 | 9.42 |
ENSMUST00000159263.2
|
Gfi1
|
growth factor independent 1 |
chr12_-_32208609 | 9.41 |
ENSMUST00000053215.7
|
Pik3cg
|
phosphoinositide-3-kinase, catalytic, gamma polypeptide |
chr7_+_18884679 | 9.37 |
ENSMUST00000032573.6
|
Pglyrp1
|
peptidoglycan recognition protein 1 |
chr3_-_106167564 | 9.36 |
ENSMUST00000063062.8
|
Chi3l3
|
chitinase 3-like 3 |
chr1_+_135132693 | 9.31 |
ENSMUST00000049449.4
|
Ptpn7
|
protein tyrosine phosphatase, non-receptor type 7 |
chrX_-_102252154 | 9.17 |
ENSMUST00000050551.3
|
Cited1
|
Cbp/p300-interacting transactivator with Glu/Asp-rich carboxy-terminal domain 1 |
chr7_-_127218303 | 9.14 |
ENSMUST00000106313.1
|
Sept1
|
septin 1 |
chr4_+_126556994 | 9.09 |
ENSMUST00000147675.1
|
Clspn
|
claspin |
chr1_+_134182150 | 9.09 |
ENSMUST00000156873.1
|
Chi3l1
|
chitinase 3-like 1 |
chr13_-_37050237 | 9.08 |
ENSMUST00000164727.1
|
F13a1
|
coagulation factor XIII, A1 subunit |
chr16_-_42340595 | 9.03 |
ENSMUST00000102817.4
|
Gap43
|
growth associated protein 43 |
chr3_-_137981523 | 8.98 |
ENSMUST00000136613.1
ENSMUST00000029806.6 |
Dapp1
|
dual adaptor for phosphotyrosine and 3-phosphoinositides 1 |
chr11_-_102469839 | 8.95 |
ENSMUST00000103086.3
|
Itga2b
|
integrin alpha 2b |
chr3_+_103832741 | 8.89 |
ENSMUST00000106822.1
|
Bcl2l15
|
BCLl2-like 15 |
chr4_-_133872304 | 8.85 |
ENSMUST00000157067.2
|
Rps6ka1
|
ribosomal protein S6 kinase polypeptide 1 |
chr16_+_32608920 | 8.84 |
ENSMUST00000023486.8
|
Tfrc
|
transferrin receptor |
chr17_+_29114142 | 8.83 |
ENSMUST00000141797.1
ENSMUST00000132262.1 ENSMUST00000141239.1 ENSMUST00000138816.1 |
Gm16194
|
predicted gene 16194 |
chr9_+_8544196 | 8.80 |
ENSMUST00000050433.6
|
Trpc6
|
transient receptor potential cation channel, subfamily C, member 6 |
chr2_+_164940742 | 8.70 |
ENSMUST00000137626.1
|
Mmp9
|
matrix metallopeptidase 9 |
chr14_-_51057242 | 8.59 |
ENSMUST00000089798.2
|
Rnase12
|
ribonuclease, RNase A family, 12 (non-active) |
chr7_-_100856289 | 8.45 |
ENSMUST00000139604.1
|
Relt
|
RELT tumor necrosis factor receptor |
chr6_+_124830217 | 8.44 |
ENSMUST00000131847.1
ENSMUST00000151674.1 |
Cdca3
|
cell division cycle associated 3 |
chrX_-_102251852 | 8.30 |
ENSMUST00000101336.3
ENSMUST00000136277.1 |
Cited1
|
Cbp/p300-interacting transactivator with Glu/Asp-rich carboxy-terminal domain 1 |
chr11_+_32276400 | 8.20 |
ENSMUST00000020531.2
|
Hba-x
|
hemoglobin X, alpha-like embryonic chain in Hba complex |
chr14_+_27000362 | 8.09 |
ENSMUST00000035433.8
|
Hesx1
|
homeobox gene expressed in ES cells |
chr14_-_87141206 | 8.08 |
ENSMUST00000022599.7
|
Diap3
|
diaphanous homolog 3 (Drosophila) |
chr11_+_32286946 | 8.08 |
ENSMUST00000101387.3
|
Hbq1b
|
hemoglobin, theta 1B |
chr4_-_118620763 | 8.04 |
ENSMUST00000071972.4
|
Wdr65
|
WD repeat domain 65 |
chr10_+_79886302 | 8.03 |
ENSMUST00000046091.5
|
Elane
|
elastase, neutrophil expressed |
chr15_+_84324716 | 8.02 |
ENSMUST00000023074.2
|
Parvg
|
parvin, gamma |
chr7_-_127218390 | 7.91 |
ENSMUST00000142356.1
ENSMUST00000106314.1 |
Sept1
|
septin 1 |
chr2_-_26360873 | 7.86 |
ENSMUST00000028294.6
|
Card9
|
caspase recruitment domain family, member 9 |
chr12_-_32208470 | 7.83 |
ENSMUST00000085469.5
|
Pik3cg
|
phosphoinositide-3-kinase, catalytic, gamma polypeptide |
chr11_+_11685909 | 7.81 |
ENSMUST00000065433.5
|
Ikzf1
|
IKAROS family zinc finger 1 |
chr14_-_79301623 | 7.80 |
ENSMUST00000022595.7
|
Rgcc
|
regulator of cell cycle |
chr9_-_109849440 | 7.75 |
ENSMUST00000112022.2
|
Camp
|
cathelicidin antimicrobial peptide |
chr7_-_100855403 | 7.71 |
ENSMUST00000156855.1
|
Relt
|
RELT tumor necrosis factor receptor |
chr6_+_60944472 | 7.71 |
ENSMUST00000129603.1
|
Mmrn1
|
multimerin 1 |
chr12_+_109734969 | 7.70 |
ENSMUST00000182268.1
ENSMUST00000181543.2 ENSMUST00000183116.1 |
Mirg
|
miRNA containing gene |
chr19_+_10015016 | 7.62 |
ENSMUST00000137637.1
ENSMUST00000149967.1 |
Rab3il1
|
RAB3A interacting protein (rabin3)-like 1 |
chr9_+_56089962 | 7.41 |
ENSMUST00000059206.7
|
Pstpip1
|
proline-serine-threonine phosphatase-interacting protein 1 |
chr7_-_45239108 | 7.40 |
ENSMUST00000033063.6
|
Cd37
|
CD37 antigen |
chr4_+_34893772 | 7.39 |
ENSMUST00000029975.3
ENSMUST00000135871.1 ENSMUST00000108130.1 |
Cga
|
glycoprotein hormones, alpha subunit |
chr3_-_109027600 | 7.31 |
ENSMUST00000171143.1
|
Fam102b
|
family with sequence similarity 102, member B |
chr17_+_34590162 | 7.30 |
ENSMUST00000173772.1
|
Gpsm3
|
G-protein signalling modulator 3 (AGS3-like, C. elegans) |
chr2_+_84988194 | 7.29 |
ENSMUST00000028466.5
|
Prg3
|
proteoglycan 3 |
chr9_+_65587149 | 7.29 |
ENSMUST00000134538.1
ENSMUST00000136205.1 |
Pif1
|
PIF1 5'-to-3' DNA helicase homolog (S. cerevisiae) |
chr2_-_126491566 | 7.27 |
ENSMUST00000040149.6
|
Atp8b4
|
ATPase, class I, type 8B, member 4 |
chr2_-_26021679 | 7.26 |
ENSMUST00000036509.7
|
Ubac1
|
ubiquitin associated domain containing 1 |
chr12_-_78906929 | 7.08 |
ENSMUST00000021544.7
|
Plek2
|
pleckstrin 2 |
chr19_-_17356631 | 7.05 |
ENSMUST00000174236.1
|
Gcnt1
|
glucosaminyl (N-acetyl) transferase 1, core 2 |
chr7_-_45239041 | 6.88 |
ENSMUST00000131290.1
|
Cd37
|
CD37 antigen |
chr16_+_17980565 | 6.84 |
ENSMUST00000075371.3
|
Vpreb2
|
pre-B lymphocyte gene 2 |
chr1_-_45503282 | 6.71 |
ENSMUST00000086430.4
|
Col5a2
|
collagen, type V, alpha 2 |
chr14_+_53763083 | 6.70 |
ENSMUST00000180859.1
ENSMUST00000103589.4 |
Trav14-3
|
T cell receptor alpha variable 14-3 |
chr15_-_66969616 | 6.68 |
ENSMUST00000170903.1
ENSMUST00000166420.1 ENSMUST00000005256.6 ENSMUST00000164070.1 |
Ndrg1
|
N-myc downstream regulated gene 1 |
chr2_-_26021532 | 6.68 |
ENSMUST00000136750.1
|
Ubac1
|
ubiquitin associated domain containing 1 |
chr17_+_48454891 | 6.67 |
ENSMUST00000074574.6
|
Unc5cl
|
unc-5 homolog C (C. elegans)-like |
chr5_+_115845229 | 6.67 |
ENSMUST00000137952.1
ENSMUST00000148245.1 |
Cit
|
citron |
chr7_-_141016892 | 6.61 |
ENSMUST00000081924.3
|
Ifitm6
|
interferon induced transmembrane protein 6 |
chr14_+_55765956 | 6.57 |
ENSMUST00000057569.3
|
Ltb4r1
|
leukotriene B4 receptor 1 |
chr1_+_134182404 | 6.52 |
ENSMUST00000153856.1
ENSMUST00000082060.3 ENSMUST00000133701.1 ENSMUST00000132873.1 |
Chi3l1
|
chitinase 3-like 1 |
chr2_+_127336152 | 6.50 |
ENSMUST00000028846.6
|
Dusp2
|
dual specificity phosphatase 2 |
chr15_-_55090422 | 6.49 |
ENSMUST00000110231.1
ENSMUST00000023059.6 |
Dscc1
|
defective in sister chromatid cohesion 1 homolog (S. cerevisiae) |
chr16_-_75909272 | 6.48 |
ENSMUST00000114239.2
|
Samsn1
|
SAM domain, SH3 domain and nuclear localization signals, 1 |
chr17_-_48146306 | 6.47 |
ENSMUST00000063481.7
|
9830107B12Rik
|
RIKEN cDNA 9830107B12 gene |
chr7_+_142460809 | 6.43 |
ENSMUST00000105968.1
|
Lsp1
|
lymphocyte specific 1 |
chr7_-_100863373 | 6.42 |
ENSMUST00000142885.1
ENSMUST00000008462.3 |
Relt
|
RELT tumor necrosis factor receptor |
chr1_+_136467958 | 6.42 |
ENSMUST00000047817.6
|
Kif14
|
kinesin family member 14 |
chr2_+_103969528 | 6.34 |
ENSMUST00000123437.1
ENSMUST00000163256.1 |
Lmo2
|
LIM domain only 2 |
chr7_+_142460834 | 6.31 |
ENSMUST00000018963.4
ENSMUST00000105967.1 |
Lsp1
|
lymphocyte specific 1 |
chr11_+_70130329 | 6.27 |
ENSMUST00000041550.5
ENSMUST00000165951.1 |
Mgl2
|
macrophage galactose N-acetyl-galactosamine specific lectin 2 |
chr11_+_115899943 | 6.27 |
ENSMUST00000152171.1
|
Smim5
|
small integral membrane protein 5 |
chr8_+_84901928 | 6.21 |
ENSMUST00000067060.7
|
Klf1
|
Kruppel-like factor 1 (erythroid) |
chr2_+_22774081 | 6.18 |
ENSMUST00000014290.8
|
Apbb1ip
|
amyloid beta (A4) precursor protein-binding, family B, member 1 interacting protein |
chr1_-_132367879 | 6.18 |
ENSMUST00000142609.1
|
Tmcc2
|
transmembrane and coiled-coil domains 2 |
chr2_+_84840612 | 6.17 |
ENSMUST00000111625.1
|
Slc43a1
|
solute carrier family 43, member 1 |
chr17_+_33555719 | 6.16 |
ENSMUST00000087605.5
ENSMUST00000174695.1 |
Myo1f
|
myosin IF |
chr3_+_96670131 | 6.15 |
ENSMUST00000048427.5
|
Ankrd35
|
ankyrin repeat domain 35 |
chr11_-_59163281 | 6.11 |
ENSMUST00000069631.2
|
Iba57
|
IBA57, iron-sulfur cluster assembly homolog (S. cerevisiae) |
chr2_+_118111876 | 6.08 |
ENSMUST00000039559.8
|
Thbs1
|
thrombospondin 1 |
chrX_-_53240101 | 6.07 |
ENSMUST00000074861.2
|
Plac1
|
placental specific protein 1 |
chr11_+_115900125 | 6.06 |
ENSMUST00000142089.1
ENSMUST00000131566.1 |
Smim5
|
small integral membrane protein 5 |
chr5_-_73191848 | 6.04 |
ENSMUST00000176910.1
|
Fryl
|
furry homolog-like (Drosophila) |
chr11_-_6520894 | 6.00 |
ENSMUST00000003459.3
|
Myo1g
|
myosin IG |
chr11_+_61126747 | 5.98 |
ENSMUST00000010286.1
ENSMUST00000146033.1 ENSMUST00000139422.1 |
Tnfrsf13b
|
tumor necrosis factor receptor superfamily, member 13b |
chr11_-_102925086 | 5.95 |
ENSMUST00000021311.9
|
Kif18b
|
kinesin family member 18B |
chr3_-_20242173 | 5.94 |
ENSMUST00000001921.1
|
Cpa3
|
carboxypeptidase A3, mast cell |
chr9_+_65587187 | 5.91 |
ENSMUST00000047099.5
ENSMUST00000131483.1 ENSMUST00000141046.1 |
Pif1
|
PIF1 5'-to-3' DNA helicase homolog (S. cerevisiae) |
chr16_-_17144415 | 5.91 |
ENSMUST00000115709.1
|
Ccdc116
|
coiled-coil domain containing 116 |
chr11_-_115133981 | 5.88 |
ENSMUST00000106561.1
ENSMUST00000051264.7 ENSMUST00000106562.2 |
Cd300lf
|
CD300 antigen like family member F |
chr17_+_47505117 | 5.85 |
ENSMUST00000183044.1
ENSMUST00000037333.10 |
Ccnd3
|
cyclin D3 |
chr16_+_33794345 | 5.84 |
ENSMUST00000023520.6
|
Muc13
|
mucin 13, epithelial transmembrane |
chr16_+_33794008 | 5.82 |
ENSMUST00000115044.1
|
Muc13
|
mucin 13, epithelial transmembrane |
chr8_+_105297663 | 5.78 |
ENSMUST00000015003.8
|
E2f4
|
E2F transcription factor 4 |
chr14_-_55788810 | 5.74 |
ENSMUST00000022830.6
ENSMUST00000168716.1 ENSMUST00000178399.1 |
Ripk3
|
receptor-interacting serine-threonine kinase 3 |
chr2_-_181693810 | 5.72 |
ENSMUST00000108776.1
ENSMUST00000108771.1 ENSMUST00000108779.1 ENSMUST00000108769.1 ENSMUST00000108772.1 ENSMUST00000002532.2 |
Rgs19
|
regulator of G-protein signaling 19 |
chr15_+_66670749 | 5.64 |
ENSMUST00000065916.7
|
Tg
|
thyroglobulin |
chr17_+_34589799 | 5.64 |
ENSMUST00000038244.8
|
Gpsm3
|
G-protein signalling modulator 3 (AGS3-like, C. elegans) |
chr7_-_121074501 | 5.64 |
ENSMUST00000047194.2
|
Igsf6
|
immunoglobulin superfamily, member 6 |
chr4_+_120666562 | 5.63 |
ENSMUST00000094814.4
|
Cited4
|
Cbp/p300-interacting transactivator, with Glu/Asp-rich carboxy-terminal domain, 4 |
chr15_-_66801577 | 5.62 |
ENSMUST00000168589.1
|
Sla
|
src-like adaptor |
chr17_+_47505149 | 5.59 |
ENSMUST00000183177.1
ENSMUST00000182848.1 |
Ccnd3
|
cyclin D3 |
chr2_+_25423234 | 5.58 |
ENSMUST00000134259.1
ENSMUST00000100320.4 |
Fut7
|
fucosyltransferase 7 |
chr1_-_169531343 | 5.55 |
ENSMUST00000028000.7
|
Nuf2
|
NUF2, NDC80 kinetochore complex component, homolog (S. cerevisiae) |
chr10_-_62327757 | 5.53 |
ENSMUST00000139228.1
|
Hk1
|
hexokinase 1 |
chr15_+_57985873 | 5.51 |
ENSMUST00000050374.2
|
Fam83a
|
family with sequence similarity 83, member A |
chr11_+_103171081 | 5.47 |
ENSMUST00000042286.5
|
Fmnl1
|
formin-like 1 |
chr6_-_123289862 | 5.46 |
ENSMUST00000032239.4
ENSMUST00000177367.1 |
Clec4e
|
C-type lectin domain family 4, member e |
chr6_-_136941694 | 5.41 |
ENSMUST00000032344.5
|
Arhgdib
|
Rho, GDP dissociation inhibitor (GDI) beta |
chr3_+_84666192 | 5.38 |
ENSMUST00000107682.1
|
Tmem154
|
transmembrane protein 154 |
chr8_+_57511833 | 5.38 |
ENSMUST00000067925.6
|
Hmgb2
|
high mobility group box 2 |
chr7_+_110773658 | 5.36 |
ENSMUST00000143786.1
|
Ampd3
|
adenosine monophosphate deaminase 3 |
chr1_+_87620306 | 5.33 |
ENSMUST00000169754.1
|
Inpp5d
|
inositol polyphosphate-5-phosphatase D |
chr1_+_130731963 | 5.32 |
ENSMUST00000039323.6
|
AA986860
|
expressed sequence AA986860 |
chr8_+_48110156 | 5.31 |
ENSMUST00000174379.1
|
Dctd
|
dCMP deaminase |
chr12_+_32378692 | 5.30 |
ENSMUST00000172332.2
|
Ccdc71l
|
coiled-coil domain containing 71 like |
chr6_+_87778084 | 5.28 |
ENSMUST00000032133.3
|
Gp9
|
glycoprotein 9 (platelet) |
chr17_+_47505211 | 5.27 |
ENSMUST00000182935.1
ENSMUST00000182506.1 |
Ccnd3
|
cyclin D3 |
chr12_-_4841583 | 5.25 |
ENSMUST00000020964.5
|
Fkbp1b
|
FK506 binding protein 1b |
chr3_-_129969989 | 5.22 |
ENSMUST00000146340.1
|
Ccdc109b
|
coiled-coil domain containing 109B |
chr2_-_156839790 | 5.21 |
ENSMUST00000134838.1
ENSMUST00000137463.1 ENSMUST00000149275.2 |
Gm14230
|
predicted gene 14230 |
chr18_-_41951187 | 5.20 |
ENSMUST00000070949.4
|
Prelid2
|
PRELI domain containing 2 |
chr19_+_4154606 | 5.20 |
ENSMUST00000061086.8
|
Ptprcap
|
protein tyrosine phosphatase, receptor type, C polypeptide-associated protein |
chr2_-_13491900 | 5.19 |
ENSMUST00000091436.5
|
Cubn
|
cubilin (intrinsic factor-cobalamin receptor) |
chr9_-_14381242 | 5.17 |
ENSMUST00000167549.1
|
Endod1
|
endonuclease domain containing 1 |
chr1_+_87620334 | 5.15 |
ENSMUST00000042275.8
ENSMUST00000168783.1 |
Inpp5d
|
inositol polyphosphate-5-phosphatase D |
chr19_-_7019423 | 5.11 |
ENSMUST00000040772.8
|
Fermt3
|
fermitin family homolog 3 (Drosophila) |
chr2_-_73486456 | 5.06 |
ENSMUST00000141264.1
|
Wipf1
|
WAS/WASL interacting protein family, member 1 |
chr11_-_69602741 | 5.06 |
ENSMUST00000138694.1
|
Atp1b2
|
ATPase, Na+/K+ transporting, beta 2 polypeptide |
chrX_-_49788204 | 5.05 |
ENSMUST00000114893.1
|
Igsf1
|
immunoglobulin superfamily, member 1 |
chr3_+_19644452 | 5.05 |
ENSMUST00000029139.7
|
Trim55
|
tripartite motif-containing 55 |
chr8_+_94977101 | 5.04 |
ENSMUST00000179619.1
|
Gpr56
|
G protein-coupled receptor 56 |
chr17_+_48247759 | 5.04 |
ENSMUST00000048065.5
|
Trem3
|
triggering receptor expressed on myeloid cells 3 |
chr8_+_48109949 | 5.03 |
ENSMUST00000170263.2
ENSMUST00000033966.6 |
Dctd
|
dCMP deaminase |
chr14_-_87141114 | 5.00 |
ENSMUST00000168889.1
|
Diap3
|
diaphanous homolog 3 (Drosophila) |
chr14_-_76556662 | 5.00 |
ENSMUST00000064517.7
|
Serp2
|
stress-associated endoplasmic reticulum protein family member 2 |
chr11_+_4236411 | 4.99 |
ENSMUST00000075221.2
|
Osm
|
oncostatin M |
chr7_+_100495987 | 4.95 |
ENSMUST00000133044.1
|
Ucp2
|
uncoupling protein 2 (mitochondrial, proton carrier) |
chr10_+_75564086 | 4.95 |
ENSMUST00000141062.1
ENSMUST00000152657.1 |
Ggt1
|
gamma-glutamyltransferase 1 |
chr14_-_69284982 | 4.93 |
ENSMUST00000183882.1
ENSMUST00000037064.4 |
Slc25a37
|
solute carrier family 25, member 37 |
chr11_+_117782076 | 4.87 |
ENSMUST00000127080.1
|
Tmc8
|
transmembrane channel-like gene family 8 |
chr2_-_118728345 | 4.87 |
ENSMUST00000159756.1
|
Plcb2
|
phospholipase C, beta 2 |
chr7_+_79660196 | 4.86 |
ENSMUST00000035977.7
|
Ticrr
|
TOPBP1-interacting checkpoint and replication regulator |
chr14_-_33185489 | 4.86 |
ENSMUST00000159606.1
|
Wdfy4
|
WD repeat and FYVE domain containing 4 |
chr1_-_144775419 | 4.85 |
ENSMUST00000027603.3
|
Rgs18
|
regulator of G-protein signaling 18 |
chr1_+_135133272 | 4.84 |
ENSMUST00000167080.1
|
Ptpn7
|
protein tyrosine phosphatase, non-receptor type 7 |
chr17_+_34605855 | 4.84 |
ENSMUST00000037489.8
|
Agpat1
|
1-acylglycerol-3-phosphate O-acyltransferase 1 (lysophosphatidic acid acyltransferase, alpha) |
chr17_-_32403551 | 4.84 |
ENSMUST00000135618.1
ENSMUST00000063824.7 |
Rasal3
|
RAS protein activator like 3 |
chr11_+_87760533 | 4.83 |
ENSMUST00000039627.5
ENSMUST00000100644.3 |
Bzrap1
|
benzodiazepine receptor associated protein 1 |
chr17_+_33638056 | 4.83 |
ENSMUST00000052079.7
|
Pram1
|
PML-RAR alpha-regulated adaptor molecule 1 |
chr3_+_95588960 | 4.82 |
ENSMUST00000176674.1
ENSMUST00000177389.1 ENSMUST00000176755.1 |
Golph3l
|
golgi phosphoprotein 3-like |
chr7_-_25615874 | 4.81 |
ENSMUST00000098663.1
|
Gm7092
|
predicted gene 7092 |
chr14_+_61309753 | 4.77 |
ENSMUST00000055159.7
|
Arl11
|
ADP-ribosylation factor-like 11 |
chr1_-_169531447 | 4.77 |
ENSMUST00000111368.1
|
Nuf2
|
NUF2, NDC80 kinetochore complex component, homolog (S. cerevisiae) |
chr18_+_61953048 | 4.76 |
ENSMUST00000051720.5
|
Sh3tc2
|
SH3 domain and tetratricopeptide repeats 2 |
chr11_+_11686213 | 4.75 |
ENSMUST00000076700.4
ENSMUST00000048122.6 |
Ikzf1
|
IKAROS family zinc finger 1 |
chr4_-_63403330 | 4.74 |
ENSMUST00000035724.4
|
Akna
|
AT-hook transcription factor |
chr9_-_111057235 | 4.72 |
ENSMUST00000111888.1
|
Ccrl2
|
chemokine (C-C motif) receptor-like 2 |
chr7_-_44748306 | 4.72 |
ENSMUST00000118162.1
ENSMUST00000140599.2 ENSMUST00000120798.1 |
Zfp473
|
zinc finger protein 473 |
chr3_+_95588990 | 4.71 |
ENSMUST00000177399.1
|
Golph3l
|
golgi phosphoprotein 3-like |
chr11_+_53519871 | 4.68 |
ENSMUST00000120878.2
|
Sept8
|
septin 8 |
chr15_-_78572754 | 4.66 |
ENSMUST00000043214.6
|
Rac2
|
RAS-related C3 botulinum substrate 2 |
chr15_+_85859689 | 4.65 |
ENSMUST00000170629.1
|
Gtse1
|
G two S phase expressed protein 1 |
chr4_-_43558386 | 4.65 |
ENSMUST00000130353.1
|
Tln1
|
talin 1 |
chr13_+_55369732 | 4.64 |
ENSMUST00000063771.7
|
Rgs14
|
regulator of G-protein signaling 14 |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
16.1 | 48.2 | GO:0002149 | hypochlorous acid metabolic process(GO:0002148) hypochlorous acid biosynthetic process(GO:0002149) |
11.5 | 34.6 | GO:0070488 | neutrophil aggregation(GO:0070488) |
6.7 | 20.2 | GO:0001807 | regulation of type IV hypersensitivity(GO:0001807) |
6.7 | 20.1 | GO:0035702 | monocyte homeostasis(GO:0035702) |
6.7 | 20.1 | GO:0030221 | basophil differentiation(GO:0030221) |
5.2 | 15.6 | GO:0002215 | defense response to nematode(GO:0002215) |
4.4 | 4.4 | GO:0032690 | negative regulation of interleukin-1 alpha production(GO:0032690) negative regulation of interleukin-1 alpha secretion(GO:0050712) |
4.3 | 17.0 | GO:0051311 | spindle assembly involved in female meiosis(GO:0007056) meiotic metaphase plate congression(GO:0051311) |
4.2 | 12.6 | GO:0045660 | positive regulation of neutrophil differentiation(GO:0045660) |
4.0 | 12.1 | GO:0070947 | neutrophil mediated killing of fungus(GO:0070947) |
3.7 | 14.9 | GO:0002752 | cell surface pattern recognition receptor signaling pathway(GO:0002752) |
3.7 | 11.0 | GO:0002277 | myeloid dendritic cell activation involved in immune response(GO:0002277) |
3.5 | 17.7 | GO:0071104 | response to interleukin-9(GO:0071104) |
3.4 | 10.3 | GO:0006226 | dUMP biosynthetic process(GO:0006226) |
3.1 | 9.4 | GO:0051710 | regulation of cytolysis in other organism(GO:0051710) positive regulation of cytolysis in other organism(GO:0051714) |
2.9 | 8.7 | GO:0071460 | cellular response to cell-matrix adhesion(GO:0071460) |
2.9 | 5.7 | GO:2000449 | regulation of CD8-positive, alpha-beta T cell extravasation(GO:2000449) |
2.7 | 13.7 | GO:2000473 | regulation of hematopoietic stem cell migration(GO:2000471) positive regulation of hematopoietic stem cell migration(GO:2000473) |
2.7 | 13.7 | GO:0007217 | tachykinin receptor signaling pathway(GO:0007217) |
2.7 | 19.1 | GO:0070942 | neutrophil mediated cytotoxicity(GO:0070942) neutrophil mediated killing of symbiont cell(GO:0070943) neutrophil mediated killing of bacterium(GO:0070944) |
2.6 | 7.8 | GO:0003331 | regulation of extracellular matrix constituent secretion(GO:0003330) positive regulation of extracellular matrix constituent secretion(GO:0003331) |
2.5 | 19.8 | GO:0038028 | insulin receptor signaling pathway via phosphatidylinositol 3-kinase(GO:0038028) |
2.5 | 14.8 | GO:0002528 | regulation of vascular permeability involved in acute inflammatory response(GO:0002528) |
2.5 | 12.3 | GO:0038094 | Fc-gamma receptor signaling pathway(GO:0038094) |
2.4 | 24.3 | GO:0030886 | negative regulation of myeloid dendritic cell activation(GO:0030886) |
2.4 | 2.4 | GO:0090004 | positive regulation of Golgi to plasma membrane protein transport(GO:0042998) positive regulation of establishment of protein localization to plasma membrane(GO:0090004) |
2.4 | 9.6 | GO:0097029 | mature conventional dendritic cell differentiation(GO:0097029) |
2.4 | 9.4 | GO:0070103 | regulation of interleukin-6-mediated signaling pathway(GO:0070103) |
2.4 | 16.5 | GO:0002322 | B cell proliferation involved in immune response(GO:0002322) |
2.3 | 9.2 | GO:0045658 | regulation of neutrophil differentiation(GO:0045658) |
2.2 | 6.6 | GO:0090076 | relaxation of skeletal muscle(GO:0090076) |
2.2 | 10.9 | GO:0038032 | termination of G-protein coupled receptor signaling pathway(GO:0038032) |
2.2 | 6.5 | GO:0035771 | interleukin-4-mediated signaling pathway(GO:0035771) |
2.1 | 6.4 | GO:0033624 | negative regulation of integrin activation(GO:0033624) |
2.1 | 23.5 | GO:0033314 | mitotic DNA replication checkpoint(GO:0033314) |
2.1 | 8.5 | GO:0045575 | basophil activation(GO:0045575) |
2.0 | 6.1 | GO:0010751 | negative regulation of nitric oxide mediated signal transduction(GO:0010751) |
2.0 | 28.0 | GO:0033572 | transferrin transport(GO:0033572) |
1.9 | 5.8 | GO:2000196 | positive regulation of female gonad development(GO:2000196) positive regulation of progesterone secretion(GO:2000872) |
1.9 | 13.5 | GO:0010897 | negative regulation of triglyceride catabolic process(GO:0010897) |
1.9 | 1.9 | GO:0042231 | interleukin-13 biosynthetic process(GO:0042231) |
1.9 | 13.2 | GO:0044806 | G-quadruplex DNA unwinding(GO:0044806) |
1.8 | 3.6 | GO:0071611 | macrophage colony-stimulating factor production(GO:0036301) granulocyte colony-stimulating factor production(GO:0071611) regulation of granulocyte colony-stimulating factor production(GO:0071655) regulation of macrophage colony-stimulating factor production(GO:1901256) |
1.8 | 5.4 | GO:0021570 | rhombomere 4 development(GO:0021570) |
1.7 | 22.2 | GO:0072378 | blood coagulation, fibrin clot formation(GO:0072378) |
1.7 | 5.0 | GO:0033082 | regulation of extrathymic T cell differentiation(GO:0033082) |
1.7 | 6.7 | GO:1903225 | negative regulation of endodermal cell differentiation(GO:1903225) |
1.7 | 6.7 | GO:0032696 | negative regulation of interleukin-13 production(GO:0032696) |
1.6 | 8.2 | GO:0051142 | regulation of NK T cell proliferation(GO:0051140) positive regulation of NK T cell proliferation(GO:0051142) |
1.6 | 3.2 | GO:0034241 | positive regulation of macrophage fusion(GO:0034241) |
1.6 | 14.4 | GO:0036371 | protein localization to M-band(GO:0036309) protein localization to T-tubule(GO:0036371) |
1.6 | 7.8 | GO:0042117 | monocyte activation(GO:0042117) |
1.5 | 11.8 | GO:0070294 | renal sodium ion absorption(GO:0070294) |
1.5 | 11.7 | GO:2000491 | positive regulation of hepatic stellate cell activation(GO:2000491) |
1.4 | 2.9 | GO:0032741 | positive regulation of interleukin-18 production(GO:0032741) |
1.4 | 5.7 | GO:0070358 | actin polymerization-dependent cell motility(GO:0070358) |
1.4 | 7.0 | GO:0061086 | negative regulation of histone H3-K27 methylation(GO:0061086) |
1.4 | 2.8 | GO:0002019 | regulation of renal output by angiotensin(GO:0002019) |
1.4 | 4.1 | GO:0015866 | ADP transport(GO:0015866) |
1.4 | 4.1 | GO:0010716 | regulation of collagen catabolic process(GO:0010710) negative regulation of extracellular matrix disassembly(GO:0010716) |
1.4 | 27.4 | GO:0030213 | hyaluronan biosynthetic process(GO:0030213) |
1.4 | 4.1 | GO:0006267 | pre-replicative complex assembly involved in nuclear cell cycle DNA replication(GO:0006267) pre-replicative complex assembly(GO:0036388) DNA replication preinitiation complex assembly(GO:0071163) pre-replicative complex assembly involved in cell cycle DNA replication(GO:1902299) |
1.4 | 1.4 | GO:2000642 | negative regulation of early endosome to late endosome transport(GO:2000642) |
1.3 | 5.4 | GO:1903898 | negative regulation of PERK-mediated unfolded protein response(GO:1903898) |
1.3 | 10.8 | GO:1901164 | negative regulation of trophoblast cell migration(GO:1901164) |
1.3 | 18.7 | GO:0002283 | neutrophil activation involved in immune response(GO:0002283) |
1.3 | 18.4 | GO:0001542 | ovulation from ovarian follicle(GO:0001542) |
1.3 | 17.1 | GO:0006977 | DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest(GO:0006977) |
1.3 | 15.7 | GO:0097067 | cellular response to thyroid hormone stimulus(GO:0097067) |
1.3 | 11.7 | GO:0032264 | IMP salvage(GO:0032264) |
1.3 | 6.5 | GO:0034421 | post-translational protein acetylation(GO:0034421) |
1.3 | 3.9 | GO:0042222 | interleukin-1 biosynthetic process(GO:0042222) |
1.3 | 11.5 | GO:0016198 | axon choice point recognition(GO:0016198) |
1.3 | 5.1 | GO:1903288 | positive regulation of potassium ion import(GO:1903288) |
1.3 | 5.0 | GO:0007356 | thorax and anterior abdomen determination(GO:0007356) |
1.3 | 3.8 | GO:0051754 | meiotic sister chromatid cohesion, centromeric(GO:0051754) |
1.2 | 3.7 | GO:0048478 | replication fork protection(GO:0048478) |
1.2 | 2.5 | GO:0033030 | negative regulation of neutrophil apoptotic process(GO:0033030) |
1.2 | 9.7 | GO:0071802 | negative regulation of podosome assembly(GO:0071802) |
1.2 | 8.5 | GO:0033632 | regulation of cell-cell adhesion mediated by integrin(GO:0033632) |
1.2 | 7.2 | GO:0003065 | positive regulation of heart rate by epinephrine(GO:0003065) |
1.2 | 3.6 | GO:0046005 | positive regulation of circadian sleep/wake cycle, REM sleep(GO:0046005) |
1.2 | 3.6 | GO:0007521 | muscle cell fate determination(GO:0007521) |
1.2 | 7.1 | GO:0032796 | uropod organization(GO:0032796) |
1.2 | 15.4 | GO:0043249 | erythrocyte maturation(GO:0043249) |
1.2 | 14.1 | GO:0033033 | negative regulation of myeloid cell apoptotic process(GO:0033033) |
1.2 | 5.8 | GO:0070934 | CRD-mediated mRNA stabilization(GO:0070934) |
1.2 | 3.5 | GO:0006404 | RNA import into nucleus(GO:0006404) mRNA export from nucleus in response to heat stress(GO:0031990) negative regulation of nucleobase-containing compound transport(GO:0032240) negative regulation of RNA export from nucleus(GO:0046832) |
1.2 | 29.1 | GO:0045730 | respiratory burst(GO:0045730) |
1.1 | 2.3 | GO:1903969 | regulation of macrophage colony-stimulating factor signaling pathway(GO:1902226) regulation of response to macrophage colony-stimulating factor(GO:1903969) regulation of cellular response to macrophage colony-stimulating factor stimulus(GO:1903972) |
1.1 | 3.4 | GO:0071922 | establishment of sister chromatid cohesion(GO:0034085) cohesin loading(GO:0071921) regulation of cohesin loading(GO:0071922) |
1.1 | 1.1 | GO:1904170 | regulation of bleb assembly(GO:1904170) |
1.1 | 11.1 | GO:0006398 | mRNA 3'-end processing by stem-loop binding and cleavage(GO:0006398) |
1.1 | 6.6 | GO:0090214 | spongiotrophoblast layer developmental growth(GO:0090214) |
1.1 | 9.9 | GO:0046645 | positive regulation of gamma-delta T cell differentiation(GO:0045588) positive regulation of gamma-delta T cell activation(GO:0046645) |
1.1 | 5.5 | GO:0002457 | T cell antigen processing and presentation(GO:0002457) |
1.1 | 3.3 | GO:0038165 | oncostatin-M-mediated signaling pathway(GO:0038165) |
1.1 | 1.1 | GO:0036269 | swimming behavior(GO:0036269) |
1.1 | 6.5 | GO:0002291 | T cell activation via T cell receptor contact with antigen bound to MHC molecule on antigen presenting cell(GO:0002291) |
1.1 | 2.1 | GO:2000568 | memory T cell activation(GO:0035709) regulation of memory T cell activation(GO:2000567) positive regulation of memory T cell activation(GO:2000568) |
1.1 | 4.2 | GO:0002030 | inhibitory G-protein coupled receptor phosphorylation(GO:0002030) |
1.0 | 8.4 | GO:0097210 | response to gonadotropin-releasing hormone(GO:0097210) cellular response to gonadotropin-releasing hormone(GO:0097211) |
1.0 | 1.0 | GO:0035700 | astrocyte chemotaxis(GO:0035700) regulation of astrocyte chemotaxis(GO:2000458) |
1.0 | 6.2 | GO:2000234 | positive regulation of ribosome biogenesis(GO:0090070) positive regulation of rRNA processing(GO:2000234) |
1.0 | 11.4 | GO:0050862 | positive regulation of T cell receptor signaling pathway(GO:0050862) |
1.0 | 2.1 | GO:0071608 | macrophage inflammatory protein-1 alpha production(GO:0071608) |
1.0 | 5.2 | GO:0014004 | microglia differentiation(GO:0014004) microglia development(GO:0014005) |
1.0 | 2.0 | GO:0061153 | trachea submucosa development(GO:0061152) trachea gland development(GO:0061153) |
1.0 | 5.1 | GO:0010920 | negative regulation of inositol phosphate biosynthetic process(GO:0010920) |
1.0 | 3.0 | GO:1905204 | negative regulation of connective tissue replacement(GO:1905204) |
1.0 | 3.0 | GO:0071169 | establishment of protein localization to chromatin(GO:0071169) |
1.0 | 2.0 | GO:0002309 | T cell proliferation involved in immune response(GO:0002309) |
1.0 | 4.0 | GO:0006014 | D-ribose metabolic process(GO:0006014) pentose catabolic process(GO:0019323) |
1.0 | 5.9 | GO:0060931 | sinoatrial node cell differentiation(GO:0060921) sinoatrial node cell development(GO:0060931) |
1.0 | 2.9 | GO:0070315 | positive regulation of satellite cell activation involved in skeletal muscle regeneration(GO:0014718) G1 to G0 transition involved in cell differentiation(GO:0070315) |
1.0 | 5.8 | GO:0035811 | negative regulation of urine volume(GO:0035811) |
1.0 | 4.8 | GO:0002678 | positive regulation of chronic inflammatory response(GO:0002678) |
1.0 | 3.8 | GO:1901842 | negative regulation of high voltage-gated calcium channel activity(GO:1901842) |
1.0 | 1.0 | GO:0051542 | elastin biosynthetic process(GO:0051542) |
0.9 | 10.2 | GO:0030277 | maintenance of gastrointestinal epithelium(GO:0030277) |
0.9 | 13.8 | GO:0048194 | Golgi vesicle budding(GO:0048194) |
0.9 | 0.9 | GO:0032472 | Golgi calcium ion transport(GO:0032472) |
0.9 | 2.7 | GO:0035574 | histone H4-K20 demethylation(GO:0035574) |
0.9 | 10.6 | GO:0000185 | activation of MAPKKK activity(GO:0000185) |
0.9 | 2.6 | GO:0002344 | peripheral B cell selection(GO:0002343) B cell affinity maturation(GO:0002344) |
0.9 | 8.7 | GO:0090527 | actin filament reorganization(GO:0090527) |
0.9 | 3.4 | GO:0090309 | positive regulation of methylation-dependent chromatin silencing(GO:0090309) |
0.9 | 2.6 | GO:0003051 | angiotensin-mediated drinking behavior(GO:0003051) |
0.9 | 6.0 | GO:0031508 | pericentric heterochromatin assembly(GO:0031508) |
0.8 | 1.7 | GO:0002582 | positive regulation of antigen processing and presentation of peptide or polysaccharide antigen via MHC class II(GO:0002582) positive regulation of antigen processing and presentation of peptide antigen via MHC class II(GO:0002588) |
0.8 | 0.8 | GO:0003284 | septum primum development(GO:0003284) |
0.8 | 6.7 | GO:0098909 | regulation of cardiac muscle cell action potential involved in regulation of contraction(GO:0098909) |
0.8 | 0.8 | GO:0032241 | positive regulation of nucleobase-containing compound transport(GO:0032241) |
0.8 | 4.9 | GO:0050917 | sensory perception of umami taste(GO:0050917) |
0.8 | 3.3 | GO:2001245 | regulation of phosphatidylcholine biosynthetic process(GO:2001245) |
0.8 | 7.4 | GO:0030916 | otic vesicle formation(GO:0030916) |
0.8 | 2.4 | GO:0098971 | anterograde dendritic transport of neurotransmitter receptor complex(GO:0098971) |
0.8 | 5.7 | GO:0033031 | positive regulation of neutrophil apoptotic process(GO:0033031) |
0.8 | 3.2 | GO:0043973 | histone H3-K4 acetylation(GO:0043973) |
0.8 | 5.6 | GO:0060923 | cardiac muscle cell fate commitment(GO:0060923) |
0.8 | 4.7 | GO:0010735 | positive regulation of transcription via serum response element binding(GO:0010735) |
0.8 | 7.1 | GO:0090232 | positive regulation of spindle checkpoint(GO:0090232) |
0.8 | 7.0 | GO:0015705 | iodide transport(GO:0015705) |
0.8 | 2.3 | GO:2000620 | positive regulation of histone H4-K16 acetylation(GO:2000620) |
0.8 | 2.3 | GO:0036090 | cleavage furrow ingression(GO:0036090) |
0.8 | 2.3 | GO:0032685 | regulation of interleukin-18 production(GO:0032661) negative regulation of granulocyte macrophage colony-stimulating factor production(GO:0032685) negative regulation of interleukin-18 production(GO:0032701) |
0.8 | 3.9 | GO:0072429 | response to intra-S DNA damage checkpoint signaling(GO:0072429) |
0.8 | 3.1 | GO:0042891 | antibiotic transport(GO:0042891) |
0.8 | 3.1 | GO:0034379 | very-low-density lipoprotein particle assembly(GO:0034379) |
0.8 | 3.8 | GO:0050915 | sensory perception of sour taste(GO:0050915) |
0.8 | 3.8 | GO:0006680 | glucosylceramide catabolic process(GO:0006680) |
0.8 | 2.3 | GO:0002018 | renin-angiotensin regulation of aldosterone production(GO:0002018) |
0.8 | 1.5 | GO:0048295 | T-helper 1 cell lineage commitment(GO:0002296) positive regulation of isotype switching to IgE isotypes(GO:0048295) positive regulation of mononuclear cell migration(GO:0071677) |
0.7 | 5.2 | GO:0051775 | response to redox state(GO:0051775) |
0.7 | 4.5 | GO:2000348 | regulation of CD40 signaling pathway(GO:2000348) |
0.7 | 3.0 | GO:0044849 | estrous cycle(GO:0044849) |
0.7 | 5.2 | GO:0051852 | disruption by host of symbiont cells(GO:0051852) killing by host of symbiont cells(GO:0051873) |
0.7 | 1.5 | GO:1904975 | response to bleomycin(GO:1904975) cellular response to bleomycin(GO:1904976) |
0.7 | 2.2 | GO:1904732 | regulation of electron carrier activity(GO:1904732) regulation of cytochrome-c oxidase activity(GO:1904959) |
0.7 | 4.4 | GO:0030240 | skeletal muscle thin filament assembly(GO:0030240) |
0.7 | 16.7 | GO:0050774 | negative regulation of dendrite morphogenesis(GO:0050774) |
0.7 | 2.9 | GO:0045347 | negative regulation of MHC class II biosynthetic process(GO:0045347) |
0.7 | 8.6 | GO:0070493 | thrombin receptor signaling pathway(GO:0070493) |
0.7 | 4.3 | GO:0010626 | negative regulation of Schwann cell proliferation(GO:0010626) |
0.7 | 2.1 | GO:0006597 | spermine biosynthetic process(GO:0006597) |
0.7 | 3.5 | GO:0045876 | positive regulation of sister chromatid cohesion(GO:0045876) |
0.7 | 5.0 | GO:0045654 | positive regulation of megakaryocyte differentiation(GO:0045654) |
0.7 | 1.4 | GO:1904879 | positive regulation of calcium ion transmembrane transport via high voltage-gated calcium channel(GO:1904879) |
0.7 | 2.8 | GO:0060032 | notochord regression(GO:0060032) |
0.7 | 5.6 | GO:1904378 | maintenance of unfolded protein(GO:0036506) tail-anchored membrane protein insertion into ER membrane(GO:0071816) maintenance of unfolded protein involved in ERAD pathway(GO:1904378) |
0.7 | 9.0 | GO:1901844 | regulation of cell communication by electrical coupling involved in cardiac conduction(GO:1901844) |
0.7 | 2.8 | GO:0035519 | protein K29-linked ubiquitination(GO:0035519) |
0.7 | 2.1 | GO:2000402 | negative regulation of lymphocyte migration(GO:2000402) |
0.7 | 7.5 | GO:0046884 | follicle-stimulating hormone secretion(GO:0046884) |
0.7 | 1.4 | GO:0009826 | unidimensional cell growth(GO:0009826) |
0.7 | 2.0 | GO:0001810 | regulation of type I hypersensitivity(GO:0001810) positive regulation of type I hypersensitivity(GO:0001812) type I hypersensitivity(GO:0016068) |
0.7 | 5.3 | GO:0021555 | midbrain-hindbrain boundary morphogenesis(GO:0021555) |
0.7 | 5.3 | GO:0030836 | positive regulation of actin filament depolymerization(GO:0030836) |
0.7 | 3.3 | GO:1901252 | regulation of intracellular transport of viral material(GO:1901252) |
0.6 | 2.5 | GO:0046075 | dTTP biosynthetic process(GO:0006235) pyrimidine deoxyribonucleoside triphosphate biosynthetic process(GO:0009212) dTTP metabolic process(GO:0046075) |
0.6 | 5.1 | GO:0016584 | nucleosome positioning(GO:0016584) |
0.6 | 3.8 | GO:0051534 | negative regulation of NFAT protein import into nucleus(GO:0051534) |
0.6 | 2.5 | GO:0006269 | DNA replication, synthesis of RNA primer(GO:0006269) leading strand elongation(GO:0006272) |
0.6 | 6.9 | GO:1901299 | negative regulation of hydrogen peroxide-mediated programmed cell death(GO:1901299) |
0.6 | 3.8 | GO:0033085 | negative regulation of T cell differentiation in thymus(GO:0033085) |
0.6 | 2.5 | GO:0045356 | positive regulation of interferon-alpha biosynthetic process(GO:0045356) |
0.6 | 3.7 | GO:0048539 | bone marrow development(GO:0048539) |
0.6 | 0.6 | GO:0006808 | regulation of nitrogen utilization(GO:0006808) nitrogen utilization(GO:0019740) |
0.6 | 1.2 | GO:0010700 | negative regulation of norepinephrine secretion(GO:0010700) |
0.6 | 3.7 | GO:0015889 | cobalamin transport(GO:0015889) |
0.6 | 3.1 | GO:0035087 | siRNA loading onto RISC involved in RNA interference(GO:0035087) |
0.6 | 4.9 | GO:1901750 | leukotriene D4 metabolic process(GO:1901748) leukotriene D4 biosynthetic process(GO:1901750) |
0.6 | 3.7 | GO:0071372 | cellular response to follicle-stimulating hormone stimulus(GO:0071372) |
0.6 | 2.5 | GO:1903215 | negative regulation of protein targeting to mitochondrion(GO:1903215) |
0.6 | 6.1 | GO:0048304 | positive regulation of isotype switching to IgG isotypes(GO:0048304) |
0.6 | 0.6 | GO:0000466 | maturation of 5.8S rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA)(GO:0000466) |
0.6 | 3.0 | GO:2000435 | regulation of protein neddylation(GO:2000434) negative regulation of protein neddylation(GO:2000435) |
0.6 | 6.0 | GO:0060087 | relaxation of vascular smooth muscle(GO:0060087) |
0.6 | 4.8 | GO:0061621 | NADH regeneration(GO:0006735) canonical glycolysis(GO:0061621) glucose catabolic process to pyruvate(GO:0061718) |
0.6 | 1.8 | GO:0010513 | phospholipase C-activating serotonin receptor signaling pathway(GO:0007208) positive regulation of phosphatidylinositol biosynthetic process(GO:0010513) |
0.6 | 10.7 | GO:0051988 | regulation of attachment of spindle microtubules to kinetochore(GO:0051988) |
0.6 | 1.8 | GO:0042271 | susceptibility to natural killer cell mediated cytotoxicity(GO:0042271) |
0.6 | 4.1 | GO:0019262 | N-acetylneuraminate catabolic process(GO:0019262) |
0.6 | 5.9 | GO:0002361 | CD4-positive, CD25-positive, alpha-beta regulatory T cell differentiation(GO:0002361) |
0.6 | 4.1 | GO:0035735 | intraciliary transport involved in cilium morphogenesis(GO:0035735) |
0.6 | 1.8 | GO:0002355 | detection of tumor cell(GO:0002355) |
0.6 | 1.7 | GO:0008292 | acetylcholine biosynthetic process(GO:0008292) acetate ester biosynthetic process(GO:1900620) |
0.6 | 14.4 | GO:0045672 | positive regulation of osteoclast differentiation(GO:0045672) |
0.6 | 1.7 | GO:0061343 | cell adhesion involved in heart morphogenesis(GO:0061343) |
0.6 | 8.0 | GO:0007076 | mitotic chromosome condensation(GO:0007076) |
0.6 | 2.9 | GO:0090521 | glomerular visceral epithelial cell migration(GO:0090521) |
0.6 | 1.7 | GO:0070213 | protein auto-ADP-ribosylation(GO:0070213) |
0.6 | 7.3 | GO:0051574 | positive regulation of histone H3-K9 methylation(GO:0051574) |
0.6 | 4.5 | GO:0045631 | regulation of auditory receptor cell differentiation(GO:0045607) regulation of mechanoreceptor differentiation(GO:0045631) regulation of inner ear receptor cell differentiation(GO:2000980) |
0.6 | 1.7 | GO:0050705 | regulation of interleukin-1 alpha production(GO:0032650) positive regulation of interleukin-1 alpha production(GO:0032730) regulation of interleukin-1 alpha secretion(GO:0050705) |
0.6 | 2.8 | GO:2000138 | positive regulation of cell proliferation involved in heart morphogenesis(GO:2000138) |
0.6 | 1.1 | GO:0045653 | negative regulation of megakaryocyte differentiation(GO:0045653) |
0.6 | 2.2 | GO:1902303 | negative regulation of potassium ion export(GO:1902303) |
0.6 | 1.7 | GO:0035926 | chemokine (C-C motif) ligand 2 secretion(GO:0035926) regulation of chemokine (C-C motif) ligand 2 secretion(GO:1904207) positive regulation of chemokine (C-C motif) ligand 2 secretion(GO:1904209) |
0.6 | 2.8 | GO:0018101 | protein citrullination(GO:0018101) histone citrullination(GO:0036414) |
0.5 | 9.8 | GO:0007190 | activation of adenylate cyclase activity(GO:0007190) |
0.5 | 1.1 | GO:0021524 | visceral motor neuron differentiation(GO:0021524) |
0.5 | 3.3 | GO:0006452 | translational frameshifting(GO:0006452) positive regulation of translational termination(GO:0045905) |
0.5 | 7.0 | GO:0006654 | phosphatidic acid biosynthetic process(GO:0006654) |
0.5 | 6.5 | GO:0006968 | cellular defense response(GO:0006968) |
0.5 | 3.8 | GO:0060352 | cell adhesion molecule production(GO:0060352) |
0.5 | 32.2 | GO:0070527 | platelet aggregation(GO:0070527) |
0.5 | 1.6 | GO:0043553 | negative regulation of phosphatidylinositol 3-kinase activity(GO:0043553) |
0.5 | 12.3 | GO:0032460 | negative regulation of protein oligomerization(GO:0032460) |
0.5 | 0.5 | GO:0072244 | metanephric glomerular epithelium development(GO:0072244) |
0.5 | 4.3 | GO:0048386 | positive regulation of retinoic acid receptor signaling pathway(GO:0048386) |
0.5 | 6.4 | GO:0042534 | tumor necrosis factor biosynthetic process(GO:0042533) regulation of tumor necrosis factor biosynthetic process(GO:0042534) |
0.5 | 2.1 | GO:0032962 | positive regulation of inositol trisphosphate biosynthetic process(GO:0032962) |
0.5 | 3.1 | GO:0060005 | vestibular reflex(GO:0060005) |
0.5 | 3.1 | GO:0006116 | NADH oxidation(GO:0006116) |
0.5 | 1.6 | GO:0060244 | negative regulation of cell proliferation involved in contact inhibition(GO:0060244) |
0.5 | 2.0 | GO:1903367 | positive regulation of fear response(GO:1903367) positive regulation of behavioral fear response(GO:2000987) |
0.5 | 3.6 | GO:0097428 | protein maturation by iron-sulfur cluster transfer(GO:0097428) |
0.5 | 2.5 | GO:0000707 | meiotic DNA recombinase assembly(GO:0000707) |
0.5 | 1.5 | GO:0014735 | regulation of muscle atrophy(GO:0014735) |
0.5 | 1.0 | GO:0072717 | cellular response to actinomycin D(GO:0072717) |
0.5 | 4.0 | GO:0071883 | activation of MAPK activity by adrenergic receptor signaling pathway(GO:0071883) |
0.5 | 1.5 | GO:0002946 | tRNA C5-cytosine methylation(GO:0002946) |
0.5 | 1.5 | GO:1900369 | negative regulation of RNA interference(GO:1900369) |
0.5 | 7.5 | GO:0071688 | striated muscle myosin thick filament assembly(GO:0071688) |
0.5 | 2.0 | GO:0048743 | positive regulation of skeletal muscle fiber development(GO:0048743) |
0.5 | 2.0 | GO:1903527 | regulation of membrane tubulation(GO:1903525) positive regulation of membrane tubulation(GO:1903527) |
0.5 | 2.4 | GO:0002430 | complement receptor mediated signaling pathway(GO:0002430) |
0.5 | 11.7 | GO:0050869 | negative regulation of B cell activation(GO:0050869) |
0.5 | 1.9 | GO:0090266 | regulation of mitotic cell cycle spindle assembly checkpoint(GO:0090266) regulation of mitotic spindle checkpoint(GO:1903504) |
0.5 | 4.8 | GO:1902083 | negative regulation of peptidyl-cysteine S-nitrosylation(GO:1902083) |
0.5 | 1.0 | GO:0042494 | detection of bacterial lipoprotein(GO:0042494) |
0.5 | 6.1 | GO:0001553 | luteinization(GO:0001553) |
0.5 | 6.6 | GO:0015747 | urate transport(GO:0015747) |
0.5 | 0.5 | GO:0010956 | negative regulation of calcidiol 1-monooxygenase activity(GO:0010956) |
0.5 | 7.0 | GO:0000083 | regulation of transcription involved in G1/S transition of mitotic cell cycle(GO:0000083) |
0.5 | 0.9 | GO:0000973 | posttranscriptional tethering of RNA polymerase II gene DNA at nuclear periphery(GO:0000973) |
0.5 | 2.8 | GO:0033601 | positive regulation of mammary gland epithelial cell proliferation(GO:0033601) |
0.5 | 2.3 | GO:0042699 | follicle-stimulating hormone signaling pathway(GO:0042699) |
0.5 | 3.7 | GO:0002002 | regulation of angiotensin levels in blood(GO:0002002) |
0.5 | 2.7 | GO:0010039 | response to iron ion(GO:0010039) |
0.5 | 2.3 | GO:2001268 | negative regulation of cysteine-type endopeptidase activity involved in apoptotic signaling pathway(GO:2001268) |
0.5 | 7.7 | GO:0008608 | attachment of spindle microtubules to kinetochore(GO:0008608) |
0.5 | 1.8 | GO:0010936 | negative regulation of macrophage cytokine production(GO:0010936) |
0.4 | 4.5 | GO:1900364 | negative regulation of mRNA polyadenylation(GO:1900364) |
0.4 | 0.9 | GO:1901738 | regulation of vitamin A metabolic process(GO:1901738) |
0.4 | 1.3 | GO:0070782 | phosphatidylserine exposure on apoptotic cell surface(GO:0070782) |
0.4 | 0.4 | GO:0072395 | signal transduction involved in cell cycle checkpoint(GO:0072395) signal transduction involved in DNA integrity checkpoint(GO:0072401) signal transduction involved in DNA damage checkpoint(GO:0072422) |
0.4 | 2.6 | GO:2000672 | negative regulation of motor neuron apoptotic process(GO:2000672) |
0.4 | 1.7 | GO:0090091 | positive regulation of extracellular matrix disassembly(GO:0090091) |
0.4 | 2.2 | GO:0001915 | negative regulation of T cell mediated cytotoxicity(GO:0001915) |
0.4 | 0.9 | GO:0010286 | heat acclimation(GO:0010286) |
0.4 | 1.7 | GO:0021776 | smoothened signaling pathway involved in ventral spinal cord interneuron specification(GO:0021775) smoothened signaling pathway involved in spinal cord motor neuron cell fate specification(GO:0021776) |
0.4 | 1.3 | GO:0045726 | positive regulation of integrin biosynthetic process(GO:0045726) |
0.4 | 1.3 | GO:0030854 | positive regulation of granulocyte differentiation(GO:0030854) |
0.4 | 1.3 | GO:0046022 | regulation of transcription from RNA polymerase II promoter, mitotic(GO:0046021) positive regulation of transcription from RNA polymerase II promoter during mitosis(GO:0046022) |
0.4 | 11.6 | GO:0048268 | clathrin coat assembly(GO:0048268) |
0.4 | 2.2 | GO:1903566 | positive regulation of protein localization to cilium(GO:1903566) |
0.4 | 1.3 | GO:0021577 | hindbrain structural organization(GO:0021577) cerebellum structural organization(GO:0021589) |
0.4 | 0.8 | GO:0061030 | epithelial cell differentiation involved in mammary gland alveolus development(GO:0061030) |
0.4 | 1.3 | GO:1903797 | positive regulation of inorganic anion transmembrane transport(GO:1903797) regulation of sodium-dependent phosphate transport(GO:2000118) |
0.4 | 2.1 | GO:0046952 | ketone body catabolic process(GO:0046952) |
0.4 | 2.9 | GO:0038166 | angiotensin-activated signaling pathway(GO:0038166) |
0.4 | 9.6 | GO:0097320 | membrane tubulation(GO:0097320) |
0.4 | 1.3 | GO:0046984 | regulation of hemoglobin biosynthetic process(GO:0046984) |
0.4 | 7.5 | GO:0001675 | acrosome assembly(GO:0001675) |
0.4 | 1.7 | GO:0010792 | DNA double-strand break processing involved in repair via single-strand annealing(GO:0010792) |
0.4 | 3.3 | GO:1903003 | positive regulation of protein deubiquitination(GO:1903003) |
0.4 | 5.4 | GO:0061179 | negative regulation of insulin secretion involved in cellular response to glucose stimulus(GO:0061179) |
0.4 | 2.9 | GO:0007221 | positive regulation of transcription of Notch receptor target(GO:0007221) |
0.4 | 13.2 | GO:0046827 | positive regulation of protein export from nucleus(GO:0046827) |
0.4 | 3.3 | GO:0002315 | marginal zone B cell differentiation(GO:0002315) |
0.4 | 1.2 | GO:1901642 | purine nucleoside transmembrane transport(GO:0015860) nucleoside transmembrane transport(GO:1901642) |
0.4 | 1.2 | GO:0014724 | regulation of twitch skeletal muscle contraction(GO:0014724) |
0.4 | 1.2 | GO:1904569 | regulation of selenocysteine incorporation(GO:1904569) |
0.4 | 1.2 | GO:2000314 | negative regulation of fibroblast growth factor receptor signaling pathway involved in neural plate anterior/posterior pattern formation(GO:2000314) |
0.4 | 2.0 | GO:0032298 | positive regulation of DNA-dependent DNA replication initiation(GO:0032298) |
0.4 | 2.0 | GO:0019516 | lactate oxidation(GO:0019516) |
0.4 | 1.5 | GO:0035694 | mitochondrial protein catabolic process(GO:0035694) |
0.4 | 1.1 | GO:0009233 | menaquinone metabolic process(GO:0009233) |
0.4 | 2.3 | GO:0001927 | exocyst assembly(GO:0001927) |
0.4 | 3.8 | GO:0030220 | platelet formation(GO:0030220) platelet morphogenesis(GO:0036344) |
0.4 | 3.4 | GO:0001973 | adenosine receptor signaling pathway(GO:0001973) |
0.4 | 1.9 | GO:2000301 | negative regulation of synaptic vesicle exocytosis(GO:2000301) |
0.4 | 1.5 | GO:0030576 | Cajal body organization(GO:0030576) |
0.4 | 2.2 | GO:0002317 | plasma cell differentiation(GO:0002317) |
0.4 | 4.0 | GO:0002726 | positive regulation of T cell cytokine production(GO:0002726) |
0.4 | 0.4 | GO:0051660 | establishment of centrosome localization(GO:0051660) |
0.4 | 0.4 | GO:1900368 | regulation of RNA interference(GO:1900368) |
0.4 | 1.5 | GO:0002335 | mature B cell differentiation(GO:0002335) |
0.4 | 0.7 | GO:2000583 | platelet-derived growth factor receptor-alpha signaling pathway(GO:0035790) regulation of platelet-derived growth factor receptor-alpha signaling pathway(GO:2000583) negative regulation of platelet-derived growth factor receptor-alpha signaling pathway(GO:2000584) |
0.4 | 0.4 | GO:0003415 | chondrocyte hypertrophy(GO:0003415) |
0.4 | 1.5 | GO:1905244 | regulation of modification of synaptic structure(GO:1905244) |
0.4 | 4.0 | GO:0040034 | regulation of development, heterochronic(GO:0040034) |
0.4 | 2.2 | GO:2001032 | regulation of double-strand break repair via nonhomologous end joining(GO:2001032) |
0.4 | 2.1 | GO:0009082 | branched-chain amino acid biosynthetic process(GO:0009082) leucine biosynthetic process(GO:0009098) valine biosynthetic process(GO:0009099) |
0.4 | 3.6 | GO:0010804 | negative regulation of tumor necrosis factor-mediated signaling pathway(GO:0010804) |
0.4 | 1.4 | GO:1904425 | negative regulation of GTP binding(GO:1904425) |
0.3 | 0.7 | GO:1903377 | negative regulation of oxidative stress-induced neuron intrinsic apoptotic signaling pathway(GO:1903377) |
0.3 | 2.4 | GO:1903715 | regulation of aerobic respiration(GO:1903715) |
0.3 | 4.5 | GO:0031163 | iron-sulfur cluster assembly(GO:0016226) metallo-sulfur cluster assembly(GO:0031163) |
0.3 | 1.4 | GO:0014846 | esophagus smooth muscle contraction(GO:0014846) |
0.3 | 0.7 | GO:1902283 | negative regulation of primary amine oxidase activity(GO:1902283) |
0.3 | 1.0 | GO:0036302 | right ventricular cardiac muscle tissue morphogenesis(GO:0003221) olfactory nerve development(GO:0021553) atrioventricular canal development(GO:0036302) |
0.3 | 2.4 | GO:0003376 | sphingosine-1-phosphate signaling pathway(GO:0003376) |
0.3 | 1.0 | GO:0010966 | regulation of phosphate transport(GO:0010966) |
0.3 | 2.0 | GO:0002158 | osteoclast proliferation(GO:0002158) |
0.3 | 8.7 | GO:0001562 | response to protozoan(GO:0001562) |
0.3 | 3.0 | GO:0032740 | positive regulation of interleukin-17 production(GO:0032740) |
0.3 | 1.6 | GO:0006177 | GMP biosynthetic process(GO:0006177) |
0.3 | 1.0 | GO:0000447 | endonucleolytic cleavage in ITS1 to separate SSU-rRNA from 5.8S rRNA and LSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA)(GO:0000447) |
0.3 | 1.6 | GO:0031860 | telomeric 3' overhang formation(GO:0031860) |
0.3 | 1.3 | GO:1903347 | negative regulation of bicellular tight junction assembly(GO:1903347) |
0.3 | 1.0 | GO:1900122 | positive regulation of receptor binding(GO:1900122) |
0.3 | 0.9 | GO:1990414 | replication-born double-strand break repair via sister chromatid exchange(GO:1990414) |
0.3 | 1.2 | GO:0030321 | transepithelial chloride transport(GO:0030321) |
0.3 | 2.5 | GO:0015074 | DNA integration(GO:0015074) |
0.3 | 1.2 | GO:0045163 | clustering of voltage-gated potassium channels(GO:0045163) |
0.3 | 1.5 | GO:0000454 | snoRNA guided rRNA pseudouridine synthesis(GO:0000454) |
0.3 | 3.4 | GO:0071173 | mitotic spindle assembly checkpoint(GO:0007094) spindle assembly checkpoint(GO:0071173) |
0.3 | 0.6 | GO:0002035 | brain renin-angiotensin system(GO:0002035) |
0.3 | 3.3 | GO:0034498 | early endosome to Golgi transport(GO:0034498) |
0.3 | 4.2 | GO:0014883 | transition between fast and slow fiber(GO:0014883) |
0.3 | 1.8 | GO:0001757 | somite specification(GO:0001757) |
0.3 | 2.1 | GO:0070235 | regulation of activation-induced cell death of T cells(GO:0070235) |
0.3 | 1.2 | GO:2001015 | negative regulation of skeletal muscle cell differentiation(GO:2001015) |
0.3 | 0.9 | GO:0060821 | inactivation of X chromosome by DNA methylation(GO:0060821) |
0.3 | 0.6 | GO:0045652 | regulation of megakaryocyte differentiation(GO:0045652) |
0.3 | 0.9 | GO:0048022 | negative regulation of melanin biosynthetic process(GO:0048022) negative regulation of secondary metabolite biosynthetic process(GO:1900377) |
0.3 | 2.0 | GO:0019240 | citrulline biosynthetic process(GO:0019240) |
0.3 | 0.3 | GO:0001802 | antibody-dependent cellular cytotoxicity(GO:0001788) type III hypersensitivity(GO:0001802) regulation of type III hypersensitivity(GO:0001803) positive regulation of type III hypersensitivity(GO:0001805) |
0.3 | 1.1 | GO:0070317 | negative regulation of G0 to G1 transition(GO:0070317) |
0.3 | 1.4 | GO:0018242 | protein O-linked glycosylation via serine(GO:0018242) |
0.3 | 2.5 | GO:1903800 | positive regulation of production of miRNAs involved in gene silencing by miRNA(GO:1903800) |
0.3 | 2.8 | GO:0045161 | neuronal ion channel clustering(GO:0045161) |
0.3 | 1.4 | GO:0090245 | axis elongation involved in somitogenesis(GO:0090245) |
0.3 | 0.3 | GO:0061010 | gall bladder development(GO:0061010) |
0.3 | 0.5 | GO:0035482 | gastric motility(GO:0035482) gastric emptying(GO:0035483) |
0.3 | 1.1 | GO:1903575 | cornified envelope assembly(GO:1903575) |
0.3 | 1.9 | GO:2000659 | regulation of interleukin-1-mediated signaling pathway(GO:2000659) |
0.3 | 1.9 | GO:0006290 | pyrimidine dimer repair(GO:0006290) |
0.3 | 2.6 | GO:0030432 | peristalsis(GO:0030432) |
0.3 | 0.8 | GO:0015760 | hexose phosphate transport(GO:0015712) glucose-6-phosphate transport(GO:0015760) |
0.3 | 1.3 | GO:1901525 | negative regulation of macromitophagy(GO:1901525) |
0.3 | 1.3 | GO:0098528 | skeletal muscle fiber differentiation(GO:0098528) |
0.3 | 0.8 | GO:0000972 | transcription-dependent tethering of RNA polymerase II gene DNA at nuclear periphery(GO:0000972) |
0.3 | 0.3 | GO:0021852 | pyramidal neuron migration(GO:0021852) |
0.3 | 4.8 | GO:0043968 | histone H2A acetylation(GO:0043968) |
0.3 | 1.0 | GO:0000480 | endonucleolytic cleavage in 5'-ETS of tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA)(GO:0000480) |
0.3 | 1.3 | GO:0044027 | hypermethylation of CpG island(GO:0044027) |
0.3 | 1.3 | GO:0070535 | histone H2A K63-linked ubiquitination(GO:0070535) |
0.3 | 2.0 | GO:0006268 | DNA unwinding involved in DNA replication(GO:0006268) |
0.3 | 0.8 | GO:1901355 | response to rapamycin(GO:1901355) |
0.2 | 1.7 | GO:1905216 | positive regulation of RNA binding(GO:1905216) |
0.2 | 0.2 | GO:0021558 | trochlear nerve development(GO:0021558) |
0.2 | 1.0 | GO:0033600 | negative regulation of mammary gland epithelial cell proliferation(GO:0033600) regulation of branching involved in mammary gland duct morphogenesis(GO:0060762) |
0.2 | 4.2 | GO:0070816 | phosphorylation of RNA polymerase II C-terminal domain(GO:0070816) |
0.2 | 1.0 | GO:0046368 | GDP-L-fucose metabolic process(GO:0046368) |
0.2 | 0.7 | GO:1903054 | negative regulation of extracellular matrix organization(GO:1903054) |
0.2 | 4.9 | GO:0000028 | ribosomal small subunit assembly(GO:0000028) |
0.2 | 9.6 | GO:0050853 | B cell receptor signaling pathway(GO:0050853) |
0.2 | 3.9 | GO:0070670 | response to interleukin-4(GO:0070670) |
0.2 | 2.2 | GO:0060059 | embryonic retina morphogenesis in camera-type eye(GO:0060059) |
0.2 | 0.7 | GO:1903984 | regulation of TRAIL-activated apoptotic signaling pathway(GO:1903121) positive regulation of TRAIL-activated apoptotic signaling pathway(GO:1903984) |
0.2 | 1.2 | GO:2000465 | regulation of glycogen (starch) synthase activity(GO:2000465) |
0.2 | 1.4 | GO:0032483 | regulation of Rab protein signal transduction(GO:0032483) |
0.2 | 0.7 | GO:0021691 | cerebellar Purkinje cell layer maturation(GO:0021691) |
0.2 | 9.6 | GO:0007019 | microtubule depolymerization(GO:0007019) |
0.2 | 1.7 | GO:1900264 | regulation of DNA-directed DNA polymerase activity(GO:1900262) positive regulation of DNA-directed DNA polymerase activity(GO:1900264) |
0.2 | 1.2 | GO:0043353 | enucleate erythrocyte differentiation(GO:0043353) |
0.2 | 0.7 | GO:0031339 | negative regulation of vesicle fusion(GO:0031339) |
0.2 | 9.3 | GO:0045071 | negative regulation of viral genome replication(GO:0045071) |
0.2 | 1.4 | GO:0032532 | regulation of microvillus length(GO:0032532) |
0.2 | 2.3 | GO:0033147 | negative regulation of intracellular estrogen receptor signaling pathway(GO:0033147) |
0.2 | 1.2 | GO:1905098 | negative regulation of guanyl-nucleotide exchange factor activity(GO:1905098) |
0.2 | 2.1 | GO:0061713 | neural crest cell migration involved in heart formation(GO:0003147) cell migration involved in heart formation(GO:0060974) anterior neural tube closure(GO:0061713) cellular response to folic acid(GO:0071231) |
0.2 | 0.7 | GO:0097051 | establishment of protein localization to endoplasmic reticulum membrane(GO:0097051) positive regulation of protein lipidation(GO:1903061) |
0.2 | 7.0 | GO:0007616 | long-term memory(GO:0007616) |
0.2 | 2.5 | GO:0002051 | osteoblast fate commitment(GO:0002051) |
0.2 | 0.2 | GO:0045955 | negative regulation of calcium ion-dependent exocytosis(GO:0045955) |
0.2 | 0.7 | GO:1900740 | regulation of protein insertion into mitochondrial membrane involved in apoptotic signaling pathway(GO:1900739) positive regulation of protein insertion into mitochondrial membrane involved in apoptotic signaling pathway(GO:1900740) |
0.2 | 0.9 | GO:1901894 | regulation of calcium-transporting ATPase activity(GO:1901894) |
0.2 | 3.3 | GO:0090336 | positive regulation of brown fat cell differentiation(GO:0090336) |
0.2 | 0.7 | GO:2000016 | negative regulation of determination of dorsal identity(GO:2000016) |
0.2 | 0.4 | GO:2000043 | regulation of cardiac cell fate specification(GO:2000043) |
0.2 | 1.3 | GO:0010890 | positive regulation of sequestering of triglyceride(GO:0010890) |
0.2 | 2.2 | GO:0071157 | negative regulation of cell cycle arrest(GO:0071157) |
0.2 | 3.7 | GO:0016973 | poly(A)+ mRNA export from nucleus(GO:0016973) |
0.2 | 0.7 | GO:0009972 | cytidine catabolic process(GO:0006216) cytidine deamination(GO:0009972) cytidine metabolic process(GO:0046087) |
0.2 | 2.8 | GO:0000463 | maturation of LSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA)(GO:0000463) |
0.2 | 2.6 | GO:0032528 | microvillus organization(GO:0032528) |
0.2 | 8.9 | GO:0045576 | mast cell activation(GO:0045576) |
0.2 | 1.3 | GO:0010587 | miRNA catabolic process(GO:0010587) |
0.2 | 1.5 | GO:0016266 | O-glycan processing(GO:0016266) |
0.2 | 0.4 | GO:0002339 | B cell selection(GO:0002339) |
0.2 | 0.4 | GO:1903279 | regulation of calcium:sodium antiporter activity(GO:1903279) |
0.2 | 0.4 | GO:1902202 | regulation of hepatocyte growth factor receptor signaling pathway(GO:1902202) |
0.2 | 1.3 | GO:1904849 | positive regulation of cell chemotaxis to fibroblast growth factor(GO:1904849) positive regulation of endothelial cell chemotaxis to fibroblast growth factor(GO:2000546) |
0.2 | 0.4 | GO:0000479 | endonucleolytic cleavage of tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA)(GO:0000479) |
0.2 | 1.7 | GO:0042126 | nitrate metabolic process(GO:0042126) |
0.2 | 0.6 | GO:0006532 | aspartate biosynthetic process(GO:0006532) |
0.2 | 1.2 | GO:0060316 | positive regulation of ryanodine-sensitive calcium-release channel activity(GO:0060316) |
0.2 | 0.8 | GO:0014807 | regulation of somitogenesis(GO:0014807) |
0.2 | 8.2 | GO:1900026 | positive regulation of substrate adhesion-dependent cell spreading(GO:1900026) |
0.2 | 1.4 | GO:0035437 | protein retention in ER lumen(GO:0006621) maintenance of protein localization in endoplasmic reticulum(GO:0035437) |
0.2 | 0.8 | GO:0090080 | positive regulation of MAPKKK cascade by fibroblast growth factor receptor signaling pathway(GO:0090080) |
0.2 | 1.4 | GO:2001214 | positive regulation of vasculogenesis(GO:2001214) |
0.2 | 6.4 | GO:0006335 | DNA replication-dependent nucleosome assembly(GO:0006335) DNA replication-dependent nucleosome organization(GO:0034723) |
0.2 | 4.5 | GO:0038092 | nodal signaling pathway(GO:0038092) |
0.2 | 0.8 | GO:0009744 | response to sucrose(GO:0009744) response to disaccharide(GO:0034285) |
0.2 | 3.1 | GO:0006910 | phagocytosis, recognition(GO:0006910) |
0.2 | 0.6 | GO:0046477 | glycosylceramide catabolic process(GO:0046477) |
0.2 | 1.4 | GO:0030263 | apoptotic chromosome condensation(GO:0030263) |
0.2 | 1.0 | GO:0016479 | negative regulation of transcription from RNA polymerase I promoter(GO:0016479) |
0.2 | 1.4 | GO:0040009 | regulation of growth rate(GO:0040009) |
0.2 | 1.5 | GO:0032876 | negative regulation of DNA endoreduplication(GO:0032876) |
0.2 | 0.6 | GO:1902167 | positive regulation of intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator(GO:1902167) |
0.2 | 0.6 | GO:0000965 | mitochondrial RNA 3'-end processing(GO:0000965) mitochondrial tRNA processing(GO:0090646) |
0.2 | 0.4 | GO:0021812 | neuronal-glial interaction involved in cerebral cortex radial glia guided migration(GO:0021812) |
0.2 | 1.1 | GO:0051901 | positive regulation of mitochondrial depolarization(GO:0051901) |
0.2 | 1.1 | GO:0061484 | hematopoietic stem cell homeostasis(GO:0061484) |
0.2 | 0.6 | GO:0090297 | positive regulation of mitochondrial DNA replication(GO:0090297) regulation of cardiolipin metabolic process(GO:1900208) positive regulation of cardiolipin metabolic process(GO:1900210) positive regulation of mitochondrial DNA metabolic process(GO:1901860) stress-induced mitochondrial fusion(GO:1990046) |
0.2 | 0.4 | GO:0018171 | peptidyl-cysteine oxidation(GO:0018171) |
0.2 | 1.1 | GO:0052205 | modulation of molecular function in other organism(GO:0044359) negative regulation of molecular function in other organism(GO:0044362) negative regulation of molecular function in other organism involved in symbiotic interaction(GO:0052204) modulation of molecular function in other organism involved in symbiotic interaction(GO:0052205) negative regulation by host of symbiont molecular function(GO:0052405) modification by host of symbiont molecular function(GO:0052428) |
0.2 | 2.9 | GO:0008340 | determination of adult lifespan(GO:0008340) |
0.2 | 2.0 | GO:0051044 | positive regulation of membrane protein ectodomain proteolysis(GO:0051044) |
0.2 | 0.9 | GO:0035616 | histone H2B conserved C-terminal lysine deubiquitination(GO:0035616) |
0.2 | 1.1 | GO:0071493 | cellular response to UV-B(GO:0071493) |
0.2 | 2.8 | GO:0048671 | negative regulation of collateral sprouting(GO:0048671) |
0.2 | 3.9 | GO:0032011 | ARF protein signal transduction(GO:0032011) regulation of ARF protein signal transduction(GO:0032012) |
0.2 | 0.7 | GO:0000379 | tRNA-type intron splice site recognition and cleavage(GO:0000379) |
0.2 | 0.9 | GO:0044406 | adhesion of symbiont to host(GO:0044406) |
0.2 | 1.4 | GO:0030644 | cellular chloride ion homeostasis(GO:0030644) |
0.2 | 0.7 | GO:1902477 | defense response, incompatible interaction(GO:0009814) defense response to bacterium, incompatible interaction(GO:0009816) regulation of defense response to bacterium, incompatible interaction(GO:1902477) |
0.2 | 0.3 | GO:1904996 | positive regulation of leukocyte adhesion to vascular endothelial cell(GO:1904996) |
0.2 | 0.5 | GO:1904579 | response to thapsigargin(GO:1904578) cellular response to thapsigargin(GO:1904579) |
0.2 | 1.0 | GO:0090503 | RNA phosphodiester bond hydrolysis, exonucleolytic(GO:0090503) |
0.2 | 1.4 | GO:0019673 | GDP-mannose metabolic process(GO:0019673) |
0.2 | 1.9 | GO:0000244 | spliceosomal tri-snRNP complex assembly(GO:0000244) |
0.2 | 2.4 | GO:0032287 | peripheral nervous system myelin maintenance(GO:0032287) |
0.2 | 2.1 | GO:0046597 | negative regulation of viral entry into host cell(GO:0046597) |
0.2 | 0.7 | GO:1901491 | negative regulation of lymphangiogenesis(GO:1901491) |
0.2 | 1.0 | GO:0010815 | bradykinin catabolic process(GO:0010815) |
0.2 | 0.8 | GO:0018343 | protein farnesylation(GO:0018343) |
0.2 | 1.0 | GO:0032596 | protein transport into membrane raft(GO:0032596) |
0.2 | 2.9 | GO:0099612 | protein localization to axon(GO:0099612) |
0.2 | 1.3 | GO:0016576 | histone dephosphorylation(GO:0016576) |
0.2 | 1.2 | GO:0045292 | mRNA cis splicing, via spliceosome(GO:0045292) |
0.2 | 2.7 | GO:1903818 | positive regulation of voltage-gated potassium channel activity(GO:1903818) |
0.2 | 5.1 | GO:0033119 | negative regulation of RNA splicing(GO:0033119) |
0.2 | 1.5 | GO:0007168 | receptor guanylyl cyclase signaling pathway(GO:0007168) |
0.2 | 0.5 | GO:0097309 | cap1 mRNA methylation(GO:0097309) |
0.2 | 4.4 | GO:0071427 | mRNA export from nucleus(GO:0006406) mRNA-containing ribonucleoprotein complex export from nucleus(GO:0071427) |
0.2 | 0.6 | GO:0099639 | neurotransmitter receptor transport, endosome to postsynaptic membrane(GO:0098887) neurotransmitter receptor transport, endosome to plasma membrane(GO:0099639) |
0.2 | 0.5 | GO:1990928 | response to amino acid starvation(GO:1990928) |
0.2 | 0.5 | GO:2000774 | positive regulation of cellular senescence(GO:2000774) |
0.2 | 6.0 | GO:0032611 | interleukin-1 beta production(GO:0032611) |
0.2 | 1.9 | GO:0001574 | ganglioside biosynthetic process(GO:0001574) |
0.2 | 4.1 | GO:0035411 | catenin import into nucleus(GO:0035411) |
0.2 | 1.7 | GO:0046549 | retinal cone cell development(GO:0046549) |
0.2 | 1.6 | GO:2000741 | positive regulation of mesenchymal stem cell differentiation(GO:2000741) |
0.2 | 1.4 | GO:0010838 | positive regulation of keratinocyte proliferation(GO:0010838) |
0.2 | 0.6 | GO:0007000 | nucleolus organization(GO:0007000) |
0.2 | 2.2 | GO:1901223 | negative regulation of NIK/NF-kappaB signaling(GO:1901223) |
0.2 | 0.3 | GO:0071492 | cellular response to UV-A(GO:0071492) |
0.2 | 3.1 | GO:0070208 | protein heterotrimerization(GO:0070208) |
0.2 | 0.3 | GO:0032423 | regulation of mismatch repair(GO:0032423) |
0.2 | 0.5 | GO:0048254 | snoRNA localization(GO:0048254) |
0.2 | 2.3 | GO:0098801 | regulation of renal system process(GO:0098801) |
0.2 | 6.4 | GO:0015804 | neutral amino acid transport(GO:0015804) |
0.2 | 0.5 | GO:0002940 | tRNA N2-guanine methylation(GO:0002940) |
0.1 | 5.1 | GO:0090162 | establishment of epithelial cell polarity(GO:0090162) |
0.1 | 0.9 | GO:0051612 | negative regulation of neurotransmitter uptake(GO:0051581) negative regulation of serotonin uptake(GO:0051612) |
0.1 | 0.4 | GO:0051866 | general adaptation syndrome(GO:0051866) |
0.1 | 0.9 | GO:0016078 | tRNA catabolic process(GO:0016078) |
0.1 | 0.7 | GO:0032901 | positive regulation of neurotrophin production(GO:0032901) |
0.1 | 2.0 | GO:0071158 | positive regulation of cell cycle arrest(GO:0071158) |
0.1 | 0.4 | GO:0034720 | histone H3-K4 demethylation(GO:0034720) |
0.1 | 1.3 | GO:0070475 | rRNA base methylation(GO:0070475) |
0.1 | 0.6 | GO:0033631 | cell-cell adhesion mediated by integrin(GO:0033631) |
0.1 | 0.1 | GO:0006361 | transcription initiation from RNA polymerase I promoter(GO:0006361) termination of RNA polymerase I transcription(GO:0006363) |
0.1 | 0.1 | GO:0045041 | protein import into mitochondrial intermembrane space(GO:0045041) |
0.1 | 2.7 | GO:0006911 | phagocytosis, engulfment(GO:0006911) |
0.1 | 0.8 | GO:0035809 | regulation of urine volume(GO:0035809) |
0.1 | 4.1 | GO:0006379 | mRNA cleavage(GO:0006379) |
0.1 | 0.8 | GO:0090238 | positive regulation of arachidonic acid secretion(GO:0090238) |
0.1 | 0.8 | GO:0098532 | histone H3-K27 trimethylation(GO:0098532) |
0.1 | 4.1 | GO:0031424 | keratinization(GO:0031424) |
0.1 | 0.4 | GO:0060715 | syncytiotrophoblast cell differentiation involved in labyrinthine layer development(GO:0060715) |
0.1 | 2.1 | GO:2000052 | positive regulation of non-canonical Wnt signaling pathway(GO:2000052) |
0.1 | 0.8 | GO:0002903 | negative regulation of B cell apoptotic process(GO:0002903) |
0.1 | 0.8 | GO:0001672 | regulation of chromatin assembly or disassembly(GO:0001672) |
0.1 | 0.9 | GO:0001840 | neural plate development(GO:0001840) |
0.1 | 0.8 | GO:0032785 | negative regulation of DNA-templated transcription, elongation(GO:0032785) negative regulation of transcription elongation from RNA polymerase II promoter(GO:0034244) |
0.1 | 0.4 | GO:0017055 | negative regulation of RNA polymerase II transcriptional preinitiation complex assembly(GO:0017055) |
0.1 | 0.5 | GO:0007089 | traversing start control point of mitotic cell cycle(GO:0007089) |
0.1 | 1.5 | GO:0031571 | mitotic G1 DNA damage checkpoint(GO:0031571) |
0.1 | 1.9 | GO:0043374 | CD8-positive, alpha-beta T cell differentiation(GO:0043374) |
0.1 | 0.8 | GO:0033564 | anterior/posterior axon guidance(GO:0033564) |
0.1 | 4.6 | GO:0042274 | ribosomal small subunit biogenesis(GO:0042274) |
0.1 | 0.9 | GO:0060965 | negative regulation of gene silencing by miRNA(GO:0060965) |
0.1 | 2.0 | GO:0031069 | hair follicle morphogenesis(GO:0031069) |
0.1 | 0.8 | GO:2000809 | positive regulation of synaptic vesicle clustering(GO:2000809) |
0.1 | 0.3 | GO:0061357 | positive regulation of Wnt protein secretion(GO:0061357) |
0.1 | 0.6 | GO:2000786 | positive regulation of autophagosome assembly(GO:2000786) |
0.1 | 0.8 | GO:2001170 | negative regulation of dopamine secretion(GO:0033602) negative regulation of ATP biosynthetic process(GO:2001170) |
0.1 | 4.4 | GO:0006376 | mRNA splice site selection(GO:0006376) |
0.1 | 1.5 | GO:0033234 | negative regulation of protein sumoylation(GO:0033234) |
0.1 | 1.2 | GO:0061615 | glycolytic process through fructose-6-phosphate(GO:0061615) |
0.1 | 0.7 | GO:0048549 | positive regulation of pinocytosis(GO:0048549) |
0.1 | 1.4 | GO:0046040 | IMP metabolic process(GO:0046040) |
0.1 | 1.2 | GO:0021796 | cerebral cortex regionalization(GO:0021796) |
0.1 | 0.7 | GO:1900042 | positive regulation of interleukin-2 secretion(GO:1900042) |
0.1 | 7.4 | GO:0007218 | neuropeptide signaling pathway(GO:0007218) |
0.1 | 0.4 | GO:0034427 | nuclear-transcribed mRNA catabolic process, exonucleolytic, 3'-5'(GO:0034427) |
0.1 | 0.5 | GO:0036151 | phosphatidylcholine acyl-chain remodeling(GO:0036151) |
0.1 | 2.8 | GO:0000387 | spliceosomal snRNP assembly(GO:0000387) |
0.1 | 1.0 | GO:0042790 | transcription of nuclear large rRNA transcript from RNA polymerase I promoter(GO:0042790) |
0.1 | 0.9 | GO:0098535 | de novo centriole assembly(GO:0098535) |
0.1 | 1.1 | GO:0010715 | regulation of extracellular matrix disassembly(GO:0010715) |
0.1 | 3.2 | GO:0051567 | histone H3-K9 methylation(GO:0051567) |
0.1 | 2.1 | GO:0010603 | regulation of cytoplasmic mRNA processing body assembly(GO:0010603) |
0.1 | 0.8 | GO:1905146 | lysosomal protein catabolic process(GO:1905146) |
0.1 | 3.1 | GO:0051482 | positive regulation of cytosolic calcium ion concentration involved in phospholipase C-activating G-protein coupled signaling pathway(GO:0051482) |
0.1 | 0.7 | GO:0071985 | multivesicular body sorting pathway(GO:0071985) |
0.1 | 0.6 | GO:0043137 | DNA replication, removal of RNA primer(GO:0043137) |
0.1 | 0.6 | GO:0048686 | regulation of sprouting of injured axon(GO:0048686) regulation of axon extension involved in regeneration(GO:0048690) |
0.1 | 1.9 | GO:0002931 | response to ischemia(GO:0002931) |
0.1 | 0.6 | GO:0002036 | regulation of L-glutamate transport(GO:0002036) |
0.1 | 0.2 | GO:1901994 | negative regulation of meiotic cell cycle phase transition(GO:1901994) |
0.1 | 0.8 | GO:0033353 | S-adenosylmethionine cycle(GO:0033353) |
0.1 | 4.1 | GO:0006611 | protein export from nucleus(GO:0006611) |
0.1 | 1.3 | GO:0036342 | post-anal tail morphogenesis(GO:0036342) |
0.1 | 0.7 | GO:0021942 | radial glia guided migration of Purkinje cell(GO:0021942) |
0.1 | 0.8 | GO:1900120 | regulation of receptor binding(GO:1900120) |
0.1 | 7.2 | GO:0006367 | transcription initiation from RNA polymerase II promoter(GO:0006367) |
0.1 | 4.2 | GO:0006289 | nucleotide-excision repair(GO:0006289) |
0.1 | 0.7 | GO:0036066 | protein O-linked fucosylation(GO:0036066) |
0.1 | 0.6 | GO:1904263 | positive regulation of TORC1 signaling(GO:1904263) |
0.1 | 1.3 | GO:0090501 | RNA phosphodiester bond hydrolysis(GO:0090501) |
0.1 | 0.5 | GO:0045084 | positive regulation of interleukin-12 biosynthetic process(GO:0045084) |
0.1 | 1.0 | GO:0038203 | TORC2 signaling(GO:0038203) |
0.1 | 0.4 | GO:0002580 | regulation of antigen processing and presentation of peptide or polysaccharide antigen via MHC class II(GO:0002580) |
0.1 | 0.6 | GO:0003418 | growth plate cartilage chondrocyte differentiation(GO:0003418) |
0.1 | 3.7 | GO:0046856 | phosphatidylinositol dephosphorylation(GO:0046856) |
0.1 | 0.3 | GO:0006436 | tryptophanyl-tRNA aminoacylation(GO:0006436) |
0.1 | 0.6 | GO:0043950 | positive regulation of cAMP-mediated signaling(GO:0043950) |
0.1 | 0.7 | GO:0060159 | regulation of dopamine receptor signaling pathway(GO:0060159) |
0.1 | 0.2 | GO:0002304 | gamma-delta intraepithelial T cell differentiation(GO:0002304) CD8-positive, gamma-delta intraepithelial T cell differentiation(GO:0002305) |
0.1 | 1.4 | GO:0007194 | negative regulation of adenylate cyclase activity(GO:0007194) |
0.1 | 3.6 | GO:0008347 | glial cell migration(GO:0008347) |
0.1 | 4.6 | GO:0006414 | translational elongation(GO:0006414) |
0.1 | 3.0 | GO:0000184 | nuclear-transcribed mRNA catabolic process, nonsense-mediated decay(GO:0000184) |
0.1 | 0.8 | GO:1901741 | positive regulation of myoblast fusion(GO:1901741) |
0.1 | 0.8 | GO:0097500 | receptor localization to nonmotile primary cilium(GO:0097500) |
0.1 | 0.2 | GO:0042119 | neutrophil activation(GO:0042119) |
0.1 | 0.3 | GO:0009624 | response to nematode(GO:0009624) |
0.1 | 0.2 | GO:0060278 | regulation of ovulation(GO:0060278) positive regulation of ovulation(GO:0060279) |
0.1 | 0.2 | GO:0090235 | regulation of metaphase plate congression(GO:0090235) |
0.1 | 1.1 | GO:0061052 | negative regulation of cell growth involved in cardiac muscle cell development(GO:0061052) |
0.1 | 0.3 | GO:0010724 | regulation of definitive erythrocyte differentiation(GO:0010724) |
0.1 | 1.6 | GO:0060539 | diaphragm development(GO:0060539) |
0.1 | 0.6 | GO:0051694 | pointed-end actin filament capping(GO:0051694) |
0.1 | 0.1 | GO:0060143 | positive regulation of syncytium formation by plasma membrane fusion(GO:0060143) |
0.1 | 4.0 | GO:0030512 | negative regulation of transforming growth factor beta receptor signaling pathway(GO:0030512) |
0.1 | 0.5 | GO:0045585 | regulation of cytotoxic T cell differentiation(GO:0045583) positive regulation of cytotoxic T cell differentiation(GO:0045585) |
0.1 | 3.9 | GO:0010501 | RNA secondary structure unwinding(GO:0010501) |
0.1 | 0.7 | GO:0060969 | negative regulation of gene silencing(GO:0060969) |
0.1 | 2.1 | GO:0010972 | negative regulation of G2/M transition of mitotic cell cycle(GO:0010972) |
0.1 | 0.9 | GO:0060065 | uterus development(GO:0060065) |
0.1 | 1.9 | GO:0006929 | substrate-dependent cell migration(GO:0006929) |
0.1 | 1.0 | GO:0070203 | regulation of establishment of protein localization to telomere(GO:0070203) protein localization to nuclear body(GO:1903405) positive regulation of establishment of protein localization to telomere(GO:1904851) protein localization to Cajal body(GO:1904867) regulation of protein localization to Cajal body(GO:1904869) positive regulation of protein localization to Cajal body(GO:1904871) protein localization to nucleoplasm(GO:1990173) |
0.1 | 1.1 | GO:2000273 | positive regulation of receptor activity(GO:2000273) |
0.1 | 1.4 | GO:0009950 | dorsal/ventral axis specification(GO:0009950) |
0.1 | 0.8 | GO:0035196 | dsRNA fragmentation(GO:0031050) production of miRNAs involved in gene silencing by miRNA(GO:0035196) production of small RNA involved in gene silencing by RNA(GO:0070918) |
0.1 | 0.1 | GO:0042637 | catagen(GO:0042637) |
0.1 | 0.3 | GO:0071285 | cellular response to lithium ion(GO:0071285) |
0.1 | 3.3 | GO:0051028 | mRNA transport(GO:0051028) |
0.1 | 0.1 | GO:0071033 | nuclear retention of pre-mRNA at the site of transcription(GO:0071033) |
0.1 | 0.6 | GO:0021615 | glossopharyngeal nerve morphogenesis(GO:0021615) |
0.1 | 0.8 | GO:0002548 | monocyte chemotaxis(GO:0002548) |
0.1 | 0.8 | GO:0006907 | pinocytosis(GO:0006907) |
0.1 | 1.8 | GO:0030488 | tRNA methylation(GO:0030488) |
0.1 | 0.1 | GO:1901668 | regulation of superoxide dismutase activity(GO:1901668) |
0.1 | 0.5 | GO:0060314 | regulation of ryanodine-sensitive calcium-release channel activity(GO:0060314) |
0.1 | 1.6 | GO:0044458 | motile cilium assembly(GO:0044458) |
0.1 | 0.7 | GO:0033627 | cell adhesion mediated by integrin(GO:0033627) |
0.1 | 0.1 | GO:2000416 | regulation of eosinophil migration(GO:2000416) positive regulation of eosinophil migration(GO:2000418) |
0.1 | 0.1 | GO:0060437 | lung growth(GO:0060437) |
0.1 | 0.3 | GO:0023016 | signal transduction by trans-phosphorylation(GO:0023016) |
0.1 | 0.4 | GO:0001731 | formation of translation preinitiation complex(GO:0001731) |
0.1 | 0.3 | GO:0099527 | postsynapse to nucleus signaling pathway(GO:0099527) |
0.1 | 0.9 | GO:0002504 | antigen processing and presentation of peptide or polysaccharide antigen via MHC class II(GO:0002504) |
0.1 | 4.6 | GO:0031532 | actin cytoskeleton reorganization(GO:0031532) |
0.1 | 1.1 | GO:0045747 | positive regulation of Notch signaling pathway(GO:0045747) |
0.1 | 1.7 | GO:0000413 | protein peptidyl-prolyl isomerization(GO:0000413) |
0.1 | 0.8 | GO:0060044 | negative regulation of cardiac muscle cell proliferation(GO:0060044) |
0.1 | 0.5 | GO:2000352 | negative regulation of endothelial cell apoptotic process(GO:2000352) |
0.1 | 0.6 | GO:0036260 | 7-methylguanosine RNA capping(GO:0009452) RNA capping(GO:0036260) |
0.1 | 0.6 | GO:0075522 | IRES-dependent viral translational initiation(GO:0075522) |
0.1 | 0.6 | GO:0006360 | transcription from RNA polymerase I promoter(GO:0006360) |
0.1 | 1.2 | GO:0015693 | magnesium ion transport(GO:0015693) |
0.1 | 0.9 | GO:0015858 | nucleoside transport(GO:0015858) |
0.1 | 0.2 | GO:0051121 | hepoxilin metabolic process(GO:0051121) hepoxilin biosynthetic process(GO:0051122) |
0.1 | 2.8 | GO:0042100 | B cell proliferation(GO:0042100) |
0.1 | 0.4 | GO:0070933 | histone H4 deacetylation(GO:0070933) |
0.1 | 0.1 | GO:2000286 | receptor internalization involved in canonical Wnt signaling pathway(GO:2000286) |
0.1 | 0.9 | GO:0048873 | homeostasis of number of cells within a tissue(GO:0048873) |
0.1 | 0.8 | GO:0021511 | spinal cord patterning(GO:0021511) |
0.1 | 0.5 | GO:2000144 | positive regulation of DNA-templated transcription, initiation(GO:2000144) |
0.1 | 0.8 | GO:0006071 | glycerol metabolic process(GO:0006071) |
0.1 | 0.8 | GO:0050901 | leukocyte tethering or rolling(GO:0050901) |
0.1 | 1.8 | GO:0030834 | regulation of actin filament depolymerization(GO:0030834) |
0.1 | 0.7 | GO:0019985 | translesion synthesis(GO:0019985) |
0.1 | 0.2 | GO:0021995 | anterior neuropore closure(GO:0021506) neuropore closure(GO:0021995) |
0.1 | 1.7 | GO:0002181 | cytoplasmic translation(GO:0002181) |
0.1 | 0.6 | GO:0071280 | cellular response to copper ion(GO:0071280) |
0.1 | 1.0 | GO:0060088 | auditory receptor cell morphogenesis(GO:0002093) auditory receptor cell stereocilium organization(GO:0060088) |
0.1 | 0.2 | GO:1902952 | positive regulation of dendritic spine maintenance(GO:1902952) |
0.1 | 0.3 | GO:1900029 | positive regulation of ruffle assembly(GO:1900029) |
0.1 | 0.1 | GO:0061763 | multivesicular body-lysosome fusion(GO:0061763) |
0.1 | 1.6 | GO:0006493 | protein O-linked glycosylation(GO:0006493) |
0.1 | 1.3 | GO:0050771 | negative regulation of axonogenesis(GO:0050771) |
0.1 | 0.6 | GO:0000305 | response to oxygen radical(GO:0000305) |
0.1 | 0.8 | GO:0021516 | dorsal spinal cord development(GO:0021516) |
0.1 | 0.5 | GO:0060444 | branching involved in mammary gland duct morphogenesis(GO:0060444) |
0.1 | 0.4 | GO:1902474 | positive regulation of protein localization to synapse(GO:1902474) |
0.1 | 0.3 | GO:2001025 | positive regulation of response to drug(GO:2001025) |
0.0 | 2.4 | GO:0045727 | positive regulation of translation(GO:0045727) |
0.0 | 0.3 | GO:0031584 | activation of phospholipase D activity(GO:0031584) |
0.0 | 0.6 | GO:0040036 | regulation of fibroblast growth factor receptor signaling pathway(GO:0040036) |
0.0 | 0.8 | GO:0030150 | protein import into mitochondrial matrix(GO:0030150) |
0.0 | 2.3 | GO:0050907 | detection of chemical stimulus involved in sensory perception(GO:0050907) |
0.0 | 0.1 | GO:0090598 | male genitalia morphogenesis(GO:0048808) male anatomical structure morphogenesis(GO:0090598) |
0.0 | 0.1 | GO:0051835 | positive regulation of synapse structural plasticity(GO:0051835) |
0.0 | 0.3 | GO:2000270 | negative regulation of fibroblast apoptotic process(GO:2000270) |
0.0 | 0.2 | GO:0032218 | riboflavin transport(GO:0032218) |
0.0 | 0.4 | GO:0005513 | detection of calcium ion(GO:0005513) |
0.0 | 0.6 | GO:0045646 | regulation of erythrocyte differentiation(GO:0045646) |
0.0 | 0.6 | GO:0001706 | endoderm formation(GO:0001706) |
0.0 | 2.7 | GO:0006342 | chromatin silencing(GO:0006342) |
0.0 | 0.2 | GO:0032485 | regulation of Ral protein signal transduction(GO:0032485) |
0.0 | 1.2 | GO:0042462 | eye photoreceptor cell development(GO:0042462) |
0.0 | 0.7 | GO:0099517 | anterograde synaptic vesicle transport(GO:0048490) synaptic vesicle cytoskeletal transport(GO:0099514) synaptic vesicle transport along microtubule(GO:0099517) |
0.0 | 0.4 | GO:0045761 | regulation of adenylate cyclase activity(GO:0045761) |
0.0 | 1.4 | GO:0045494 | photoreceptor cell maintenance(GO:0045494) |
0.0 | 0.2 | GO:0072053 | renal inner medulla development(GO:0072053) |
0.0 | 0.5 | GO:0006744 | ubiquinone biosynthetic process(GO:0006744) |
0.0 | 1.2 | GO:0071277 | cellular response to calcium ion(GO:0071277) |
0.0 | 0.2 | GO:0051900 | regulation of mitochondrial depolarization(GO:0051900) |
0.0 | 0.6 | GO:0033233 | regulation of protein sumoylation(GO:0033233) |
0.0 | 0.3 | GO:0031274 | positive regulation of pseudopodium assembly(GO:0031274) |
0.0 | 1.2 | GO:0002690 | positive regulation of leukocyte chemotaxis(GO:0002690) |
0.0 | 0.1 | GO:0042635 | positive regulation of hair cycle(GO:0042635) positive regulation of hair follicle development(GO:0051798) |
0.0 | 0.1 | GO:0006421 | asparaginyl-tRNA aminoacylation(GO:0006421) |
0.0 | 0.8 | GO:0021680 | cerebellar Purkinje cell layer development(GO:0021680) |
0.0 | 0.3 | GO:0035879 | lactate transport(GO:0015727) lactate transmembrane transport(GO:0035873) plasma membrane lactate transport(GO:0035879) |
0.0 | 0.1 | GO:0014010 | Schwann cell proliferation(GO:0014010) |
0.0 | 0.3 | GO:0060219 | camera-type eye photoreceptor cell differentiation(GO:0060219) |
0.0 | 1.5 | GO:0006970 | response to osmotic stress(GO:0006970) |
0.0 | 0.3 | GO:0042759 | long-chain fatty acid biosynthetic process(GO:0042759) |
0.0 | 1.2 | GO:0016574 | histone ubiquitination(GO:0016574) |
0.0 | 0.1 | GO:0044773 | mitotic DNA damage checkpoint(GO:0044773) |
0.0 | 0.2 | GO:0030046 | parallel actin filament bundle assembly(GO:0030046) |
0.0 | 0.2 | GO:0032099 | negative regulation of response to food(GO:0032096) negative regulation of appetite(GO:0032099) |
0.0 | 0.9 | GO:0006826 | iron ion transport(GO:0006826) |
0.0 | 0.5 | GO:0035428 | hexose transmembrane transport(GO:0035428) |
0.0 | 0.4 | GO:0006700 | C21-steroid hormone biosynthetic process(GO:0006700) |
0.0 | 0.4 | GO:0032958 | inositol phosphate biosynthetic process(GO:0032958) |
0.0 | 1.6 | GO:0051225 | spindle assembly(GO:0051225) |
0.0 | 0.2 | GO:2001256 | regulation of store-operated calcium entry(GO:2001256) |
0.0 | 0.1 | GO:0036297 | interstrand cross-link repair(GO:0036297) |
0.0 | 0.2 | GO:0035855 | megakaryocyte development(GO:0035855) |
0.0 | 0.1 | GO:0007308 | oocyte construction(GO:0007308) oocyte axis specification(GO:0007309) oocyte anterior/posterior axis specification(GO:0007314) pole plasm assembly(GO:0007315) maternal determination of anterior/posterior axis, embryo(GO:0008358) P granule organization(GO:0030719) |
0.0 | 0.6 | GO:1902808 | positive regulation of cell cycle G1/S phase transition(GO:1902808) |
0.0 | 0.1 | GO:0072697 | protein localization to cell cortex(GO:0072697) |
0.0 | 0.3 | GO:0016180 | snRNA processing(GO:0016180) |
0.0 | 0.1 | GO:0033962 | cytoplasmic mRNA processing body assembly(GO:0033962) |
0.0 | 0.2 | GO:0035721 | intraciliary retrograde transport(GO:0035721) |
0.0 | 0.2 | GO:0046339 | diacylglycerol metabolic process(GO:0046339) |
0.0 | 0.4 | GO:0000281 | mitotic cytokinesis(GO:0000281) |
0.0 | 0.0 | GO:0075525 | viral translational termination-reinitiation(GO:0075525) |
0.0 | 0.2 | GO:0035455 | response to interferon-alpha(GO:0035455) |
0.0 | 0.3 | GO:0006270 | DNA replication initiation(GO:0006270) |
0.0 | 0.3 | GO:2000480 | negative regulation of cAMP-dependent protein kinase activity(GO:2000480) |
0.0 | 0.3 | GO:0003351 | epithelial cilium movement(GO:0003351) |
0.0 | 0.3 | GO:0031122 | cytoplasmic microtubule organization(GO:0031122) |
0.0 | 0.4 | GO:2000045 | regulation of G1/S transition of mitotic cell cycle(GO:2000045) |
0.0 | 0.1 | GO:1902166 | negative regulation of intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator(GO:1902166) |
0.0 | 0.2 | GO:0007257 | activation of JUN kinase activity(GO:0007257) |
0.0 | 0.0 | GO:0070682 | proteasome regulatory particle assembly(GO:0070682) |
0.0 | 0.2 | GO:0008156 | negative regulation of DNA replication(GO:0008156) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
4.6 | 18.6 | GO:0005944 | phosphatidylinositol 3-kinase complex, class IB(GO:0005944) |
2.9 | 45.8 | GO:0042582 | primary lysosome(GO:0005766) azurophil granule(GO:0042582) |
2.3 | 25.0 | GO:0043020 | NADPH oxidase complex(GO:0043020) |
2.2 | 6.7 | GO:0005588 | collagen type V trimer(GO:0005588) |
2.1 | 10.6 | GO:0097149 | centralspindlin complex(GO:0097149) |
2.0 | 8.2 | GO:0008623 | CHRAC(GO:0008623) |
2.0 | 6.1 | GO:0030905 | retromer, tubulation complex(GO:0030905) |
2.0 | 11.9 | GO:0031262 | Ndc80 complex(GO:0031262) |
1.9 | 9.3 | GO:0031680 | G-protein beta/gamma-subunit complex(GO:0031680) |
1.6 | 16.2 | GO:0042581 | specific granule(GO:0042581) |
1.5 | 12.2 | GO:0031232 | extrinsic component of external side of plasma membrane(GO:0031232) |
1.5 | 12.0 | GO:0005833 | hemoglobin complex(GO:0005833) |
1.5 | 4.5 | GO:0005673 | transcription factor TFIIE complex(GO:0005673) |
1.4 | 15.3 | GO:1990712 | HFE-transferrin receptor complex(GO:1990712) |
1.4 | 5.4 | GO:0008537 | proteasome activator complex(GO:0008537) |
1.4 | 4.1 | GO:0036387 | nuclear pre-replicative complex(GO:0005656) pre-replicative complex(GO:0036387) |
1.3 | 5.4 | GO:0097169 | AIM2 inflammasome complex(GO:0097169) |
1.3 | 7.9 | GO:0097443 | sorting endosome(GO:0097443) |
1.3 | 16.3 | GO:0031254 | uropod(GO:0001931) cell trailing edge(GO:0031254) |
1.2 | 7.4 | GO:0044615 | nuclear pore nuclear basket(GO:0044615) |
1.2 | 13.6 | GO:0072687 | meiotic spindle(GO:0072687) |
1.2 | 8.2 | GO:0005826 | actomyosin contractile ring(GO:0005826) |
1.2 | 3.5 | GO:0042585 | nuclear condensin complex(GO:0000799) germinal vesicle(GO:0042585) |
1.1 | 3.4 | GO:0042272 | nuclear RNA export factor complex(GO:0042272) |
1.1 | 1.1 | GO:0061574 | ASAP complex(GO:0061574) |
1.0 | 4.1 | GO:0071438 | invadopodium membrane(GO:0071438) |
1.0 | 3.1 | GO:0002944 | cyclin K-CDK12 complex(GO:0002944) |
1.0 | 6.2 | GO:0031673 | H zone(GO:0031673) |
1.0 | 3.0 | GO:0031933 | telomeric heterochromatin(GO:0031933) |
0.9 | 2.8 | GO:0033186 | CAF-1 complex(GO:0033186) |
0.9 | 6.4 | GO:0019815 | B cell receptor complex(GO:0019815) |
0.9 | 26.3 | GO:0001891 | phagocytic cup(GO:0001891) |
0.9 | 8.2 | GO:0031390 | Ctf18 RFC-like complex(GO:0031390) |
0.9 | 5.2 | GO:0070937 | CRD-mediated mRNA stability complex(GO:0070937) |
0.8 | 5.1 | GO:0005890 | sodium:potassium-exchanging ATPase complex(GO:0005890) cation-transporting ATPase complex(GO:0090533) |
0.8 | 12.6 | GO:0031618 | nuclear pericentric heterochromatin(GO:0031618) |
0.8 | 2.5 | GO:0032127 | dense core granule membrane(GO:0032127) |
0.8 | 0.8 | GO:0030690 | Noc1p-Noc2p complex(GO:0030690) |
0.8 | 12.4 | GO:0097539 | ciliary transition fiber(GO:0097539) |
0.8 | 4.1 | GO:0048476 | Holliday junction resolvase complex(GO:0048476) |
0.8 | 5.7 | GO:0031466 | Cul5-RING ubiquitin ligase complex(GO:0031466) |
0.8 | 4.0 | GO:0043202 | lysosomal lumen(GO:0043202) |
0.8 | 5.6 | GO:0072379 | BAT3 complex(GO:0071818) ER membrane insertion complex(GO:0072379) |
0.7 | 7.5 | GO:0097197 | tetraspanin-enriched microdomain(GO:0097197) |
0.7 | 3.6 | GO:0001740 | Barr body(GO:0001740) |
0.7 | 4.9 | GO:0005927 | muscle tendon junction(GO:0005927) |
0.7 | 4.1 | GO:0000235 | astral microtubule(GO:0000235) |
0.7 | 12.7 | GO:0005721 | pericentric heterochromatin(GO:0005721) |
0.7 | 2.6 | GO:0097058 | CRLF-CLCF1 complex(GO:0097058) |
0.7 | 15.1 | GO:0000242 | pericentriolar material(GO:0000242) |
0.6 | 38.1 | GO:0000307 | cyclin-dependent protein kinase holoenzyme complex(GO:0000307) |
0.6 | 5.7 | GO:0008278 | cohesin complex(GO:0008278) |
0.6 | 2.5 | GO:0033063 | Rad51B-Rad51C-Rad51D-XRCC2 complex(GO:0033063) |
0.6 | 15.8 | GO:0035098 | ESC/E(Z) complex(GO:0035098) |
0.6 | 5.4 | GO:0005577 | fibrinogen complex(GO:0005577) |
0.6 | 4.8 | GO:0001739 | sex chromatin(GO:0001739) |
0.6 | 7.8 | GO:0005862 | muscle thin filament tropomyosin(GO:0005862) |
0.6 | 4.8 | GO:0097342 | ripoptosome(GO:0097342) |
0.6 | 1.7 | GO:0042584 | chromaffin granule membrane(GO:0042584) |
0.6 | 11.2 | GO:0031527 | filopodium membrane(GO:0031527) |
0.6 | 9.9 | GO:0031235 | intrinsic component of the cytoplasmic side of the plasma membrane(GO:0031235) |
0.5 | 25.0 | GO:0031430 | M band(GO:0031430) |
0.5 | 5.9 | GO:0000812 | Swr1 complex(GO:0000812) |
0.5 | 2.1 | GO:0032280 | symmetric synapse(GO:0032280) |
0.5 | 3.7 | GO:0000796 | condensin complex(GO:0000796) |
0.5 | 1.5 | GO:1990257 | piccolo-bassoon transport vesicle(GO:1990257) |
0.5 | 2.5 | GO:0005658 | alpha DNA polymerase:primase complex(GO:0005658) |
0.5 | 6.5 | GO:0031315 | extrinsic component of mitochondrial outer membrane(GO:0031315) |
0.5 | 9.0 | GO:0005861 | troponin complex(GO:0005861) |
0.5 | 0.5 | GO:0070820 | tertiary granule(GO:0070820) |
0.5 | 17.7 | GO:0008305 | integrin complex(GO:0008305) |
0.5 | 1.5 | GO:0071001 | U4/U6 snRNP(GO:0071001) |
0.5 | 2.4 | GO:0070876 | SOSS complex(GO:0070876) |
0.5 | 16.1 | GO:0002102 | podosome(GO:0002102) |
0.5 | 1.4 | GO:0099524 | region of cytosol(GO:0099522) postsynaptic cytosol(GO:0099524) |
0.5 | 8.9 | GO:0044224 | juxtaparanode region of axon(GO:0044224) |
0.5 | 2.8 | GO:1990075 | periciliary membrane compartment(GO:1990075) |
0.5 | 3.7 | GO:0042382 | paraspeckles(GO:0042382) |
0.5 | 2.3 | GO:0031467 | Cul7-RING ubiquitin ligase complex(GO:0031467) |
0.5 | 1.8 | GO:1902937 | inward rectifier potassium channel complex(GO:1902937) |
0.4 | 2.7 | GO:0031428 | box C/D snoRNP complex(GO:0031428) |
0.4 | 7.1 | GO:0036056 | filtration diaphragm(GO:0036056) slit diaphragm(GO:0036057) |
0.4 | 1.3 | GO:0035061 | interchromatin granule(GO:0035061) |
0.4 | 1.3 | GO:0038045 | large latent transforming growth factor-beta complex(GO:0038045) |
0.4 | 2.5 | GO:0005672 | transcription factor TFIIA complex(GO:0005672) |
0.4 | 6.8 | GO:0002199 | zona pellucida receptor complex(GO:0002199) |
0.4 | 4.6 | GO:1990907 | beta-catenin-TCF complex(GO:1990907) |
0.4 | 2.0 | GO:0031298 | replication fork protection complex(GO:0031298) |
0.4 | 2.0 | GO:0001651 | dense fibrillar component(GO:0001651) |
0.4 | 16.7 | GO:0015030 | Cajal body(GO:0015030) |
0.4 | 3.1 | GO:0035068 | micro-ribonucleoprotein complex(GO:0035068) |
0.4 | 1.2 | GO:0034457 | Mpp10 complex(GO:0034457) |
0.4 | 9.8 | GO:0008074 | guanylate cyclase complex, soluble(GO:0008074) |
0.4 | 3.8 | GO:0000940 | condensed chromosome outer kinetochore(GO:0000940) |
0.4 | 0.7 | GO:0031523 | Myb complex(GO:0031523) |
0.4 | 40.6 | GO:0017053 | transcriptional repressor complex(GO:0017053) |
0.4 | 1.1 | GO:1990667 | PCSK9-AnxA2 complex(GO:1990667) |
0.4 | 28.6 | GO:0022625 | cytosolic large ribosomal subunit(GO:0022625) |
0.4 | 1.1 | GO:0071953 | elastic fiber(GO:0071953) |
0.3 | 7.0 | GO:0051233 | spindle midzone(GO:0051233) |
0.3 | 1.3 | GO:0005683 | U7 snRNP(GO:0005683) |
0.3 | 1.3 | GO:0032021 | NELF complex(GO:0032021) |
0.3 | 2.9 | GO:0071141 | SMAD protein complex(GO:0071141) |
0.3 | 6.6 | GO:0005682 | U5 snRNP(GO:0005682) |
0.3 | 0.9 | GO:0030981 | cortical microtubule cytoskeleton(GO:0030981) |
0.3 | 4.3 | GO:0031672 | A band(GO:0031672) |
0.3 | 4.5 | GO:0042555 | MCM complex(GO:0042555) |
0.3 | 2.7 | GO:0032009 | early phagosome(GO:0032009) |
0.3 | 2.1 | GO:0070938 | contractile ring(GO:0070938) |
0.3 | 3.0 | GO:0043219 | lateral loop(GO:0043219) |
0.3 | 0.9 | GO:0001405 | presequence translocase-associated import motor(GO:0001405) |
0.3 | 1.2 | GO:0097450 | astrocyte end-foot(GO:0097450) |
0.3 | 3.3 | GO:0097431 | mitotic spindle pole(GO:0097431) |
0.3 | 13.7 | GO:0022627 | cytosolic small ribosomal subunit(GO:0022627) |
0.3 | 1.9 | GO:0042406 | extrinsic component of endoplasmic reticulum membrane(GO:0042406) |
0.3 | 13.8 | GO:0005657 | replication fork(GO:0005657) |
0.3 | 4.2 | GO:0005852 | eukaryotic translation initiation factor 3 complex(GO:0005852) |
0.3 | 2.1 | GO:0098837 | postsynaptic recycling endosome(GO:0098837) |
0.3 | 0.8 | GO:0072534 | perineuronal net(GO:0072534) |
0.3 | 1.0 | GO:0005742 | mitochondrial outer membrane translocase complex(GO:0005742) |
0.3 | 7.9 | GO:0031307 | integral component of mitochondrial outer membrane(GO:0031307) |
0.3 | 19.2 | GO:0031985 | Golgi cisterna(GO:0031985) |
0.2 | 1.5 | GO:0044530 | supraspliceosomal complex(GO:0044530) |
0.2 | 4.0 | GO:0005685 | U1 snRNP(GO:0005685) |
0.2 | 2.5 | GO:0030688 | preribosome, small subunit precursor(GO:0030688) |
0.2 | 3.4 | GO:0033202 | DNA helicase complex(GO:0033202) |
0.2 | 2.6 | GO:0033093 | Weibel-Palade body(GO:0033093) |
0.2 | 3.8 | GO:0071011 | precatalytic spliceosome(GO:0071011) |
0.2 | 1.2 | GO:1990769 | proximal neuron projection(GO:1990769) |
0.2 | 0.5 | GO:0044292 | dendrite terminus(GO:0044292) |
0.2 | 1.1 | GO:0033503 | HULC complex(GO:0033503) |
0.2 | 2.7 | GO:0005865 | striated muscle thin filament(GO:0005865) |
0.2 | 1.5 | GO:0033116 | endoplasmic reticulum-Golgi intermediate compartment membrane(GO:0033116) |
0.2 | 7.7 | GO:0005720 | nuclear heterochromatin(GO:0005720) |
0.2 | 0.9 | GO:0000120 | RNA polymerase I transcription factor complex(GO:0000120) |
0.2 | 3.5 | GO:0032045 | guanyl-nucleotide exchange factor complex(GO:0032045) |
0.2 | 0.6 | GO:0032783 | ELL-EAF complex(GO:0032783) |
0.2 | 2.4 | GO:0043194 | axon initial segment(GO:0043194) |
0.2 | 2.4 | GO:0019773 | proteasome core complex, alpha-subunit complex(GO:0019773) |
0.2 | 2.4 | GO:0070852 | cell body fiber(GO:0070852) |
0.2 | 4.9 | GO:0031362 | anchored component of external side of plasma membrane(GO:0031362) |
0.2 | 16.2 | GO:0016529 | sarcoplasmic reticulum(GO:0016529) |
0.2 | 1.0 | GO:0043527 | tRNA methyltransferase complex(GO:0043527) |
0.2 | 1.2 | GO:0000172 | ribonuclease MRP complex(GO:0000172) |
0.2 | 1.4 | GO:1990454 | L-type voltage-gated calcium channel complex(GO:1990454) |
0.2 | 3.4 | GO:0016528 | sarcoplasm(GO:0016528) |
0.2 | 1.2 | GO:0070847 | core mediator complex(GO:0070847) |
0.2 | 2.1 | GO:0031209 | SCAR complex(GO:0031209) |
0.2 | 4.5 | GO:0043196 | varicosity(GO:0043196) |
0.2 | 2.6 | GO:0097542 | ciliary tip(GO:0097542) |
0.2 | 1.8 | GO:0042629 | mast cell granule(GO:0042629) |
0.2 | 1.2 | GO:0071439 | clathrin complex(GO:0071439) |
0.2 | 0.5 | GO:0005608 | laminin-3 complex(GO:0005608) |
0.2 | 0.9 | GO:0005859 | muscle myosin complex(GO:0005859) |
0.2 | 6.5 | GO:0030136 | clathrin-coated vesicle(GO:0030136) |
0.2 | 5.6 | GO:0000788 | nuclear nucleosome(GO:0000788) |
0.2 | 0.7 | GO:0097504 | Gemini of coiled bodies(GO:0097504) |
0.2 | 2.0 | GO:0097208 | alveolar lamellar body(GO:0097208) |
0.2 | 2.2 | GO:0005641 | nuclear envelope lumen(GO:0005641) |
0.2 | 1.6 | GO:0070545 | PeBoW complex(GO:0070545) |
0.2 | 23.5 | GO:0005884 | actin filament(GO:0005884) |
0.1 | 0.7 | GO:0005955 | calcineurin complex(GO:0005955) |
0.1 | 4.6 | GO:0097228 | sperm principal piece(GO:0097228) |
0.1 | 12.1 | GO:0005905 | clathrin-coated pit(GO:0005905) |
0.1 | 0.4 | GO:0033553 | rDNA heterochromatin(GO:0033553) |
0.1 | 1.9 | GO:1990124 | messenger ribonucleoprotein complex(GO:1990124) |
0.1 | 3.7 | GO:0045335 | phagocytic vesicle(GO:0045335) |
0.1 | 0.7 | GO:0044352 | pinosome(GO:0044352) macropinosome(GO:0044354) |
0.1 | 0.6 | GO:0071797 | LUBAC complex(GO:0071797) |
0.1 | 4.9 | GO:0035145 | exon-exon junction complex(GO:0035145) |
0.1 | 2.6 | GO:0042627 | chylomicron(GO:0042627) |
0.1 | 4.1 | GO:0045095 | keratin filament(GO:0045095) |
0.1 | 1.0 | GO:0030015 | CCR4-NOT core complex(GO:0030015) |
0.1 | 3.1 | GO:0016327 | apicolateral plasma membrane(GO:0016327) |
0.1 | 0.5 | GO:0071203 | WASH complex(GO:0071203) |
0.1 | 0.4 | GO:0005606 | laminin-1 complex(GO:0005606) laminin-2 complex(GO:0005607) |
0.1 | 0.6 | GO:0061689 | tricellular tight junction(GO:0061689) |
0.1 | 0.6 | GO:0097136 | Bcl-2 family protein complex(GO:0097136) |
0.1 | 0.4 | GO:0055087 | Ski complex(GO:0055087) |
0.1 | 17.5 | GO:0031234 | extrinsic component of cytoplasmic side of plasma membrane(GO:0031234) |
0.1 | 0.5 | GO:0071148 | TEAD-1-YAP complex(GO:0071148) |
0.1 | 4.5 | GO:0097440 | apical dendrite(GO:0097440) |
0.1 | 0.7 | GO:0000214 | tRNA-intron endonuclease complex(GO:0000214) |
0.1 | 8.6 | GO:0032432 | actin filament bundle(GO:0032432) |
0.1 | 0.9 | GO:0097524 | sperm plasma membrane(GO:0097524) |
0.1 | 0.6 | GO:1990131 | EGO complex(GO:0034448) Gtr1-Gtr2 GTPase complex(GO:1990131) |
0.1 | 2.6 | GO:0030131 | clathrin adaptor complex(GO:0030131) |
0.1 | 0.7 | GO:0032299 | ribonuclease H2 complex(GO:0032299) |
0.1 | 0.7 | GO:0071986 | Ragulator complex(GO:0071986) |
0.1 | 1.3 | GO:0034518 | mRNA cap binding complex(GO:0005845) RNA cap binding complex(GO:0034518) |
0.1 | 0.1 | GO:0044614 | nuclear pore cytoplasmic filaments(GO:0044614) |
0.1 | 2.4 | GO:0032040 | small-subunit processome(GO:0032040) |
0.1 | 2.6 | GO:0005680 | anaphase-promoting complex(GO:0005680) |
0.1 | 1.2 | GO:0043240 | Fanconi anaemia nuclear complex(GO:0043240) |
0.1 | 4.0 | GO:0000786 | nucleosome(GO:0000786) DNA packaging complex(GO:0044815) |
0.1 | 1.5 | GO:0008250 | oligosaccharyltransferase complex(GO:0008250) |
0.1 | 1.0 | GO:0008385 | IkappaB kinase complex(GO:0008385) |
0.1 | 1.4 | GO:0071006 | U2-type catalytic step 1 spliceosome(GO:0071006) |
0.1 | 0.4 | GO:0090543 | Flemming body(GO:0090543) |
0.1 | 0.8 | GO:0034464 | BBSome(GO:0034464) |
0.1 | 1.0 | GO:0000445 | THO complex(GO:0000347) THO complex part of transcription export complex(GO:0000445) |
0.1 | 0.4 | GO:0000221 | vacuolar proton-transporting V-type ATPase, V1 domain(GO:0000221) |
0.1 | 9.3 | GO:0005913 | cell-cell adherens junction(GO:0005913) |
0.1 | 0.9 | GO:0031080 | nuclear pore outer ring(GO:0031080) |
0.1 | 5.7 | GO:0009898 | cytoplasmic side of plasma membrane(GO:0009898) |
0.1 | 0.7 | GO:0045180 | basal cortex(GO:0045180) |
0.1 | 1.5 | GO:0005689 | U12-type spliceosomal complex(GO:0005689) |
0.1 | 0.4 | GO:0031021 | interphase microtubule organizing center(GO:0031021) |
0.1 | 2.4 | GO:0032588 | trans-Golgi network membrane(GO:0032588) |
0.1 | 0.2 | GO:0033596 | TSC1-TSC2 complex(GO:0033596) |
0.1 | 3.4 | GO:0008180 | COP9 signalosome(GO:0008180) |
0.1 | 1.2 | GO:0036157 | outer dynein arm(GO:0036157) |
0.1 | 1.2 | GO:0017101 | aminoacyl-tRNA synthetase multienzyme complex(GO:0017101) |
0.1 | 0.3 | GO:1990452 | Parkin-FBXW7-Cul1 ubiquitin ligase complex(GO:1990452) |
0.1 | 2.7 | GO:0080008 | Cul4-RING E3 ubiquitin ligase complex(GO:0080008) |
0.1 | 0.6 | GO:0005638 | lamin filament(GO:0005638) |
0.1 | 0.5 | GO:0005850 | eukaryotic translation initiation factor 2 complex(GO:0005850) |
0.1 | 1.7 | GO:0097038 | perinuclear endoplasmic reticulum(GO:0097038) |
0.1 | 1.3 | GO:0034451 | centriolar satellite(GO:0034451) |
0.1 | 4.9 | GO:0000118 | histone deacetylase complex(GO:0000118) |
0.1 | 1.0 | GO:0098827 | endoplasmic reticulum tubular network(GO:0071782) endoplasmic reticulum subcompartment(GO:0098827) |
0.1 | 9.3 | GO:0001726 | ruffle(GO:0001726) |
0.1 | 1.3 | GO:0005736 | DNA-directed RNA polymerase I complex(GO:0005736) |
0.1 | 0.9 | GO:0005640 | nuclear outer membrane(GO:0005640) |
0.1 | 0.4 | GO:0097422 | tubular endosome(GO:0097422) |
0.1 | 12.1 | GO:0043209 | myelin sheath(GO:0043209) |
0.1 | 3.1 | GO:0000776 | kinetochore(GO:0000776) |
0.1 | 1.0 | GO:0031932 | TORC2 complex(GO:0031932) |
0.1 | 2.2 | GO:0001533 | cornified envelope(GO:0001533) |
0.1 | 0.3 | GO:0071014 | post-mRNA release spliceosomal complex(GO:0071014) |
0.1 | 32.2 | GO:0031012 | extracellular matrix(GO:0031012) |
0.1 | 3.2 | GO:0071013 | catalytic step 2 spliceosome(GO:0071013) |
0.1 | 0.6 | GO:0000801 | central element(GO:0000801) |
0.1 | 0.9 | GO:0030061 | mitochondrial crista(GO:0030061) |
0.1 | 10.9 | GO:0005819 | spindle(GO:0005819) |
0.1 | 2.4 | GO:0016459 | myosin complex(GO:0016459) |
0.1 | 0.5 | GO:0042405 | nuclear inclusion body(GO:0042405) |
0.1 | 0.4 | GO:0044294 | dendritic growth cone(GO:0044294) |
0.1 | 1.8 | GO:0032809 | neuronal cell body membrane(GO:0032809) cell body membrane(GO:0044298) |
0.1 | 1.0 | GO:0019814 | immunoglobulin complex(GO:0019814) immunoglobulin complex, circulating(GO:0042571) |
0.1 | 0.2 | GO:0017109 | glutamate-cysteine ligase complex(GO:0017109) |
0.1 | 2.8 | GO:0030139 | endocytic vesicle(GO:0030139) |
0.1 | 0.7 | GO:0001518 | voltage-gated sodium channel complex(GO:0001518) |
0.1 | 0.3 | GO:0070531 | BRCA1-A complex(GO:0070531) |
0.0 | 1.0 | GO:0005942 | phosphatidylinositol 3-kinase complex(GO:0005942) |
0.0 | 1.6 | GO:0014704 | intercalated disc(GO:0014704) |
0.0 | 0.9 | GO:0000145 | exocyst(GO:0000145) |
0.0 | 0.4 | GO:0016593 | Cdc73/Paf1 complex(GO:0016593) |
0.0 | 0.5 | GO:0008541 | proteasome regulatory particle, lid subcomplex(GO:0008541) |
0.0 | 1.2 | GO:0016592 | mediator complex(GO:0016592) |
0.0 | 0.1 | GO:0043512 | inhibin A complex(GO:0043512) |
0.0 | 0.7 | GO:0000178 | exosome (RNase complex)(GO:0000178) |
0.0 | 0.3 | GO:0030686 | 90S preribosome(GO:0030686) |
0.0 | 1.0 | GO:0005637 | nuclear inner membrane(GO:0005637) |
0.0 | 0.1 | GO:0032593 | insulin-responsive compartment(GO:0032593) |
0.0 | 0.6 | GO:0000775 | chromosome, centromeric region(GO:0000775) |
0.0 | 0.3 | GO:0005697 | telomerase holoenzyme complex(GO:0005697) |
0.0 | 0.5 | GO:0005868 | cytoplasmic dynein complex(GO:0005868) |
0.0 | 1.8 | GO:0005643 | nuclear pore(GO:0005643) |
0.0 | 0.3 | GO:0042588 | zymogen granule(GO:0042588) |
0.0 | 0.5 | GO:0044295 | axonal growth cone(GO:0044295) |
0.0 | 0.2 | GO:0045120 | pronucleus(GO:0045120) |
0.0 | 0.3 | GO:0044754 | secondary lysosome(GO:0005767) autolysosome(GO:0044754) |
0.0 | 7.6 | GO:0005667 | transcription factor complex(GO:0005667) |
0.0 | 0.1 | GO:0032983 | kainate selective glutamate receptor complex(GO:0032983) |
0.0 | 6.5 | GO:0005813 | centrosome(GO:0005813) |
0.0 | 0.1 | GO:0031205 | endoplasmic reticulum Sec complex(GO:0031205) |
0.0 | 0.2 | GO:0043034 | costamere(GO:0043034) |
0.0 | 0.1 | GO:0000815 | ESCRT III complex(GO:0000815) |
0.0 | 0.4 | GO:0032993 | protein-DNA complex(GO:0032993) |
0.0 | 0.2 | GO:0032039 | integrator complex(GO:0032039) |
0.0 | 0.1 | GO:0042641 | actomyosin(GO:0042641) |
0.0 | 1.1 | GO:0000793 | condensed chromosome(GO:0000793) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
6.6 | 19.8 | GO:0004998 | transferrin receptor activity(GO:0004998) |
5.7 | 17.0 | GO:0035717 | chemokine (C-C motif) ligand 7 binding(GO:0035717) |
5.1 | 40.5 | GO:0050786 | RAGE receptor binding(GO:0050786) |
4.4 | 13.2 | GO:0033680 | ATP-dependent DNA/RNA helicase activity(GO:0033680) |
4.1 | 16.3 | GO:0015057 | thrombin receptor activity(GO:0015057) |
3.9 | 15.5 | GO:0004566 | beta-glucuronidase activity(GO:0004566) |
3.1 | 18.7 | GO:0010997 | anaphase-promoting complex binding(GO:0010997) |
3.1 | 25.0 | GO:0003810 | protein-glutamine gamma-glutamyltransferase activity(GO:0003810) |
3.0 | 15.0 | GO:0070051 | fibrinogen binding(GO:0070051) |
2.5 | 22.8 | GO:0016176 | superoxide-generating NADPH oxidase activator activity(GO:0016176) |
2.5 | 7.4 | GO:0005136 | interleukin-4 receptor binding(GO:0005136) |
2.4 | 9.4 | GO:0016286 | small conductance calcium-activated potassium channel activity(GO:0016286) |
2.4 | 7.1 | GO:0003829 | beta-1,3-galactosyl-O-glycosyl-glycoprotein beta-1,6-N-acetylglucosaminyltransferase activity(GO:0003829) |
2.2 | 11.1 | GO:0042610 | CD8 receptor binding(GO:0042610) |
2.1 | 22.6 | GO:0052813 | phosphatidylinositol-4,5-bisphosphate 3-kinase activity(GO:0046934) phosphatidylinositol bisphosphate kinase activity(GO:0052813) |
1.9 | 13.6 | GO:0004687 | myosin light chain kinase activity(GO:0004687) |
1.8 | 10.7 | GO:0051425 | PTB domain binding(GO:0051425) |
1.7 | 5.2 | GO:1990050 | phosphatidic acid transporter activity(GO:1990050) |
1.7 | 18.3 | GO:0004908 | interleukin-1 receptor activity(GO:0004908) |
1.5 | 6.1 | GO:1990460 | leptin receptor binding(GO:1990460) |
1.5 | 6.0 | GO:0004974 | leukotriene receptor activity(GO:0004974) |
1.5 | 4.5 | GO:0097677 | STAT family protein binding(GO:0097677) |
1.5 | 13.4 | GO:0008865 | fructokinase activity(GO:0008865) mannokinase activity(GO:0019158) |
1.4 | 6.9 | GO:0016019 | N-acetylmuramoyl-L-alanine amidase activity(GO:0008745) peptidoglycan receptor activity(GO:0016019) |
1.4 | 20.4 | GO:0008301 | DNA binding, bending(GO:0008301) |
1.3 | 4.0 | GO:0001042 | RNA polymerase I core binding(GO:0001042) |
1.3 | 4.0 | GO:0044715 | 8-oxo-dGDP phosphatase activity(GO:0044715) |
1.3 | 10.5 | GO:0035727 | lysophosphatidic acid binding(GO:0035727) |
1.3 | 11.7 | GO:0003876 | AMP deaminase activity(GO:0003876) adenosine-phosphate deaminase activity(GO:0047623) |
1.3 | 9.0 | GO:0030492 | hemoglobin binding(GO:0030492) |
1.3 | 3.8 | GO:0004686 | elongation factor-2 kinase activity(GO:0004686) |
1.2 | 10.4 | GO:0033691 | sialic acid binding(GO:0033691) |
1.2 | 6.9 | GO:0046920 | alpha-(1->3)-fucosyltransferase activity(GO:0046920) |
1.1 | 17.2 | GO:0050693 | LBD domain binding(GO:0050693) |
1.1 | 4.5 | GO:0046624 | sphingolipid transporter activity(GO:0046624) |
1.1 | 8.7 | GO:0005094 | Rho GDP-dissociation inhibitor activity(GO:0005094) |
1.1 | 3.2 | GO:0004967 | glucagon receptor activity(GO:0004967) |
1.0 | 3.0 | GO:0004348 | glucosylceramidase activity(GO:0004348) |
1.0 | 3.0 | GO:0023025 | MHC class Ib protein complex binding(GO:0023025) MHC class Ib protein binding, via antigen binding groove(GO:0023030) |
1.0 | 5.8 | GO:0005344 | oxygen transporter activity(GO:0005344) |
1.0 | 2.9 | GO:0035500 | MH2 domain binding(GO:0035500) |
1.0 | 6.7 | GO:0042834 | peptidoglycan binding(GO:0042834) |
1.0 | 3.8 | GO:0051373 | FATZ binding(GO:0051373) |
1.0 | 2.9 | GO:0008457 | beta-galactosyl-N-acetylglucosaminylgalactosylglucosyl-ceramide beta-1,3-acetylglucosaminyltransferase activity(GO:0008457) lactosylceramide 1,3-N-acetyl-beta-D-glucosaminyltransferase activity(GO:0047256) |
1.0 | 3.8 | GO:0004945 | angiotensin type II receptor activity(GO:0004945) |
0.9 | 2.8 | GO:0031711 | bradykinin receptor binding(GO:0031711) |
0.9 | 2.7 | GO:0035575 | histone demethylase activity (H4-K20 specific)(GO:0035575) |
0.9 | 28.8 | GO:0005031 | tumor necrosis factor-activated receptor activity(GO:0005031) death receptor activity(GO:0005035) |
0.8 | 28.9 | GO:0043325 | phosphatidylinositol-3,4-bisphosphate binding(GO:0043325) |
0.8 | 4.9 | GO:0017077 | oxidative phosphorylation uncoupler activity(GO:0017077) |
0.8 | 48.1 | GO:0004601 | peroxidase activity(GO:0004601) |
0.8 | 2.4 | GO:0047179 | platelet-activating factor acetyltransferase activity(GO:0047179) |
0.8 | 12.9 | GO:0035612 | AP-2 adaptor complex binding(GO:0035612) |
0.8 | 8.9 | GO:0030274 | LIM domain binding(GO:0030274) |
0.8 | 1.5 | GO:0034046 | poly(G) binding(GO:0034046) |
0.8 | 30.1 | GO:1990841 | promoter-specific chromatin binding(GO:1990841) |
0.8 | 8.4 | GO:0033170 | DNA clamp loader activity(GO:0003689) protein-DNA loading ATPase activity(GO:0033170) |
0.8 | 8.4 | GO:0050700 | CARD domain binding(GO:0050700) |
0.8 | 2.3 | GO:0005157 | macrophage colony-stimulating factor receptor binding(GO:0005157) |
0.8 | 15.1 | GO:0032794 | GTPase activating protein binding(GO:0032794) |
0.8 | 3.0 | GO:0008859 | exoribonuclease II activity(GO:0008859) |
0.7 | 3.0 | GO:0000822 | inositol hexakisphosphate binding(GO:0000822) |
0.7 | 38.4 | GO:0004693 | cyclin-dependent protein serine/threonine kinase activity(GO:0004693) |
0.7 | 5.2 | GO:0001851 | complement component C3b binding(GO:0001851) |
0.7 | 2.2 | GO:0019959 | interleukin-8 binding(GO:0019959) |
0.7 | 4.2 | GO:0003828 | alpha-N-acetylneuraminate alpha-2,8-sialyltransferase activity(GO:0003828) |
0.7 | 3.5 | GO:0004105 | choline-phosphate cytidylyltransferase activity(GO:0004105) |
0.7 | 2.8 | GO:0003953 | NAD+ nucleosidase activity(GO:0003953) |
0.7 | 3.4 | GO:0000405 | bubble DNA binding(GO:0000405) |
0.7 | 2.0 | GO:0004088 | carbamoyl-phosphate synthase (ammonia) activity(GO:0004087) carbamoyl-phosphate synthase (glutamine-hydrolyzing) activity(GO:0004088) |
0.6 | 2.6 | GO:0000700 | mismatch base pair DNA N-glycosylase activity(GO:0000700) |
0.6 | 8.4 | GO:0015279 | store-operated calcium channel activity(GO:0015279) |
0.6 | 2.5 | GO:0000010 | trans-hexaprenyltranstransferase activity(GO:0000010) trans-octaprenyltranstransferase activity(GO:0050347) |
0.6 | 1.3 | GO:0035373 | chondroitin sulfate proteoglycan binding(GO:0035373) |
0.6 | 1.2 | GO:0017116 | single-stranded DNA-dependent ATP-dependent DNA helicase activity(GO:0017116) |
0.6 | 9.8 | GO:0004016 | adenylate cyclase activity(GO:0004016) |
0.6 | 1.8 | GO:0008534 | oxidized purine nucleobase lesion DNA N-glycosylase activity(GO:0008534) |
0.6 | 5.8 | GO:0008527 | taste receptor activity(GO:0008527) |
0.6 | 5.8 | GO:0035197 | siRNA binding(GO:0035197) |
0.6 | 3.5 | GO:0044729 | hemi-methylated DNA-binding(GO:0044729) |
0.6 | 1.7 | GO:0004800 | thyroxine 5'-deiodinase activity(GO:0004800) |
0.6 | 5.2 | GO:0034711 | inhibin binding(GO:0034711) |
0.6 | 5.2 | GO:0032564 | dATP binding(GO:0032564) |
0.6 | 1.7 | GO:0033829 | O-fucosylpeptide 3-beta-N-acetylglucosaminyltransferase activity(GO:0033829) |
0.6 | 1.7 | GO:0098809 | nitrite reductase activity(GO:0098809) |
0.6 | 4.4 | GO:0004064 | arylesterase activity(GO:0004064) |
0.6 | 2.8 | GO:0004668 | protein-arginine deiminase activity(GO:0004668) |
0.5 | 3.3 | GO:0030229 | very-low-density lipoprotein particle receptor activity(GO:0030229) |
0.5 | 10.8 | GO:0001618 | virus receptor activity(GO:0001618) |
0.5 | 18.8 | GO:0001965 | G-protein alpha-subunit binding(GO:0001965) |
0.5 | 4.8 | GO:0061133 | endopeptidase activator activity(GO:0061133) |
0.5 | 2.1 | GO:0008260 | 3-oxoacid CoA-transferase activity(GO:0008260) |
0.5 | 2.6 | GO:0004994 | somatostatin receptor activity(GO:0004994) |
0.5 | 2.6 | GO:0005127 | ciliary neurotrophic factor receptor binding(GO:0005127) |
0.5 | 1.5 | GO:0018479 | benzaldehyde dehydrogenase (NAD+) activity(GO:0018479) |
0.5 | 1.5 | GO:0050501 | hyaluronan synthase activity(GO:0050501) |
0.5 | 17.7 | GO:0030676 | Rac guanyl-nucleotide exchange factor activity(GO:0030676) |
0.5 | 4.0 | GO:0055104 | ligase inhibitor activity(GO:0055104) ubiquitin ligase inhibitor activity(GO:1990948) |
0.5 | 10.1 | GO:0032036 | myosin heavy chain binding(GO:0032036) |
0.5 | 1.5 | GO:0009383 | rRNA (cytosine-C5-)-methyltransferase activity(GO:0009383) |
0.5 | 1.5 | GO:0003692 | left-handed Z-DNA binding(GO:0003692) |
0.5 | 2.0 | GO:0001847 | opsonin receptor activity(GO:0001847) |
0.5 | 1.5 | GO:0005128 | erythropoietin receptor binding(GO:0005128) |
0.5 | 2.0 | GO:0047389 | glycerophosphocholine phosphodiesterase activity(GO:0047389) |
0.5 | 1.0 | GO:0050220 | prostaglandin-E synthase activity(GO:0050220) |
0.5 | 9.7 | GO:0031681 | G-protein beta-subunit binding(GO:0031681) |
0.5 | 11.0 | GO:0004435 | phosphatidylinositol phospholipase C activity(GO:0004435) |
0.5 | 4.3 | GO:1990405 | protein antigen binding(GO:1990405) |
0.5 | 24.7 | GO:0005158 | insulin receptor binding(GO:0005158) |
0.5 | 3.3 | GO:0097322 | 7SK snRNA binding(GO:0097322) |
0.5 | 1.4 | GO:0043141 | ATP-dependent 5'-3' DNA helicase activity(GO:0043141) |
0.4 | 14.8 | GO:0008187 | poly-pyrimidine tract binding(GO:0008187) |
0.4 | 1.3 | GO:0071209 | U7 snRNA binding(GO:0071209) |
0.4 | 4.4 | GO:0036310 | annealing helicase activity(GO:0036310) |
0.4 | 4.9 | GO:0001609 | G-protein coupled adenosine receptor activity(GO:0001609) |
0.4 | 3.5 | GO:0016618 | hydroxypyruvate reductase activity(GO:0016618) glyoxylate reductase (NADP) activity(GO:0030267) |
0.4 | 2.2 | GO:0008889 | glycerophosphodiester phosphodiesterase activity(GO:0008889) |
0.4 | 2.6 | GO:0008273 | calcium, potassium:sodium antiporter activity(GO:0008273) |
0.4 | 3.1 | GO:0070181 | small ribosomal subunit rRNA binding(GO:0070181) |
0.4 | 3.0 | GO:0044548 | S100 protein binding(GO:0044548) |
0.4 | 18.3 | GO:0043027 | cysteine-type endopeptidase inhibitor activity involved in apoptotic process(GO:0043027) |
0.4 | 1.3 | GO:0004711 | ribosomal protein S6 kinase activity(GO:0004711) |
0.4 | 3.0 | GO:0008046 | axon guidance receptor activity(GO:0008046) |
0.4 | 5.1 | GO:0005338 | nucleotide-sugar transmembrane transporter activity(GO:0005338) |
0.4 | 7.7 | GO:0097493 | structural molecule activity conferring elasticity(GO:0097493) |
0.4 | 2.5 | GO:0008821 | crossover junction endodeoxyribonuclease activity(GO:0008821) |
0.4 | 3.8 | GO:0019103 | pyrimidine nucleotide binding(GO:0019103) |
0.4 | 1.6 | GO:0003938 | IMP dehydrogenase activity(GO:0003938) |
0.4 | 4.9 | GO:0036374 | glutathione hydrolase activity(GO:0036374) |
0.4 | 3.3 | GO:0070538 | oleic acid binding(GO:0070538) |
0.4 | 3.2 | GO:0071253 | connexin binding(GO:0071253) |
0.4 | 1.6 | GO:0008184 | glycogen phosphorylase activity(GO:0008184) |
0.4 | 1.6 | GO:0036313 | phosphatidylinositol 3-kinase catalytic subunit binding(GO:0036313) |
0.4 | 15.5 | GO:0005070 | SH3/SH2 adaptor activity(GO:0005070) |
0.4 | 2.0 | GO:0004966 | galanin receptor activity(GO:0004966) |
0.4 | 3.9 | GO:0016713 | oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced iron-sulfur protein as one donor, and incorporation of one atom of oxygen(GO:0016713) |
0.4 | 2.3 | GO:0030899 | calcium-dependent ATPase activity(GO:0030899) |
0.4 | 3.5 | GO:0005004 | GPI-linked ephrin receptor activity(GO:0005004) |
0.4 | 3.8 | GO:0004691 | cAMP-dependent protein kinase activity(GO:0004691) |
0.4 | 4.8 | GO:0036312 | phosphatidylinositol 3-kinase regulatory subunit binding(GO:0036312) |
0.4 | 4.5 | GO:0015093 | ferrous iron transmembrane transporter activity(GO:0015093) |
0.4 | 3.3 | GO:0005138 | interleukin-6 receptor binding(GO:0005138) |
0.4 | 2.2 | GO:0000155 | phosphorelay sensor kinase activity(GO:0000155) |
0.4 | 1.1 | GO:0070140 | isopeptidase activity(GO:0070122) ubiquitin-like protein-specific isopeptidase activity(GO:0070138) SUMO-specific isopeptidase activity(GO:0070140) |
0.4 | 2.5 | GO:0000150 | recombinase activity(GO:0000150) |
0.4 | 6.5 | GO:0008253 | 5'-nucleotidase activity(GO:0008253) |
0.4 | 1.1 | GO:0042936 | dipeptide transporter activity(GO:0042936) |
0.4 | 9.0 | GO:0034987 | immunoglobulin receptor binding(GO:0034987) |
0.4 | 2.1 | GO:0004084 | branched-chain-amino-acid transaminase activity(GO:0004084) L-leucine transaminase activity(GO:0052654) L-valine transaminase activity(GO:0052655) L-isoleucine transaminase activity(GO:0052656) |
0.3 | 11.2 | GO:0070273 | phosphatidylinositol-4-phosphate binding(GO:0070273) |
0.3 | 2.1 | GO:0000099 | sulfur amino acid transmembrane transporter activity(GO:0000099) |
0.3 | 1.4 | GO:0008449 | N-acetylglucosamine-6-sulfatase activity(GO:0008449) |
0.3 | 2.1 | GO:0032027 | myosin light chain binding(GO:0032027) |
0.3 | 3.4 | GO:0043138 | 3'-5' DNA helicase activity(GO:0043138) |
0.3 | 1.3 | GO:0046935 | 1-phosphatidylinositol-3-kinase regulator activity(GO:0046935) |
0.3 | 2.7 | GO:0004332 | fructose-bisphosphate aldolase activity(GO:0004332) |
0.3 | 3.0 | GO:0005000 | vasopressin receptor activity(GO:0005000) |
0.3 | 1.6 | GO:0016936 | galactoside binding(GO:0016936) |
0.3 | 2.3 | GO:0001515 | opioid peptide activity(GO:0001515) |
0.3 | 5.3 | GO:0015643 | toxic substance binding(GO:0015643) |
0.3 | 2.6 | GO:0043199 | sulfate binding(GO:0043199) |
0.3 | 1.3 | GO:0050436 | microfibril binding(GO:0050436) |
0.3 | 6.5 | GO:0004622 | lysophospholipase activity(GO:0004622) |
0.3 | 2.8 | GO:0035198 | miRNA binding(GO:0035198) |
0.3 | 1.6 | GO:0035614 | snRNA stem-loop binding(GO:0035614) |
0.3 | 6.3 | GO:0005527 | macrolide binding(GO:0005527) FK506 binding(GO:0005528) |
0.3 | 1.9 | GO:0050897 | cobalt ion binding(GO:0050897) |
0.3 | 1.3 | GO:0004694 | eukaryotic translation initiation factor 2alpha kinase activity(GO:0004694) |
0.3 | 0.9 | GO:0000386 | second spliceosomal transesterification activity(GO:0000386) |
0.3 | 1.6 | GO:0004692 | cGMP-dependent protein kinase activity(GO:0004692) |
0.3 | 4.6 | GO:0017017 | MAP kinase tyrosine/serine/threonine phosphatase activity(GO:0017017) |
0.3 | 26.0 | GO:0001190 | transcriptional activator activity, RNA polymerase II transcription factor binding(GO:0001190) transcriptional repressor activity, RNA polymerase II activating transcription factor binding(GO:0098811) |
0.3 | 1.5 | GO:0005105 | type 1 fibroblast growth factor receptor binding(GO:0005105) |
0.3 | 28.3 | GO:0005200 | structural constituent of cytoskeleton(GO:0005200) |
0.3 | 8.8 | GO:0004181 | metallocarboxypeptidase activity(GO:0004181) |
0.3 | 2.7 | GO:0045028 | G-protein coupled nucleotide receptor activity(GO:0001608) G-protein coupled purinergic nucleotide receptor activity(GO:0045028) |
0.3 | 8.0 | GO:0043395 | heparan sulfate proteoglycan binding(GO:0043395) |
0.3 | 2.1 | GO:0004035 | alkaline phosphatase activity(GO:0004035) |
0.3 | 0.9 | GO:0000171 | ribonuclease MRP activity(GO:0000171) |
0.3 | 1.5 | GO:0000340 | RNA 7-methylguanosine cap binding(GO:0000340) |
0.3 | 2.4 | GO:0001075 | transcription factor activity, RNA polymerase II core promoter sequence-specific binding involved in preinitiation complex assembly(GO:0001075) |
0.3 | 2.9 | GO:0031014 | troponin T binding(GO:0031014) |
0.3 | 1.8 | GO:0032052 | bile acid binding(GO:0032052) |
0.3 | 23.3 | GO:0003730 | mRNA 3'-UTR binding(GO:0003730) |
0.3 | 8.8 | GO:0016814 | hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in cyclic amidines(GO:0016814) |
0.3 | 5.1 | GO:0070182 | DNA polymerase binding(GO:0070182) |
0.3 | 2.0 | GO:0004459 | L-lactate dehydrogenase activity(GO:0004459) |
0.3 | 1.4 | GO:0086056 | voltage-gated calcium channel activity involved in AV node cell action potential(GO:0086056) |
0.3 | 3.0 | GO:0035613 | RNA stem-loop binding(GO:0035613) |
0.3 | 0.8 | GO:0031493 | nucleosomal histone binding(GO:0031493) |
0.3 | 2.7 | GO:0022833 | mechanically-gated ion channel activity(GO:0008381) mechanically gated channel activity(GO:0022833) |
0.3 | 3.8 | GO:0008349 | MAP kinase kinase kinase kinase activity(GO:0008349) |
0.3 | 0.8 | GO:0050309 | glucose-6-phosphatase activity(GO:0004346) sugar-terminal-phosphatase activity(GO:0050309) |
0.3 | 1.1 | GO:0019834 | phospholipase A2 inhibitor activity(GO:0019834) |
0.3 | 2.1 | GO:1990446 | U1 snRNP binding(GO:1990446) |
0.3 | 8.8 | GO:0008574 | ATP-dependent microtubule motor activity, plus-end-directed(GO:0008574) |
0.3 | 1.1 | GO:0072345 | NAADP-sensitive calcium-release channel activity(GO:0072345) |
0.3 | 10.1 | GO:0032452 | histone demethylase activity(GO:0032452) |
0.3 | 11.0 | GO:0005201 | extracellular matrix structural constituent(GO:0005201) |
0.3 | 1.3 | GO:0030171 | voltage-gated proton channel activity(GO:0030171) |
0.3 | 1.0 | GO:0048495 | Roundabout binding(GO:0048495) |
0.3 | 2.8 | GO:0004439 | phosphatidylinositol-4,5-bisphosphate 5-phosphatase activity(GO:0004439) |
0.3 | 1.3 | GO:0004758 | serine C-palmitoyltransferase activity(GO:0004758) C-palmitoyltransferase activity(GO:0016454) |
0.3 | 1.3 | GO:0016941 | natriuretic peptide receptor activity(GO:0016941) |
0.3 | 5.3 | GO:0003841 | 1-acylglycerol-3-phosphate O-acyltransferase activity(GO:0003841) |
0.3 | 1.3 | GO:0015321 | sodium-dependent phosphate transmembrane transporter activity(GO:0015321) |
0.3 | 1.5 | GO:1903136 | cuprous ion binding(GO:1903136) |
0.3 | 16.6 | GO:0035064 | methylated histone binding(GO:0035064) |
0.3 | 4.8 | GO:0005184 | neuropeptide hormone activity(GO:0005184) |
0.2 | 1.5 | GO:0034597 | phosphatidylinositol-4,5-bisphosphate 4-phosphatase activity(GO:0034597) |
0.2 | 1.2 | GO:0005415 | nucleoside:sodium symporter activity(GO:0005415) |
0.2 | 1.0 | GO:0031800 | type 3 metabotropic glutamate receptor binding(GO:0031800) |
0.2 | 1.0 | GO:0019767 | IgE receptor activity(GO:0019767) |
0.2 | 4.6 | GO:0030215 | semaphorin receptor binding(GO:0030215) |
0.2 | 0.7 | GO:0016018 | cyclosporin A binding(GO:0016018) |
0.2 | 24.3 | GO:0017048 | Rho GTPase binding(GO:0017048) |
0.2 | 1.9 | GO:0008454 | alpha-1,3-mannosylglycoprotein 4-beta-N-acetylglucosaminyltransferase activity(GO:0008454) |
0.2 | 2.1 | GO:0051525 | NFAT protein binding(GO:0051525) |
0.2 | 0.7 | GO:0030284 | mineralocorticoid receptor activity(GO:0017082) estrogen receptor activity(GO:0030284) |
0.2 | 3.5 | GO:0017091 | AU-rich element binding(GO:0017091) |
0.2 | 1.2 | GO:0004111 | creatine kinase activity(GO:0004111) |
0.2 | 1.4 | GO:0015111 | iodide transmembrane transporter activity(GO:0015111) |
0.2 | 11.9 | GO:0030507 | spectrin binding(GO:0030507) |
0.2 | 0.7 | GO:0052595 | tryptamine:oxygen oxidoreductase (deaminating) activity(GO:0052593) aminoacetone:oxygen oxidoreductase(deaminating) activity(GO:0052594) aliphatic-amine oxidase activity(GO:0052595) phenethylamine:oxygen oxidoreductase (deaminating) activity(GO:0052596) |
0.2 | 1.5 | GO:0034513 | box H/ACA snoRNA binding(GO:0034513) |
0.2 | 0.9 | GO:0035800 | deubiquitinase activator activity(GO:0035800) |
0.2 | 2.4 | GO:0008179 | adenylate cyclase binding(GO:0008179) |
0.2 | 0.6 | GO:0016309 | 1-phosphatidylinositol-5-phosphate 4-kinase activity(GO:0016309) |
0.2 | 1.5 | GO:1990825 | sequence-specific mRNA binding(GO:1990825) |
0.2 | 1.0 | GO:0008142 | oxysterol binding(GO:0008142) |
0.2 | 0.6 | GO:0004069 | L-aspartate:2-oxoglutarate aminotransferase activity(GO:0004069) |
0.2 | 1.4 | GO:0008417 | fucosyltransferase activity(GO:0008417) |
0.2 | 2.1 | GO:0051870 | methotrexate binding(GO:0051870) |
0.2 | 0.8 | GO:0097108 | hedgehog family protein binding(GO:0097108) |
0.2 | 0.8 | GO:2001069 | glycogen binding(GO:2001069) |
0.2 | 2.8 | GO:1990226 | histone methyltransferase binding(GO:1990226) |
0.2 | 0.8 | GO:0032422 | purine-rich negative regulatory element binding(GO:0032422) |
0.2 | 0.8 | GO:0034714 | type III transforming growth factor beta receptor binding(GO:0034714) |
0.2 | 1.2 | GO:0030249 | guanylate cyclase regulator activity(GO:0030249) |
0.2 | 0.8 | GO:0070976 | TIR domain binding(GO:0070976) |
0.2 | 2.1 | GO:0004791 | thioredoxin-disulfide reductase activity(GO:0004791) |
0.2 | 1.7 | GO:0035312 | 5'-3' exodeoxyribonuclease activity(GO:0035312) |
0.2 | 1.3 | GO:0016428 | tRNA (cytosine-5-)-methyltransferase activity(GO:0016428) |
0.2 | 5.1 | GO:0001968 | fibronectin binding(GO:0001968) |
0.2 | 6.0 | GO:0005487 | nucleocytoplasmic transporter activity(GO:0005487) |
0.2 | 0.9 | GO:0043515 | kinetochore binding(GO:0043515) |
0.2 | 3.9 | GO:0004653 | polypeptide N-acetylgalactosaminyltransferase activity(GO:0004653) |
0.2 | 1.1 | GO:0003886 | DNA (cytosine-5-)-methyltransferase activity(GO:0003886) |
0.2 | 1.8 | GO:0008239 | dipeptidyl-peptidase activity(GO:0008239) |
0.2 | 1.3 | GO:0001164 | RNA polymerase I regulatory region sequence-specific DNA binding(GO:0001163) RNA polymerase I CORE element sequence-specific DNA binding(GO:0001164) |
0.2 | 13.6 | GO:0005179 | hormone activity(GO:0005179) |
0.2 | 4.7 | GO:0004115 | 3',5'-cyclic-AMP phosphodiesterase activity(GO:0004115) |
0.2 | 0.7 | GO:0031727 | CCR2 chemokine receptor binding(GO:0031727) |
0.2 | 0.7 | GO:0043024 | ribosomal small subunit binding(GO:0043024) |
0.2 | 1.7 | GO:0045499 | chemorepellent activity(GO:0045499) |
0.2 | 0.7 | GO:0046923 | ER retention sequence binding(GO:0046923) |
0.2 | 1.4 | GO:0005519 | cytoskeletal regulatory protein binding(GO:0005519) |
0.2 | 0.7 | GO:0004949 | cannabinoid receptor activity(GO:0004949) |
0.2 | 1.3 | GO:0098505 | G-rich strand telomeric DNA binding(GO:0098505) |
0.2 | 1.5 | GO:0017070 | U6 snRNA binding(GO:0017070) |
0.2 | 1.6 | GO:0016724 | ferroxidase activity(GO:0004322) oxidoreductase activity, oxidizing metal ions, oxygen as acceptor(GO:0016724) |
0.2 | 3.9 | GO:0003746 | translation elongation factor activity(GO:0003746) |
0.2 | 0.5 | GO:0019002 | GMP binding(GO:0019002) |
0.2 | 3.8 | GO:0004385 | guanylate kinase activity(GO:0004385) |
0.2 | 0.8 | GO:0031697 | beta-1 adrenergic receptor binding(GO:0031697) |
0.2 | 0.6 | GO:0051434 | BH3 domain binding(GO:0051434) |
0.2 | 0.9 | GO:0070180 | large ribosomal subunit rRNA binding(GO:0070180) |
0.2 | 2.0 | GO:0004143 | diacylglycerol kinase activity(GO:0004143) |
0.2 | 3.5 | GO:0003755 | peptidyl-prolyl cis-trans isomerase activity(GO:0003755) |
0.2 | 2.1 | GO:0008191 | metalloendopeptidase inhibitor activity(GO:0008191) |
0.2 | 0.5 | GO:0000992 | polymerase III regulatory region sequence-specific DNA binding(GO:0000992) RNA polymerase III type 1 promoter sequence-specific DNA binding(GO:0001002) RNA polymerase III type 2 promoter sequence-specific DNA binding(GO:0001003) RNA polymerase III transcription factor activity, sequence-specific DNA binding(GO:0001034) |
0.1 | 4.3 | GO:0004869 | cysteine-type endopeptidase inhibitor activity(GO:0004869) |
0.1 | 8.4 | GO:0030295 | protein kinase activator activity(GO:0030295) |
0.1 | 1.8 | GO:0046703 | natural killer cell lectin-like receptor binding(GO:0046703) |
0.1 | 1.4 | GO:0001091 | RNA polymerase II basal transcription factor binding(GO:0001091) |
0.1 | 2.7 | GO:0004535 | poly(A)-specific ribonuclease activity(GO:0004535) |
0.1 | 8.1 | GO:0019894 | kinesin binding(GO:0019894) |
0.1 | 5.4 | GO:0051959 | dynein light intermediate chain binding(GO:0051959) |
0.1 | 3.6 | GO:0004198 | calcium-dependent cysteine-type endopeptidase activity(GO:0004198) |
0.1 | 0.4 | GO:0005171 | hepatocyte growth factor receptor binding(GO:0005171) |
0.1 | 0.6 | GO:1901612 | cardiolipin binding(GO:1901612) |
0.1 | 1.5 | GO:0005522 | profilin binding(GO:0005522) |
0.1 | 1.2 | GO:0008097 | 5S rRNA binding(GO:0008097) |
0.1 | 0.7 | GO:0003945 | N-acetyllactosamine synthase activity(GO:0003945) |
0.1 | 1.1 | GO:0008526 | phosphatidylinositol transporter activity(GO:0008526) |
0.1 | 0.4 | GO:0002153 | steroid receptor RNA activator RNA binding(GO:0002153) |
0.1 | 0.8 | GO:0005042 | netrin receptor activity(GO:0005042) |
0.1 | 2.1 | GO:0004707 | MAP kinase activity(GO:0004707) |
0.1 | 0.1 | GO:0051011 | microtubule minus-end binding(GO:0051011) |
0.1 | 1.6 | GO:0015197 | peptide transporter activity(GO:0015197) |
0.1 | 0.9 | GO:0015220 | choline transmembrane transporter activity(GO:0015220) |
0.1 | 1.9 | GO:0015143 | urate transmembrane transporter activity(GO:0015143) salt transmembrane transporter activity(GO:1901702) |
0.1 | 0.3 | GO:0045322 | unmethylated CpG binding(GO:0045322) |
0.1 | 2.0 | GO:0004003 | ATP-dependent DNA helicase activity(GO:0004003) |
0.1 | 19.2 | GO:0017124 | SH3 domain binding(GO:0017124) |
0.1 | 3.6 | GO:0051537 | 2 iron, 2 sulfur cluster binding(GO:0051537) |
0.1 | 0.5 | GO:0004483 | mRNA (nucleoside-2'-O-)-methyltransferase activity(GO:0004483) |
0.1 | 0.7 | GO:0032051 | clathrin light chain binding(GO:0032051) |
0.1 | 1.2 | GO:0050733 | RS domain binding(GO:0050733) |
0.1 | 1.1 | GO:0038062 | protein tyrosine kinase collagen receptor activity(GO:0038062) |
0.1 | 4.7 | GO:0019843 | rRNA binding(GO:0019843) |
0.1 | 3.7 | GO:0004012 | phospholipid-translocating ATPase activity(GO:0004012) |
0.1 | 4.9 | GO:0003684 | damaged DNA binding(GO:0003684) |
0.1 | 1.5 | GO:0004576 | oligosaccharyl transferase activity(GO:0004576) dolichyl-diphosphooligosaccharide-protein glycotransferase activity(GO:0004579) |
0.1 | 0.7 | GO:0000213 | tRNA-intron endonuclease activity(GO:0000213) |
0.1 | 2.6 | GO:0004033 | aldo-keto reductase (NADP) activity(GO:0004033) |
0.1 | 0.8 | GO:0016802 | adenosylhomocysteinase activity(GO:0004013) trialkylsulfonium hydrolase activity(GO:0016802) |
0.1 | 3.5 | GO:0004386 | helicase activity(GO:0004386) |
0.1 | 0.3 | GO:0004962 | endothelin receptor activity(GO:0004962) |
0.1 | 1.1 | GO:0050291 | sphingosine N-acyltransferase activity(GO:0050291) |
0.1 | 0.4 | GO:0008559 | xenobiotic-transporting ATPase activity(GO:0008559) |
0.1 | 0.3 | GO:0016262 | protein N-acetylglucosaminyltransferase activity(GO:0016262) |
0.1 | 0.6 | GO:0008131 | primary amine oxidase activity(GO:0008131) |
0.1 | 0.6 | GO:0004704 | NF-kappaB-inducing kinase activity(GO:0004704) |
0.1 | 0.4 | GO:0071987 | WD40-repeat domain binding(GO:0071987) |
0.1 | 0.3 | GO:0004830 | tryptophan-tRNA ligase activity(GO:0004830) |
0.1 | 0.5 | GO:0005250 | A-type (transient outward) potassium channel activity(GO:0005250) |
0.1 | 0.3 | GO:0004698 | calcium-dependent protein kinase C activity(GO:0004698) |
0.1 | 3.1 | GO:0005086 | ARF guanyl-nucleotide exchange factor activity(GO:0005086) |
0.1 | 0.3 | GO:0042895 | antibiotic transporter activity(GO:0042895) |
0.1 | 1.0 | GO:0004862 | cAMP-dependent protein kinase inhibitor activity(GO:0004862) |
0.1 | 1.9 | GO:0017160 | Ral GTPase binding(GO:0017160) |
0.1 | 4.6 | GO:0017112 | Rab guanyl-nucleotide exchange factor activity(GO:0017112) |
0.1 | 0.3 | GO:0030369 | ICAM-3 receptor activity(GO:0030369) |
0.1 | 0.3 | GO:0070139 | ubiquitin-like protein-specific endopeptidase activity(GO:0070137) SUMO-specific endopeptidase activity(GO:0070139) |
0.1 | 0.3 | GO:0036033 | mediator complex binding(GO:0036033) chromo shadow domain binding(GO:0070087) |
0.1 | 0.3 | GO:0034511 | U3 snoRNA binding(GO:0034511) |
0.1 | 5.9 | GO:0003743 | translation initiation factor activity(GO:0003743) |
0.1 | 0.7 | GO:0048403 | brain-derived neurotrophic factor binding(GO:0048403) |
0.1 | 1.5 | GO:0000146 | microfilament motor activity(GO:0000146) |
0.1 | 1.2 | GO:0016493 | C-C chemokine receptor activity(GO:0016493) |
0.1 | 0.4 | GO:0050265 | RNA uridylyltransferase activity(GO:0050265) |
0.1 | 0.4 | GO:0034452 | dynactin binding(GO:0034452) |
0.1 | 0.5 | GO:0004311 | farnesyltranstransferase activity(GO:0004311) |
0.1 | 0.6 | GO:0061665 | SUMO ligase activity(GO:0061665) |
0.1 | 6.4 | GO:0033613 | activating transcription factor binding(GO:0033613) |
0.1 | 0.3 | GO:0050816 | phosphothreonine binding(GO:0050816) |
0.1 | 4.9 | GO:0070491 | repressing transcription factor binding(GO:0070491) |
0.1 | 4.5 | GO:0001104 | RNA polymerase II transcription cofactor activity(GO:0001104) |
0.1 | 1.3 | GO:0001054 | RNA polymerase I activity(GO:0001054) |
0.1 | 0.6 | GO:0004523 | RNA-DNA hybrid ribonuclease activity(GO:0004523) |
0.1 | 0.4 | GO:0004565 | beta-galactosidase activity(GO:0004565) |
0.1 | 3.2 | GO:0031492 | nucleosomal DNA binding(GO:0031492) |
0.1 | 0.4 | GO:0052723 | inositol hexakisphosphate kinase activity(GO:0000828) inositol hexakisphosphate 5-kinase activity(GO:0000832) inositol hexakisphosphate 1-kinase activity(GO:0052723) inositol hexakisphosphate 3-kinase activity(GO:0052724) |
0.1 | 1.6 | GO:0030553 | cGMP binding(GO:0030553) |
0.1 | 0.9 | GO:0042162 | telomeric DNA binding(GO:0042162) |
0.1 | 2.0 | GO:0070840 | dynein complex binding(GO:0070840) |
0.1 | 8.2 | GO:0005085 | guanyl-nucleotide exchange factor activity(GO:0005085) |
0.1 | 4.8 | GO:0008186 | RNA helicase activity(GO:0003724) ATP-dependent RNA helicase activity(GO:0004004) RNA-dependent ATPase activity(GO:0008186) |
0.1 | 0.8 | GO:0070300 | phosphatidic acid binding(GO:0070300) |
0.1 | 0.2 | GO:0038064 | collagen receptor activity(GO:0038064) |
0.1 | 0.6 | GO:0061578 | Lys63-specific deubiquitinase activity(GO:0061578) |
0.1 | 0.4 | GO:0008502 | melatonin receptor activity(GO:0008502) |
0.1 | 10.8 | GO:0003735 | structural constituent of ribosome(GO:0003735) |
0.1 | 0.2 | GO:0016015 | morphogen activity(GO:0016015) |
0.1 | 2.3 | GO:0045309 | protein phosphorylated amino acid binding(GO:0045309) |
0.1 | 0.4 | GO:0004839 | ubiquitin activating enzyme activity(GO:0004839) |
0.1 | 1.1 | GO:0070577 | lysine-acetylated histone binding(GO:0070577) |
0.1 | 1.2 | GO:0050321 | tau-protein kinase activity(GO:0050321) |
0.1 | 0.3 | GO:0008440 | inositol-1,4,5-trisphosphate 3-kinase activity(GO:0008440) |
0.1 | 0.6 | GO:0019209 | kinase activator activity(GO:0019209) |
0.1 | 2.1 | GO:0003785 | actin monomer binding(GO:0003785) |
0.1 | 0.2 | GO:0004357 | glutamate-cysteine ligase activity(GO:0004357) |
0.1 | 1.6 | GO:0008536 | Ran GTPase binding(GO:0008536) |
0.1 | 1.6 | GO:0043015 | gamma-tubulin binding(GO:0043015) |
0.1 | 0.6 | GO:0015377 | cation:chloride symporter activity(GO:0015377) |
0.1 | 0.3 | GO:0031701 | angiotensin receptor binding(GO:0031701) |
0.1 | 0.3 | GO:0048248 | CXCR3 chemokine receptor binding(GO:0048248) |
0.1 | 0.8 | GO:0031005 | filamin binding(GO:0031005) |
0.1 | 14.8 | GO:0030695 | GTPase regulator activity(GO:0030695) |
0.1 | 0.7 | GO:0017128 | phospholipid scramblase activity(GO:0017128) |
0.1 | 0.7 | GO:0031957 | very long-chain fatty acid-CoA ligase activity(GO:0031957) |
0.1 | 4.7 | GO:0042393 | histone binding(GO:0042393) |
0.0 | 1.7 | GO:0008374 | O-acyltransferase activity(GO:0008374) |
0.0 | 0.1 | GO:0031728 | CCR3 chemokine receptor binding(GO:0031728) |
0.0 | 0.3 | GO:0019788 | NEDD8 transferase activity(GO:0019788) |
0.0 | 0.3 | GO:0015129 | lactate transmembrane transporter activity(GO:0015129) |
0.0 | 0.8 | GO:0005123 | death receptor binding(GO:0005123) |
0.0 | 0.9 | GO:0008171 | O-methyltransferase activity(GO:0008171) |
0.0 | 1.1 | GO:0030551 | cyclic nucleotide binding(GO:0030551) |
0.0 | 0.1 | GO:0004816 | asparagine-tRNA ligase activity(GO:0004816) |
0.0 | 0.2 | GO:0032217 | riboflavin transporter activity(GO:0032217) |
0.0 | 0.4 | GO:0004536 | deoxyribonuclease activity(GO:0004536) |
0.0 | 0.2 | GO:0016004 | phospholipase activator activity(GO:0016004) |
0.0 | 0.1 | GO:0008079 | translation release factor activity(GO:0003747) translation termination factor activity(GO:0008079) |
0.0 | 14.2 | GO:0003779 | actin binding(GO:0003779) |
0.0 | 0.3 | GO:0050692 | DBD domain binding(GO:0050692) |
0.0 | 0.4 | GO:0098821 | BMP receptor activity(GO:0098821) |
0.0 | 0.2 | GO:0031802 | type 5 metabotropic glutamate receptor binding(GO:0031802) |
0.0 | 1.2 | GO:0050699 | WW domain binding(GO:0050699) |
0.0 | 11.8 | GO:0005525 | GTP binding(GO:0005525) |
0.0 | 0.5 | GO:0070628 | proteasome binding(GO:0070628) |
0.0 | 3.4 | GO:0047485 | protein N-terminus binding(GO:0047485) |
0.0 | 0.9 | GO:0005337 | nucleoside transmembrane transporter activity(GO:0005337) |
0.0 | 3.4 | GO:0004519 | endonuclease activity(GO:0004519) |
0.0 | 0.5 | GO:0001223 | transcription coactivator binding(GO:0001223) |
0.0 | 0.3 | GO:0016595 | glutamate binding(GO:0016595) |
0.0 | 0.5 | GO:0008553 | hydrogen-exporting ATPase activity, phosphorylative mechanism(GO:0008553) |
0.0 | 0.1 | GO:0045545 | syndecan binding(GO:0045545) |
0.0 | 0.9 | GO:0070063 | RNA polymerase binding(GO:0070063) |
0.0 | 0.3 | GO:0005540 | hyaluronic acid binding(GO:0005540) |
0.0 | 0.6 | GO:0070003 | threonine-type endopeptidase activity(GO:0004298) threonine-type peptidase activity(GO:0070003) |
0.0 | 0.5 | GO:0005355 | glucose transmembrane transporter activity(GO:0005355) |
0.0 | 1.7 | GO:0004725 | protein tyrosine phosphatase activity(GO:0004725) |
0.0 | 0.1 | GO:0016308 | 1-phosphatidylinositol-4-phosphate 5-kinase activity(GO:0016308) |
0.0 | 0.1 | GO:0008307 | structural constituent of muscle(GO:0008307) |
0.0 | 0.4 | GO:0030544 | Hsp70 protein binding(GO:0030544) |
0.0 | 0.8 | GO:0003823 | antigen binding(GO:0003823) |
0.0 | 0.0 | GO:0097157 | pre-mRNA intronic binding(GO:0097157) |
0.0 | 0.0 | GO:0005499 | vitamin D binding(GO:0005499) |
0.0 | 0.6 | GO:0004197 | cysteine-type endopeptidase activity(GO:0004197) |
0.0 | 0.2 | GO:0017075 | syntaxin-1 binding(GO:0017075) |
0.0 | 0.0 | GO:0070878 | primary miRNA binding(GO:0070878) |
0.0 | 0.1 | GO:0030515 | snoRNA binding(GO:0030515) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
1.8 | 36.7 | PID THROMBIN PAR4 PATHWAY | PAR4-mediated thrombin signaling events |
1.6 | 21.9 | SA MMP CYTOKINE CONNECTION | Cytokines can induce activation of matrix metalloproteinases, which degrade extracellular matrix. |
1.1 | 51.6 | PID IL23 PATHWAY | IL23-mediated signaling events |
0.8 | 66.9 | PID PI3KCI PATHWAY | Class I PI3K signaling events |
0.8 | 50.5 | PID PLK1 PATHWAY | PLK1 signaling events |
0.8 | 13.0 | PID TCR RAS PATHWAY | Ras signaling in the CD4+ TCR pathway |
0.8 | 3.2 | ST JAK STAT PATHWAY | Jak-STAT Pathway |
0.8 | 24.6 | PID SYNDECAN 4 PATHWAY | Syndecan-4-mediated signaling events |
0.7 | 7.4 | PID TCR JNK PATHWAY | JNK signaling in the CD4+ TCR pathway |
0.7 | 14.1 | SA B CELL RECEPTOR COMPLEXES | Antigen binding to B cell receptors activates protein tyrosine kinases, such as the Src family, which ultimate activate MAP kinases. |
0.7 | 11.4 | PID IL8 CXCR2 PATHWAY | IL8- and CXCR2-mediated signaling events |
0.7 | 20.4 | PID INTEGRIN A9B1 PATHWAY | Alpha9 beta1 integrin signaling events |
0.6 | 28.4 | PID IL2 STAT5 PATHWAY | IL2 signaling events mediated by STAT5 |
0.6 | 10.2 | PID ERBB1 RECEPTOR PROXIMAL PATHWAY | EGF receptor (ErbB1) signaling pathway |
0.6 | 1.1 | SA G2 AND M PHASES | Cdc25 activates the cdc2/cyclin B complex to induce the G2/M transition. |
0.6 | 21.6 | PID THROMBIN PAR1 PATHWAY | PAR1-mediated thrombin signaling events |
0.6 | 3.9 | ST PAC1 RECEPTOR PATHWAY | PAC1 Receptor Pathway |
0.5 | 7.7 | SA REG CASCADE OF CYCLIN EXPR | Expression of cyclins regulates progression through the cell cycle by activating cyclin-dependent kinases. |
0.5 | 16.3 | PID INTEGRIN CS PATHWAY | Integrin family cell surface interactions |
0.5 | 8.6 | PID P38 GAMMA DELTA PATHWAY | Signaling mediated by p38-gamma and p38-delta |
0.5 | 21.3 | PID AURORA B PATHWAY | Aurora B signaling |
0.5 | 23.7 | PID HNF3B PATHWAY | FOXA2 and FOXA3 transcription factor networks |
0.4 | 46.6 | PID CMYB PATHWAY | C-MYB transcription factor network |
0.4 | 14.7 | PID TOLL ENDOGENOUS PATHWAY | Endogenous TLR signaling |
0.4 | 5.9 | PID GMCSF PATHWAY | GMCSF-mediated signaling events |
0.4 | 13.1 | PID P38 MK2 PATHWAY | p38 signaling mediated by MAPKAP kinases |
0.4 | 8.0 | PID LPA4 PATHWAY | LPA4-mediated signaling events |
0.4 | 7.4 | PID HIF1A PATHWAY | Hypoxic and oxygen homeostasis regulation of HIF-1-alpha |
0.4 | 12.7 | PID RAC1 PATHWAY | RAC1 signaling pathway |
0.4 | 11.5 | PID BCR 5PATHWAY | BCR signaling pathway |
0.4 | 34.4 | PID SMAD2 3NUCLEAR PATHWAY | Regulation of nuclear SMAD2/3 signaling |
0.4 | 10.9 | PID REELIN PATHWAY | Reelin signaling pathway |
0.4 | 13.1 | PID RHOA PATHWAY | RhoA signaling pathway |
0.4 | 12.9 | PID FCER1 PATHWAY | Fc-epsilon receptor I signaling in mast cells |
0.3 | 10.4 | PID ATR PATHWAY | ATR signaling pathway |
0.3 | 16.3 | PID TELOMERASE PATHWAY | Regulation of Telomerase |
0.3 | 12.4 | SIG REGULATION OF THE ACTIN CYTOSKELETON BY RHO GTPASES | Genes related to regulation of the actin cytoskeleton |
0.3 | 6.7 | PID INTEGRIN2 PATHWAY | Beta2 integrin cell surface interactions |
0.3 | 3.9 | PID ERBB NETWORK PATHWAY | ErbB receptor signaling network |
0.3 | 8.4 | PID ATF2 PATHWAY | ATF-2 transcription factor network |
0.3 | 11.1 | PID ILK PATHWAY | Integrin-linked kinase signaling |
0.3 | 1.0 | PID WNT NONCANONICAL PATHWAY | Noncanonical Wnt signaling pathway |
0.2 | 9.4 | PID E2F PATHWAY | E2F transcription factor network |
0.2 | 3.5 | PID HDAC CLASSIII PATHWAY | Signaling events mediated by HDAC Class III |
0.2 | 7.0 | PID HEDGEHOG GLI PATHWAY | Hedgehog signaling events mediated by Gli proteins |
0.2 | 4.6 | PID NCADHERIN PATHWAY | N-cadherin signaling events |
0.2 | 10.5 | PID RAC1 REG PATHWAY | Regulation of RAC1 activity |
0.2 | 3.1 | PID IFNG PATHWAY | IFN-gamma pathway |
0.2 | 0.6 | PID ANTHRAX PATHWAY | Cellular roles of Anthrax toxin |
0.2 | 6.0 | PID RAS PATHWAY | Regulation of Ras family activation |
0.2 | 8.2 | NABA PROTEOGLYCANS | Genes encoding proteoglycans |
0.2 | 4.1 | PID IL1 PATHWAY | IL1-mediated signaling events |
0.2 | 30.4 | NABA ECM AFFILIATED | Genes encoding proteins affiliated structurally or functionally to extracellular matrix proteins |
0.2 | 2.1 | PID P38 ALPHA BETA PATHWAY | Regulation of p38-alpha and p38-beta |
0.2 | 2.1 | PID MYC PATHWAY | C-MYC pathway |
0.2 | 0.5 | PID INSULIN PATHWAY | Insulin Pathway |
0.2 | 2.4 | PID HEDGEHOG 2PATHWAY | Signaling events mediated by the Hedgehog family |
0.1 | 2.5 | PID ARF 3PATHWAY | Arf1 pathway |
0.1 | 1.2 | PID ERBB2 ERBB3 PATHWAY | ErbB2/ErbB3 signaling events |
0.1 | 5.7 | PID P53 REGULATION PATHWAY | p53 pathway |
0.1 | 2.2 | PID ANGIOPOIETIN RECEPTOR PATHWAY | Angiopoietin receptor Tie2-mediated signaling |
0.1 | 0.8 | PID FRA PATHWAY | Validated transcriptional targets of AP1 family members Fra1 and Fra2 |
0.1 | 2.6 | PID CD40 PATHWAY | CD40/CD40L signaling |
0.1 | 2.4 | PID LIS1 PATHWAY | Lissencephaly gene (LIS1) in neuronal migration and development |
0.1 | 4.6 | PID ARF6 TRAFFICKING PATHWAY | Arf6 trafficking events |
0.1 | 1.8 | PID RET PATHWAY | Signaling events regulated by Ret tyrosine kinase |
0.1 | 5.7 | PID NFAT TFPATHWAY | Calcineurin-regulated NFAT-dependent transcription in lymphocytes |
0.1 | 1.8 | PID KIT PATHWAY | Signaling events mediated by Stem cell factor receptor (c-Kit) |
0.1 | 6.4 | PID HIF1 TFPATHWAY | HIF-1-alpha transcription factor network |
0.1 | 2.8 | PID FANCONI PATHWAY | Fanconi anemia pathway |
0.1 | 1.6 | PID ARF6 PATHWAY | Arf6 signaling events |
0.1 | 6.3 | NABA COLLAGENS | Genes encoding collagen proteins |
0.1 | 1.0 | ST PHOSPHOINOSITIDE 3 KINASE PATHWAY | PI3K Pathway |
0.1 | 3.7 | PID RHOA REG PATHWAY | Regulation of RhoA activity |
0.1 | 0.4 | PID IL3 PATHWAY | IL3-mediated signaling events |
0.1 | 5.7 | PID MYC ACTIV PATHWAY | Validated targets of C-MYC transcriptional activation |
0.1 | 7.3 | PID BETA CATENIN NUC PATHWAY | Regulation of nuclear beta catenin signaling and target gene transcription |
0.1 | 0.8 | PID INSULIN GLUCOSE PATHWAY | Insulin-mediated glucose transport |
0.1 | 6.2 | PID P53 DOWNSTREAM PATHWAY | Direct p53 effectors |
0.1 | 0.8 | PID GLYPICAN 1PATHWAY | Glypican 1 network |
0.1 | 0.5 | PID P38 MKK3 6PATHWAY | p38 MAPK signaling pathway |
0.1 | 1.5 | PID ERBB1 INTERNALIZATION PATHWAY | Internalization of ErbB1 |
0.1 | 1.8 | PID REG GR PATHWAY | Glucocorticoid receptor regulatory network |
0.1 | 0.5 | PID ERB GENOMIC PATHWAY | Validated nuclear estrogen receptor beta network |
0.1 | 2.5 | PID AR PATHWAY | Coregulation of Androgen receptor activity |
0.1 | 1.0 | ST WNT BETA CATENIN PATHWAY | Wnt/beta-catenin Pathway |
0.0 | 1.8 | PID ERA GENOMIC PATHWAY | Validated nuclear estrogen receptor alpha network |
0.0 | 0.4 | PID SMAD2 3PATHWAY | Regulation of cytoplasmic and nuclear SMAD2/3 signaling |
0.0 | 0.7 | PID CDC42 REG PATHWAY | Regulation of CDC42 activity |
0.0 | 1.5 | PID AJDISS 2PATHWAY | Posttranslational regulation of adherens junction stability and dissassembly |
0.0 | 0.3 | PID PI3KCI AKT PATHWAY | Class I PI3K signaling events mediated by Akt |
0.0 | 0.4 | PID NEPHRIN NEPH1 PATHWAY | Nephrin/Neph1 signaling in the kidney podocyte |
0.0 | 0.5 | PID EPHA FWDPATHWAY | EPHA forward signaling |
0.0 | 0.7 | PID RB 1PATHWAY | Regulation of retinoblastoma protein |
0.0 | 0.2 | SIG CHEMOTAXIS | Genes related to chemotaxis |
0.0 | 0.2 | PID IL2 PI3K PATHWAY | IL2 signaling events mediated by PI3K |
0.0 | 0.4 | ST TUMOR NECROSIS FACTOR PATHWAY | Tumor Necrosis Factor Pathway. |
0.0 | 0.7 | PID TRKR PATHWAY | Neurotrophic factor-mediated Trk receptor signaling |
0.0 | 0.2 | PID BETA CATENIN DEG PATHWAY | Degradation of beta catenin |
0.0 | 0.3 | PID UPA UPAR PATHWAY | Urokinase-type plasminogen activator (uPA) and uPAR-mediated signaling |
0.0 | 0.1 | PID SYNDECAN 1 PATHWAY | Syndecan-1-mediated signaling events |
0.0 | 0.3 | PID TNF PATHWAY | TNF receptor signaling pathway |
0.0 | 0.3 | ST FAS SIGNALING PATHWAY | Fas Signaling Pathway |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
3.4 | 20.3 | REACTOME TRANSFERRIN ENDOCYTOSIS AND RECYCLING | Genes involved in Transferrin endocytosis and recycling |
1.7 | 24.9 | REACTOME P130CAS LINKAGE TO MAPK SIGNALING FOR INTEGRINS | Genes involved in p130Cas linkage to MAPK signaling for integrins |
1.6 | 9.4 | REACTOME PHOSPHORYLATION OF CD3 AND TCR ZETA CHAINS | Genes involved in Phosphorylation of CD3 and TCR zeta chains |
1.5 | 22.9 | REACTOME COMMON PATHWAY | Genes involved in Common Pathway |
1.4 | 4.2 | REACTOME ADP SIGNALLING THROUGH P2RY1 | Genes involved in ADP signalling through P2Y purinoceptor 1 |
1.3 | 25.7 | REACTOME REGULATION OF INSULIN LIKE GROWTH FACTOR IGF ACTIVITY BY INSULIN LIKE GROWTH FACTOR BINDING PROTEINS IGFBPS | Genes involved in Regulation of Insulin-like Growth Factor (IGF) Activity by Insulin-like Growth Factor Binding Proteins (IGFBPs) |
1.3 | 8.8 | REACTOME PLATELET ADHESION TO EXPOSED COLLAGEN | Genes involved in Platelet Adhesion to exposed collagen |
1.2 | 15.2 | REACTOME THE NLRP3 INFLAMMASOME | Genes involved in The NLRP3 inflammasome |
1.0 | 8.6 | REACTOME ELEVATION OF CYTOSOLIC CA2 LEVELS | Genes involved in Elevation of cytosolic Ca2+ levels |
0.9 | 7.4 | REACTOME HORMONE LIGAND BINDING RECEPTORS | Genes involved in Hormone ligand-binding receptors |
0.9 | 4.5 | REACTOME GENERATION OF SECOND MESSENGER MOLECULES | Genes involved in Generation of second messenger molecules |
0.8 | 21.3 | REACTOME ANTIGEN ACTIVATES B CELL RECEPTOR LEADING TO GENERATION OF SECOND MESSENGERS | Genes involved in Antigen Activates B Cell Receptor Leading to Generation of Second Messengers |
0.8 | 8.9 | REACTOME REGULATION OF INSULIN SECRETION BY ACETYLCHOLINE | Genes involved in Regulation of Insulin Secretion by Acetylcholine |
0.8 | 26.0 | REACTOME BASIGIN INTERACTIONS | Genes involved in Basigin interactions |
0.8 | 44.2 | REACTOME GPVI MEDIATED ACTIVATION CASCADE | Genes involved in GPVI-mediated activation cascade |
0.7 | 20.8 | REACTOME PLATELET AGGREGATION PLUG FORMATION | Genes involved in Platelet Aggregation (Plug Formation) |
0.7 | 5.2 | REACTOME ADVANCED GLYCOSYLATION ENDPRODUCT RECEPTOR SIGNALING | Genes involved in Advanced glycosylation endproduct receptor signaling |
0.7 | 11.7 | REACTOME APOPTOSIS INDUCED DNA FRAGMENTATION | Genes involved in Apoptosis induced DNA fragmentation |
0.7 | 4.4 | REACTOME BETA DEFENSINS | Genes involved in Beta defensins |
0.7 | 35.2 | REACTOME G1 PHASE | Genes involved in G1 Phase |
0.7 | 27.7 | REACTOME LATENT INFECTION OF HOMO SAPIENS WITH MYCOBACTERIUM TUBERCULOSIS | Genes involved in Latent infection of Homo sapiens with Mycobacterium tuberculosis |
0.7 | 9.8 | REACTOME ADENYLATE CYCLASE ACTIVATING PATHWAY | Genes involved in Adenylate cyclase activating pathway |
0.6 | 6.9 | REACTOME RECEPTOR LIGAND BINDING INITIATES THE SECOND PROTEOLYTIC CLEAVAGE OF NOTCH RECEPTOR | Genes involved in Receptor-ligand binding initiates the second proteolytic cleavage of Notch receptor |
0.6 | 2.5 | REACTOME INHIBITION OF REPLICATION INITIATION OF DAMAGED DNA BY RB1 E2F1 | Genes involved in Inhibition of replication initiation of damaged DNA by RB1/E2F1 |
0.6 | 13.8 | REACTOME TERMINATION OF O GLYCAN BIOSYNTHESIS | Genes involved in Termination of O-glycan biosynthesis |
0.6 | 5.8 | REACTOME PLATELET CALCIUM HOMEOSTASIS | Genes involved in Platelet calcium homeostasis |
0.6 | 4.0 | REACTOME DOWNREGULATION OF ERBB2 ERBB3 SIGNALING | Genes involved in Downregulation of ERBB2:ERBB3 signaling |
0.6 | 15.6 | REACTOME ERK MAPK TARGETS | Genes involved in ERK/MAPK targets |
0.6 | 2.8 | REACTOME IL 7 SIGNALING | Genes involved in Interleukin-7 signaling |
0.5 | 8.6 | REACTOME UNWINDING OF DNA | Genes involved in Unwinding of DNA |
0.5 | 22.0 | REACTOME THROMBIN SIGNALLING THROUGH PROTEINASE ACTIVATED RECEPTORS PARS | Genes involved in Thrombin signalling through proteinase activated receptors (PARs) |
0.5 | 25.9 | REACTOME GLUCOSE TRANSPORT | Genes involved in Glucose transport |
0.5 | 8.6 | REACTOME PURINE SALVAGE | Genes involved in Purine salvage |
0.4 | 46.1 | REACTOME PEPTIDE CHAIN ELONGATION | Genes involved in Peptide chain elongation |
0.4 | 22.2 | REACTOME STRIATED MUSCLE CONTRACTION | Genes involved in Striated Muscle Contraction |
0.4 | 16.4 | REACTOME O LINKED GLYCOSYLATION OF MUCINS | Genes involved in O-linked glycosylation of mucins |
0.4 | 5.8 | REACTOME SIGNAL REGULATORY PROTEIN SIRP FAMILY INTERACTIONS | Genes involved in Signal regulatory protein (SIRP) family interactions |
0.4 | 14.0 | REACTOME SIGNALING BY ROBO RECEPTOR | Genes involved in Signaling by Robo receptor |
0.4 | 31.3 | REACTOME NRAGE SIGNALS DEATH THROUGH JNK | Genes involved in NRAGE signals death through JNK |
0.4 | 4.5 | REACTOME P38MAPK EVENTS | Genes involved in p38MAPK events |
0.4 | 5.9 | REACTOME POST CHAPERONIN TUBULIN FOLDING PATHWAY | Genes involved in Post-chaperonin tubulin folding pathway |
0.3 | 4.1 | REACTOME SLBP DEPENDENT PROCESSING OF REPLICATION DEPENDENT HISTONE PRE MRNAS | Genes involved in SLBP Dependent Processing of Replication-Dependent Histone Pre-mRNAs |
0.3 | 3.0 | REACTOME INTERACTIONS OF VPR WITH HOST CELLULAR PROTEINS | Genes involved in Interactions of Vpr with host cellular proteins |
0.3 | 1.9 | REACTOME IRAK2 MEDIATED ACTIVATION OF TAK1 COMPLEX UPON TLR7 8 OR 9 STIMULATION | Genes involved in IRAK2 mediated activation of TAK1 complex upon TLR7/8 or 9 stimulation |
0.3 | 3.8 | REACTOME THE ROLE OF NEF IN HIV1 REPLICATION AND DISEASE PATHOGENESIS | Genes involved in The role of Nef in HIV-1 replication and disease pathogenesis |
0.3 | 5.3 | REACTOME IRON UPTAKE AND TRANSPORT | Genes involved in Iron uptake and transport |
0.3 | 0.6 | REACTOME ABORTIVE ELONGATION OF HIV1 TRANSCRIPT IN THE ABSENCE OF TAT | Genes involved in Abortive elongation of HIV-1 transcript in the absence of Tat |
0.3 | 4.7 | REACTOME RIP MEDIATED NFKB ACTIVATION VIA DAI | Genes involved in RIP-mediated NFkB activation via DAI |
0.3 | 3.2 | REACTOME MTORC1 MEDIATED SIGNALLING | Genes involved in mTORC1-mediated signalling |
0.3 | 2.9 | REACTOME ELONGATION ARREST AND RECOVERY | Genes involved in Elongation arrest and recovery |
0.3 | 22.9 | REACTOME RESPONSE TO ELEVATED PLATELET CYTOSOLIC CA2 | Genes involved in Response to elevated platelet cytosolic Ca2+ |
0.3 | 5.1 | REACTOME HOMOLOGOUS RECOMBINATION REPAIR OF REPLICATION INDEPENDENT DOUBLE STRAND BREAKS | Genes involved in Homologous recombination repair of replication-independent double-strand breaks |
0.3 | 1.4 | REACTOME INHIBITION OF INSULIN SECRETION BY ADRENALINE NORADRENALINE | Genes involved in Inhibition of Insulin Secretion by Adrenaline/Noradrenaline |
0.3 | 4.1 | REACTOME FORMATION OF THE TERNARY COMPLEX AND SUBSEQUENTLY THE 43S COMPLEX | Genes involved in Formation of the ternary complex, and subsequently, the 43S complex |
0.3 | 7.1 | REACTOME NONSENSE MEDIATED DECAY ENHANCED BY THE EXON JUNCTION COMPLEX | Genes involved in Nonsense Mediated Decay Enhanced by the Exon Junction Complex |
0.3 | 5.2 | REACTOME NUCLEOTIDE LIKE PURINERGIC RECEPTORS | Genes involved in Nucleotide-like (purinergic) receptors |
0.3 | 10.4 | REACTOME CHEMOKINE RECEPTORS BIND CHEMOKINES | Genes involved in Chemokine receptors bind chemokines |
0.2 | 23.0 | REACTOME MITOTIC PROMETAPHASE | Genes involved in Mitotic Prometaphase |
0.2 | 3.5 | REACTOME PROCESSING OF CAPPED INTRONLESS PRE MRNA | Genes involved in Processing of Capped Intronless Pre-mRNA |
0.2 | 4.8 | REACTOME GLUCAGON TYPE LIGAND RECEPTORS | Genes involved in Glucagon-type ligand receptors |
0.2 | 4.6 | REACTOME CHONDROITIN SULFATE BIOSYNTHESIS | Genes involved in Chondroitin sulfate biosynthesis |
0.2 | 1.8 | REACTOME RECYCLING OF BILE ACIDS AND SALTS | Genes involved in Recycling of bile acids and salts |
0.2 | 4.1 | REACTOME FANCONI ANEMIA PATHWAY | Genes involved in Fanconi Anemia pathway |
0.2 | 1.5 | REACTOME INFLAMMASOMES | Genes involved in Inflammasomes |
0.2 | 8.9 | REACTOME MRNA SPLICING MINOR PATHWAY | Genes involved in mRNA Splicing - Minor Pathway |
0.2 | 26.2 | REACTOME G ALPHA I SIGNALLING EVENTS | Genes involved in G alpha (i) signalling events |
0.2 | 7.3 | REACTOME CGMP EFFECTS | Genes involved in cGMP effects |
0.2 | 0.8 | REACTOME SPRY REGULATION OF FGF SIGNALING | Genes involved in Spry regulation of FGF signaling |
0.2 | 2.4 | REACTOME ENDOGENOUS STEROLS | Genes involved in Endogenous sterols |
0.2 | 4.4 | REACTOME NOD1 2 SIGNALING PATHWAY | Genes involved in NOD1/2 Signaling Pathway |
0.2 | 2.5 | REACTOME SEMA3A PAK DEPENDENT AXON REPULSION | Genes involved in Sema3A PAK dependent Axon repulsion |
0.2 | 1.0 | REACTOME SHC1 EVENTS IN ERBB4 SIGNALING | Genes involved in SHC1 events in ERBB4 signaling |
0.2 | 1.1 | REACTOME SIGNAL ATTENUATION | Genes involved in Signal attenuation |
0.2 | 3.7 | REACTOME DARPP 32 EVENTS | Genes involved in DARPP-32 events |
0.2 | 1.7 | REACTOME EXTRINSIC PATHWAY FOR APOPTOSIS | Genes involved in Extrinsic Pathway for Apoptosis |
0.2 | 2.8 | REACTOME OXYGEN DEPENDENT PROLINE HYDROXYLATION OF HYPOXIA INDUCIBLE FACTOR ALPHA | Genes involved in Oxygen-dependent Proline Hydroxylation of Hypoxia-inducible Factor Alpha |
0.2 | 1.4 | REACTOME G ALPHA1213 SIGNALLING EVENTS | Genes involved in G alpha (12/13) signalling events |
0.2 | 0.5 | REACTOME REGULATION OF HYPOXIA INDUCIBLE FACTOR HIF BY OXYGEN | Genes involved in Regulation of Hypoxia-inducible Factor (HIF) by Oxygen |
0.2 | 5.2 | REACTOME SYNTHESIS OF PC | Genes involved in Synthesis of PC |
0.2 | 5.0 | REACTOME MYOGENESIS | Genes involved in Myogenesis |
0.2 | 1.6 | REACTOME TRANSPORT OF ORGANIC ANIONS | Genes involved in Transport of organic anions |
0.2 | 1.4 | REACTOME ABACAVIR TRANSPORT AND METABOLISM | Genes involved in Abacavir transport and metabolism |
0.1 | 9.9 | REACTOME SIGNALING BY SCF KIT | Genes involved in Signaling by SCF-KIT |
0.1 | 2.0 | REACTOME NOTCH HLH TRANSCRIPTION PATHWAY | Genes involved in Notch-HLH transcription pathway |
0.1 | 2.5 | REACTOME G0 AND EARLY G1 | Genes involved in G0 and Early G1 |
0.1 | 7.1 | REACTOME INTERFERON ALPHA BETA SIGNALING | Genes involved in Interferon alpha/beta signaling |
0.1 | 1.9 | REACTOME NEF MEDIATED DOWNREGULATION OF MHC CLASS I COMPLEX CELL SURFACE EXPRESSION | Genes involved in Nef mediated downregulation of MHC class I complex cell surface expression |
0.1 | 4.3 | REACTOME INTERFERON GAMMA SIGNALING | Genes involved in Interferon gamma signaling |
0.1 | 3.8 | REACTOME DOWNREGULATION OF SMAD2 3 SMAD4 TRANSCRIPTIONAL ACTIVITY | Genes involved in Downregulation of SMAD2/3:SMAD4 transcriptional activity |
0.1 | 2.9 | REACTOME OTHER SEMAPHORIN INTERACTIONS | Genes involved in Other semaphorin interactions |
0.1 | 2.1 | REACTOME MRNA 3 END PROCESSING | Genes involved in mRNA 3'-end processing |
0.1 | 1.0 | REACTOME MICRORNA MIRNA BIOGENESIS | Genes involved in MicroRNA (miRNA) Biogenesis |
0.1 | 0.3 | REACTOME ENDOSOMAL VACUOLAR PATHWAY | Genes involved in Endosomal/Vacuolar pathway |
0.1 | 2.1 | REACTOME METABOLISM OF POLYAMINES | Genes involved in Metabolism of polyamines |
0.1 | 4.3 | REACTOME CELL SURFACE INTERACTIONS AT THE VASCULAR WALL | Genes involved in Cell surface interactions at the vascular wall |
0.1 | 2.9 | REACTOME N GLYCAN ANTENNAE ELONGATION IN THE MEDIAL TRANS GOLGI | Genes involved in N-glycan antennae elongation in the medial/trans-Golgi |
0.1 | 1.6 | REACTOME PURINE RIBONUCLEOSIDE MONOPHOSPHATE BIOSYNTHESIS | Genes involved in Purine ribonucleoside monophosphate biosynthesis |
0.1 | 1.7 | REACTOME MEIOTIC RECOMBINATION | Genes involved in Meiotic Recombination |
0.1 | 2.0 | REACTOME HDL MEDIATED LIPID TRANSPORT | Genes involved in HDL-mediated lipid transport |
0.1 | 1.2 | REACTOME BASE FREE SUGAR PHOSPHATE REMOVAL VIA THE SINGLE NUCLEOTIDE REPLACEMENT PATHWAY | Genes involved in Base-free sugar-phosphate removal via the single-nucleotide replacement pathway |
0.1 | 1.5 | REACTOME RNA POL I TRANSCRIPTION TERMINATION | Genes involved in RNA Polymerase I Transcription Termination |
0.1 | 11.6 | REACTOME FACTORS INVOLVED IN MEGAKARYOCYTE DEVELOPMENT AND PLATELET PRODUCTION | Genes involved in Factors involved in megakaryocyte development and platelet production |
0.1 | 6.0 | REACTOME LOSS OF NLP FROM MITOTIC CENTROSOMES | Genes involved in Loss of Nlp from mitotic centrosomes |
0.1 | 3.2 | REACTOME SYNTHESIS OF PIPS AT THE PLASMA MEMBRANE | Genes involved in Synthesis of PIPs at the plasma membrane |
0.1 | 4.3 | REACTOME NCAM1 INTERACTIONS | Genes involved in NCAM1 interactions |
0.1 | 5.7 | REACTOME PEPTIDE LIGAND BINDING RECEPTORS | Genes involved in Peptide ligand-binding receptors |
0.1 | 3.5 | REACTOME YAP1 AND WWTR1 TAZ STIMULATED GENE EXPRESSION | Genes involved in YAP1- and WWTR1 (TAZ)-stimulated gene expression |
0.1 | 1.0 | REACTOME FORMATION OF TUBULIN FOLDING INTERMEDIATES BY CCT TRIC | Genes involved in Formation of tubulin folding intermediates by CCT/TriC |
0.1 | 1.5 | REACTOME NEPHRIN INTERACTIONS | Genes involved in Nephrin interactions |
0.1 | 2.4 | REACTOME CYTOSOLIC TRNA AMINOACYLATION | Genes involved in Cytosolic tRNA aminoacylation |
0.1 | 4.6 | REACTOME MRNA SPLICING | Genes involved in mRNA Splicing |
0.1 | 0.9 | REACTOME BILE SALT AND ORGANIC ANION SLC TRANSPORTERS | Genes involved in Bile salt and organic anion SLC transporters |
0.1 | 7.9 | REACTOME SIGNALING BY RHO GTPASES | Genes involved in Signaling by Rho GTPases |
0.1 | 1.9 | REACTOME RNA POL II PRE TRANSCRIPTION EVENTS | Genes involved in RNA Polymerase II Pre-transcription Events |
0.1 | 1.3 | REACTOME INSULIN SYNTHESIS AND PROCESSING | Genes involved in Insulin Synthesis and Processing |
0.1 | 5.2 | REACTOME POTASSIUM CHANNELS | Genes involved in Potassium Channels |
0.0 | 0.6 | REACTOME PRE NOTCH PROCESSING IN GOLGI | Genes involved in Pre-NOTCH Processing in Golgi |
0.0 | 2.0 | REACTOME MITOCHONDRIAL PROTEIN IMPORT | Genes involved in Mitochondrial Protein Import |
0.0 | 1.3 | REACTOME DEPOSITION OF NEW CENPA CONTAINING NUCLEOSOMES AT THE CENTROMERE | Genes involved in Deposition of New CENPA-containing Nucleosomes at the Centromere |
0.0 | 1.1 | REACTOME IMMUNOREGULATORY INTERACTIONS BETWEEN A LYMPHOID AND A NON LYMPHOID CELL | Genes involved in Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell |
0.0 | 0.4 | REACTOME METABOLISM OF NON CODING RNA | Genes involved in Metabolism of non-coding RNA |
0.0 | 1.0 | REACTOME NOTCH1 INTRACELLULAR DOMAIN REGULATES TRANSCRIPTION | Genes involved in NOTCH1 Intracellular Domain Regulates Transcription |
0.0 | 1.3 | REACTOME HOST INTERACTIONS OF HIV FACTORS | Genes involved in Host Interactions of HIV factors |
0.0 | 0.7 | REACTOME PYRIMIDINE METABOLISM | Genes involved in Pyrimidine metabolism |
0.0 | 0.1 | REACTOME GLYCOPROTEIN HORMONES | Genes involved in Glycoprotein hormones |
0.0 | 1.4 | REACTOME TRIGLYCERIDE BIOSYNTHESIS | Genes involved in Triglyceride Biosynthesis |
0.0 | 0.7 | REACTOME INTERACTION BETWEEN L1 AND ANKYRINS | Genes involved in Interaction between L1 and Ankyrins |
0.0 | 0.1 | REACTOME CD28 DEPENDENT PI3K AKT SIGNALING | Genes involved in CD28 dependent PI3K/Akt signaling |
0.0 | 0.5 | REACTOME TIGHT JUNCTION INTERACTIONS | Genes involved in Tight junction interactions |
0.0 | 0.2 | REACTOME ACTIVATION OF ATR IN RESPONSE TO REPLICATION STRESS | Genes involved in Activation of ATR in response to replication stress |
0.0 | 0.2 | REACTOME ACTIVATION OF GENES BY ATF4 | Genes involved in Activation of Genes by ATF4 |